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Abstract 
Standardisation of healthcare has been the focus of hospital management and clinicians since the 
1990’s. Electronic health records were already intended to provide clinicians with real-time access to 
clinical knowledge and care plans while also recording and storing vast amounts of patient data. It took 
more than three decades for electronic health records to start to become ubiquitous in all aspects of 
healthcare. Learning health systems are the next stage in health information systems whose potential 
benefits have been promoted for more than a decade - yet few are seen in clinical practice. Clinical care 
process specifications are a primary form of clinical documentation used in all aspects of healthcare, 
but they lack standardisation. This thesis contends that this lack of standardisation was inherited by 
electronic health records and that this is a significant issue holding back the development and adoption 
of learning health systems. Standardisation of clinical documents is used to mitigate issues in electronic 
health records as a basis for enabling learning health systems. One type of clinical document, the 
caremap, is standardised in order to achieve an effective approach to containing resources and ensuring 
consistency and quality. This led not only to improved clinicians’ comprehension and acceptance of the 
clinical document, but also to reduced time expended in developing complicated learning health systems 
built using the input of clinical experts. 
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Chapter 1: Introduction 
In 2016, the per person spend in US dollars on healthcare for the United States 
of America (USA) was $9,892, Germany $4,876, Australia $4,708, France $4,600, 
United Kingdom (UK) $4,192, and New Zealand (NZ) $3,590 [1]. Including 
government, prepaid private and out-of-pocket expenses, the annual global cost of 
healthcare was calculated as falling between US$7.7 and US$7.83 trillion for 2014 [2, 
3], being the last year in which this total amount could be located1. This amount is 
forecast to rise to US$8.7 trillion by 2020 [4], and more than double to over US$18 
trillion annually by 2033 [2]. In the UK, around 70% of the National Health Service 
(NHS) budget is currently spent on treating slightly more than 30%2 of the population 
who have been diagnosed with a chronic condition [5, 6]. Hospital overspend has left 
the NHS with debts over £12bn [7], and NHS trusts like that which operates Barts and 
The London hospital struggle under the weight of Private Finance Initiative (PFI) 
contracts that will see it repay more than £7bn on a 43-year loan of only £1.1bn [8].  
Electronic health records (EHR) were intended to standardise health information 
and the documentation of interactions between clinicians and patients, enable 
execution of standardised models of clinical and guideline knowledge, and allow use 
of coding systems like SNOMED that were designed to standardise terminology [9, 
10]. They were also seen as a vehicle to standardise business information, 
communication between healthcare providers, and the recording process and format of 
patient data [11, 10, 12]. Some hospitals believed they would realise substantial returns 
on investment from implementing EHR; in some cases, in the range of tens of millions 
of dollars [13]. EHR were envisioned to be a singular, or at least significant, solution 
for increasing healthcare quality and safety, reducing costs and increasing efficiency 
[14, 15]. However, a large number of barriers have meant that EHR are yet to deliver 
on many of these promises and goals.  
 
 
1 More recent figures published by the WHO and the OECD for 2016 provide global health as: (i) cost 
per capita; and (ii) percentage of GDP, but have not as yet provided the global total expenditure amount. 
2 In 2014 chronic disease affected 23% of the English population, and 46% of the Scottish population 
(source: [5, 6]).  
In the early 1990’s the focus of hospital management and clinical literature 
shifted from their prior reliance on project management and total quality management 
tools more common to industry, to promoting standardisation as being of paramount 
importance to the future of quality and efficiency in healthcare [16-19]. More recently 
researchers and clinicians have expanded this focus even further, joining together to 
describe the multitude of inefficiencies and voice the need for current healthcare 
services to transition to a system that continuously learns and improves: termed the 
Learning Health System (LHS) [20-22]. LHS are a recent concept, with the majority 
of works in the domain having been published only since 2011 [23]. Although they are 
not well understood, they embody the relationship between care practice, research and 
knowledge translation and are recognised to be one of the major potential computing 
technological advances in healthcare [24-26].  
This introductory chapter describes the background for standardisation and 
learning health systems (section 1.1) and outlines the thesis research problem, 
hypothesis and objectives (section 1.2). Section 1.3 describes the thesis significance 
while section 1.5 summarises its novelty. Finally, section 1.6 provides an outline of 
the remaining chapters of the thesis. 
 
1.1 BACKGROUND 
1.1.1 Standardisation 
Researchers, politicians and hospital managers have sought to achieve 
standardisation of such things as clinical decisions, diagnostic and therapeutic models, 
evidence-based guidelines, approaches to patient care, practice standards and even the 
clinical information recorded in health records [27-30, 18, 31, 32]. Standardisation in 
the name of quality care and outcomes has become the single-minded national focus 
of healthcare service delivery for entire countries [33, 29, 32]. This type of 
standardisation has been passionately promoted such that multiple teams within the 
same country, or even the same organisation, can be seen developing standardisation 
frameworks with some degree of similarity and overlap [34-36]. However, a review of 
the literature and current working practices in hospitals shows that the drive towards 
standardisation has had little effect on the definition, development and structure of 
clinical documentation. As shown in Appendix D, authors cannot seem to agree as to 
whether some types of clinical care process specifications (CCPS) represent distinct 
clinical documents with different content and purpose or are simply different names 
for the same clinical document. As we approached the end of the first full decade of 
standardisation, calls for standardised clinical documents continued to increase [29, 
37-42], and an unmet need was also identified in calls to resolve poorly standardised 
taxonomy and nomenclatures being used in developing and cataloguing some clinical 
documentation [43].  
The UK’s NHS has promoted efficiency as their model for continued viability 
over the next five years [44]. However, health service providers everywhere are 
finding this goal difficult to achieve because, as this thesis contends, it, and successful 
implementation and integration of LHS in clinical practice, are restrained by a lack of 
standardisation. Even though standardisation of healthcare practice, procedure and 
tools is seen to improve healthcare in terms of quality, outcomes and accountability, a 
lack of development and significant resistance persists such that standardisation has 
remained a key issue [45, 39, 46]. NHS hospitals, like health service providers of many 
countries, struggle to find financial resources sufficient to employ adequate staff to 
meet patient demand [47, 48]. This makes the potential benefits from standardisation 
and the targeted treatment identification of LHS especially important in the struggle to 
contain budgets. Standardisation of care processes can significantly aid providers in 
their efforts to optimise quality and efficiency [49, 50] yet in many cases, and 
especially in the management of chronic diseases like diabetes, standardisation is 
lacking and as a result, care remains costly and suboptimal [51-53]. 
Traditionally, standards and innovation have been seen in juxtaposition: 
standardisation obstructs innovation while innovation disrupts the orderly nature of 
standards [54-56]. While it is widely accepted that standards are important, they are 
not well understood [57]. There is however, a growing understanding which this thesis 
will explore in chapter 2, that engaging with standards can support the goals and 
activities of innovation [54, 58, 56, 57]. 
1.1.2 Learning Health Systems 
In July 2006 the Institute of Medicine (IoM)3 convened the Roundtable on 
Evidence-Based Medicine committee with the intention to help transform the way 
evidence on clinical effectiveness is generated and used to improve health and health 
care [59]. Their overarching goal was that by 2020 more than 90 percent of clinical 
decisions will be supported with near real-time clinical data [59]. It was this committee 
that introduced the concept of LHS, which they promoted as necessary to meeting 
ever-growing demands for evidence to improve healthcare delivery, health outcomes 
and ensure the ongoing economic viability of healthcare services [59]. Committee 
members either alone or in small groups developed papers that were presented as 
chapter sections in the IoM Learning Healthcare System: Workshop Summary 
proceedings [59], each describing how a variety of elements that existed in healthcare 
environments of the day were necessary or could be used to help create LHS, 
including: large system databases; current evidence creation and gathering approaches 
like randomised control trials (RCTs) and medical device evaluation trials; 
mathematical modelling; pharmacogenetics; quality improvement processes from 
industry; the internet; clinical education processes; and most importantly, the 
Electronic Health Record (EHR).  
The IoM defined the Learning Health System (LHS) as one in which progress in 
science, informatics and care culture converges to continuously create new knowledge 
as a natural by-product of a care process in which best practice is applied for 
continuous improvement [60].  
In 2011 the IoM renamed the committee as the Roundtable on Value and 
Science-Driven Health Care and convened their second workshop, titled the Digital 
Infrastructure for the Learning Health System: The Foundation for Continuous 
Improvement in Health and Health Care [60]. With the same charter and vision 
statement and comprised of many of the same members, the proceedings of this second 
workshop focused more specifically on the role of digital health data systems and their 
ability to be the information backbone for LHS [60]. While they acknowledge their 
 
 
3 The IoM was established in 1970 under the USA’s National Academy of Sciences charter to 
specifically study and address policy matters of medicine, healthcare conduct, and the health of the 
public. Annually, the IoM convene as many as 50 workshops where members with a range of 
multidisciplinary expertise are brought together for what are described as roundtable focused on a 
particular domain or issue of contemporary interest. 
task as building on previous efforts, their introductions carefully skirted a significant 
issue: that very little progress had been made in the years since their original 2006 
workshop [60].  
LHS remain largely an academic proposition; the best-known systems that could 
be classified as LHS solutions like IBM’s Watson Health and Google’s DeepMind 
Health, either fail to recognise they represent an LHS solution or avoid entirely 
identifying themselves within the wider LHS domain. Further, while a literature search 
for LHS finds many recent publications, the literature returned is not sufficiently 
representative to describe the entire domain and remains sparse when it comes to 
resolving why the precision-medicine approach of LHS [61, 62], a concept considered 
to be the next evolution of evidence-based medicine [63], remains an elusive goal. As 
publicly-funded health systems like those of the United Kingdom, Australia and New 
Zealand struggle to meet ever-increasing demand with shrinking budgets, we may 
come to appreciate the IoM’s efforts to establish LHS as the natural evolution of 
evidence-based medicine: one capable of improving public health while reducing 
healthcare costs. 
 
1.2 RESEARCH PROBLEM, HYPOTHESIS AND OBJECTIVES 
1.2.1 Research problem 
In spite of agreement on the importance of standardisation there has been little 
progress on standardisation of clinical care process specification documents. 
Standardisation of the building blocks, the underlying documentation and the data they 
collect, is an important and necessary step [64]. We want to know what effect this lack 
of standardisation has had on health information systems like EHR and LHS, and 
whether solutions to standardise clinical documents can mitigate the barriers that have 
prevented their adoption and use in clinical settings.  
 
1.2.2 Thesis research hypothesis 
The research hypothesis is that by understanding the ongoing barriers that have 
inhibited health IT implementation, it is possible to develop models to achieve the 
standardisation necessary for development and implementation of LHS with a new 
approach to standardising CCPS.  
1.2.3 Objectives 
The research objectives are:  
1. Investigate and identify the lack of standardisation in CCPS; 
2. Investigate the issues currently constraining implementation and clinical 
adoption of LHS, including: 
a. Explore and apply an approach for analysing barriers and benefits 
of health information technology (HIT) implementation; 
b. Identify approaches that have mitigated other HIT adoption 
barriers, and whether these may improve the success of LHS 
implementations. 
3. Explore: (a) the relationship between CCPS, EHR and LHS; (b) the role of 
standardisation in that relationship; (c) their application in clinical 
practice; and, (d) a unifying model that integrates and focuses each on their 
application to clinical practice and treatment of the individual patient; 
4. Investigate and evaluate an approach to standardising CCPS. 
 
1.3 SIGNIFICANCE 
Presently, 53% of all publications self-identifying in the LHS domain propose a 
potential solution that is yet to be built and tested [23]. Of the remaining, those that 
have been constructed in some form were most often built only to test the theory, 
almost none are in clinical use, and many could be categorised as primarily for 
identifying patient cohorts for use in other research. Of those systems in use which 
could be classified as LHS, such as the much-hyped IBM Watson Health, we first 
heard the unbelievable promises [65, 66] and then watched as tens of millions of 
dollars and half a decade delivered a system with narrow applicability that made unsafe 
treatment recommendations [67] and failed in its mission to cure cancer [68]. Such 
public failings should not be considered a failure of LHS generally. Rather, it 
represents a lesson we had to learn and which we should embrace on the path towards 
efficiency, quality and precision medicine. Identification of the issues that currently 
make LHS expensive and difficult to adopt is an important first step to resolving these 
problems and setting about the implementation of solutions that make cost effective, 
accessible and accurate precision medicine available to all healthcare service 
consumers.   
 
1.4 RELATIONSHIP BETWEEN OUTPUTS AND THESIS OBJECTIVES 
AND OVERALL NARRATIVE 
This section relates the research objectives described in Section 1.2.3 with the 
novel contributions listed in Section 1.5.3 and overall narrative of this thesis. 
Contributions 1 and 2 focus on resolving requirements for Objective 1. 
Contribution 1, presented in Chapter 5, provides a stable base from which to define 
and describe CCPS and in doing so, identifies that the lack of standardisation extends 
beyond structure and content to even include the names used for particular clinical 
documents. Contribution 2, also in Chapter 5, exemplifies the proposed taxonomy in 
a case study describing CCPS for the care of those with Diabetes Mellitus in the United 
Kingdom.  
Contributions 3 and 4 apply directly to Objective 4 in that they develop, apply 
and evaluate an approach termed TaSC to standardisation of one type of CCPS, the 
caremap. Contribution 3, which describes the standardised approach to the 
development, structure and presentation of caremaps is presented in Chapter 8. 
Contribution 4 is the subject of Chapter 9, and presents both quantitative resource 
assessment and qualitative survey evaluation of the standardised caremap.  
Contributions 5 and 6 occur within the scope of Objective 2 and are presented 
collectively as components of the Heimdall Framework in Chapter 6. Contributions 5 
and 6 describe and validate a complete taxonomy of LHS solutions, while Contribution 
7 presents the results of literature reviews of EHR and LHS literature into their barriers, 
benefits and facilitators. 
Contributions 8 and 9 apply to Objective 3. Contribution 8 comparatively 
analyses the barriers, benefits and facilitators for EHR and LHS using a new extension 
to ITPOSMO that is described in Section 3.3.2 and applied in Section 6.4 under the 
title ITPOSMO-BBF. Contribution 9 resolved the LAGOS framework which is 
presented in Chapter 7.  
 
1.5 NOVELTY 
The thesis makes several novel research contributions in the areas of 
standardising clinical documentation and in identifying and mitigating the research 
community awareness challenge that has restrained LHS. We summarise these 
contributions here and link them to the seven publications (listed on page ix) that are 
direct outputs of the thesis. 
1.5.1 Standardising Clinical Documentation 
There is extensive literature on approaches and benefits that can be realised from 
standardisation of healthcare processes and procedures. However, while there has been 
an attempt to standardise the definition and identify the structure of a single clinical 
care process specification (CCPS), the clinical pathway, confusion continues with 
respect to the broad range of CCPS that are currently in use. This thesis reviews the 
literature and provides a new taxonomy defining and describing all relevant CCPS and 
demonstrates application of that taxonomy in the context of a case study in 
documentation for Type 2 Diabetes. This research is the focus of Publication 1 listed 
on page ix. 
Further, this thesis presents a thorough examination of the history, development 
and current state for another type of CCPS, the caremap, and presents one solution for 
standardising caremap structure, content and development that is distilled directly 
from analysis of a large pool of literature and clinical expertise. This research is the 
focus of Publication 2. 
While validating caremaps with clinicians, the presence of latent clinical 
decisions within activity nodes at points where a caremap path diverges, and which 
guide selection of the appropriate path for a given patient, were discovered. Indication 
of clinical decisions necessary to identification of the patient’s progression through the 
caremap gave caremaps greater utility, increased their accuracy and made them more 
approachable for clinicians. This research is the focus of Publication 7.  
1.5.2 The LHS Research Community Awareness Challenge 
Review of proceedings from two health informatics conferences highlighted that 
most authors at both failed to appropriately identify the proposed solutions of their 
papers as LHS. Discussions with some of the authors at one of those conferences 
highlighted that many were unaware of LHS, and for those that were, they were 
unaware of an identifiable comprehensive taxonomy that could be used to rule 
solutions as LHS, or indeed as a particular type of LHS. This issue is described in this 
thesis as the research community awareness challenge and was the focus of 
Publication 3.  
While a review of the literature identified three papers that had attempted to 
produce descriptions for the different LHS types, there were distinct differences 
between all three such that none provided a complete picture of the domain. This thesis 
presents a taxonomy describing nine novel types of LHS and validates that taxonomy 
against a collection of 240 published solutions that self-identified as LHS. This 
research is the focus of Publication 4. 
It was clear from the literature that in contrast to EHR, LHS as a research domain 
was still in its infancy. While extensive research had looked at the benefits, barriers 
and facilitating factors for successful implementation of EHR, only anecdotal 
observations existed in the literature for LHS. This research collected and analysed 
those observations and contrasted them with those described in systematic reviews of 
the EHR literature, finding that LHS are inheriting many of the same challenges from 
EHR, and that the majority of facilitating action is directed towards promoting or 
resolving human factors issues, and very little facilitating effort is directed towards 
resolving barriers that lead to improved efficiency, patient safety or health outcomes. 
This research was the focus of Publication 5. 
Discussions with clinicians during the conduct of this research identified that 
there was a lack of understanding regarding where the different LHS and CCPS 
applied in clinical care, and how they were related to the levels of medical application: 
population medicine, evidence-based medicine and precision medicine. This thesis 
presents a framework which integrates and describes LHS and CCPS in the context of 
their relationship to the levels of medical application. This research was the focus of 
Publication 6. 
1.5.3 Summary of New Contributions 
Nine contributions are presented in this thesis: 
1. A taxonomy for CCPS; 
2. A case study demonstrating application and validation of the CCPS 
taxonomy; 
3. An approach to standardising one type of CCPS, the caremap; 
4. Case studies demonstrating application, and a convenience survey of 
clinicians to assess the usability and accuracy of the standardised caremap 
model; 
5. A taxonomy for LHS; 
6. Validation of the LHS taxonomy against all research self-identifying as LHS; 
7. A systematic review to identify the Benefits, Barriers and Facilitating factors 
(BBF) for EHR and LHS; 
8. Comparative analysis of the BBF for EHR and LHS;  
9. A framework to guide integration of new healthcare tools. 
 
1.6 THESIS OUTLINE 
Figure 1 illustrates the structure and organisation of this thesis. This thesis 
consists of five major parts. Part 1 consists of chapters 1 and 2. It describes the 
problem under investigation and sets the context by illuminating the background and 
history of standardisation in healthcare. Part 2 presents the overall methodology and 
approach for the conduct of this research. A number of analysis methods are also 
described in detail. Part 3 begins with chapter 4 which presents literature reviews into 
CCPS, EHR and LHS that are used in chapter 5 to demonstrate the lack of 
standardisation in clinical documentation. The results of these literature reviews are 
used to support development and presentation of a taxonomy and characterisation for 
clinical documentation. Part 4 consists of chapters 6 to 9 which present the 
frameworks, standardisation approach, evaluation and results of this thesis. It begins 
in chapter 6 by presenting a taxonomy, characterisation and unifying framework for 
LHS, followed by identification and analysis of the barriers, benefits and facilitating 
factors for EHR and LHS implementations. Chapter 7 presents a framework to guide 
integration of new healthcare tools. Lastly, chapter’s 8 and 9 present and evaluate a 
new standardisation approach for one type of clinical document, the caremap. Part 5 
consists only of chapter 10, and presents a review of the thesis, its contributions, and 
a conclusion. 
 
 
Figure 1: Thesis Structure 
 
  
Chapter 2: Background and Motivation 
 
 
This chapter begins with discussion of the background and motivation for this 
research (section 0), followed by discussion of the interplay between standardisation 
and innovation (section 2.2).  
 
2.1 THE DRIVE TOWARDS STANDARDISATION 
Florence Nightingale transformed healthcare through the introduction of formal 
and descriptive documentation that would become a vital component of effective care 
delivery [69]. Clinical documentation, also known as clinical care process 
specifications (CCPS), were introduced to healthcare to streamline, record and 
improve healthcare delivery. CCPS developed from the notation and reporting 
methods of Nightingale’s early nursing practice as a structured method to record the 
treatments performed and observations concerning the response of the patient to that 
treatment.  Since then CCPS have continued to develop extensively, sometimes in 
ways that have had no direct relationship to patient care [69, 70]. It is suggested that 
clinical documentation represents only one essential component of the patient record 
[71]. That the practice of documenting care: (i) influences information collection and 
reasoning strategies; (ii) increases diagnostic accuracy; and (iii) can prompt clinicians. 
In doing these things it may also mitigate deficiencies in clinical practice [72, 73].  
Unfortunately, CCPS have been hampered by a lack of standardisation in 
nomenclature, document structure, content, and in some cases, development. Clinical 
documentation gives form and structure to the processes that underpin population and 
evidence-based medicine (EBM). Electronic health records (EHR) are a health 
information system (HIS) created to replace paper and give digital form to clinical 
documentation [74-77]. Learning health systems (LHS) are a more recent evolution of 
HIS capable of identifying new knowledge for application in precision medicine from 
data-mining large collections of EHR [61, 62, 78].  
Some CCPS present as templates to guide evidence-based care, while others 
provide templates onto which individual patient needs, metrics or treatments can be 
charted. CCPS serve many purposes, the most important of which is to ensure 
continuity and quality of patient care [79, 69]. EHR are CCPS and the patient care data 
normally captured on them in digital form [80, 81]. They capture into an electronic 
record the patient histories, allergies, acute health problems, test results, observations, 
measurements, treatments, prescription records and other information traditionally 
recorded in separate CCPS in the patient file [82, 83, 81]. Learning Health Systems 
(LHS) require EHR. They operate on the acquisition and use of knowledge data mined 
from collections of aggregated, filtered and analysed EHR [84]. LHS can be as simple 
as a rule-based monitor to identify and notify health regulators when a patient is 
diagnosed with a communicable disease or suffers an adverse event (surveillance) [85-
87], or as complicated as a precision medicine system that identifies prospective 
cohorts of like patients from which to predict in near real-time treatment decisions that 
have a higher probability of being curative for the individual patient (cohort 
identification) [86, 87]. LHS could have as great an effect on patient care as 
Nightingale’s advances in sanitation and note-taking during the Crimean War. 
However, as we come to the end of their first decade, LHS are yet to begin realising 
their true potential.  
Standardised approaches to documentation, paper or digital, can ensure that each 
time a clinician approaches a particular CCPS, the content and format meet 
expectation, can be read more quickly, and are better retained; all of which improves 
patient safety and outcomes [88, 89]. Standardisation is a key mitigant for clinical 
challenges and enables clinicians to concentrate efforts on accurately identifying 
disease or developing appropriate treatments [90, 91]. Standardisation of clinical 
documentation improves the availability of information for subsequent care providers, 
reduces documentation errors, and improves patient safety and outcomes; yet efforts 
towards standardising clinical documentation are often resisted [92, 45, 93]. The call 
to standardise in healthcare is one which is repeated often in the literature; calling for 
standardisation of clinical terminology [91, 94], treatment approaches [95, 96], 
consistency in clinical documentation [97], or provision of uniform methods for the 
conduct of clinical investigations (tests) [98, 99] and units of value for reporting of 
measurands4 [100, 101]. It is difficult to comprehend how many of these CCPS can be 
intended to standardise different aspects of the conduct, management or reporting of 
clinical care, when the nomenclature, content and method of construction for CCPS 
are themselves not standardised. This research is motivated both by a wish to see what 
LHS can become, and a belief, that whilst initially anecdotally based on more than a 
decade of experience in health informatics has been observed by others [102], that the 
failure to adopt LHS has possibly resulted from their inheritance of the unresolved 
familiar challenges of EHR and CCPS.  
 
2.2 STANDARDISATION VERSUS INNOVATION 
Standardisation and the use of established standards are ubiquitous in our daily 
lives [58]. Examples include the USA’s CAFÉ and similar international fuel economy 
standards used to govern efficiency and emissions of new motor vehicles offered for 
sale [103]; standards instituted for terminology and language, especially for mission-
critical applications like satellite and aeronautical navigation systems [104] and air 
traffic control [105]; and standards used to ensure safe development, testing, 
production, prescription and administration of medicines [106-108]. Standardisation 
has been described as the activity of establishing and recording a limited set of 
solutions to actual or potential matching problems directed at benefits for the party or 
parties involved in balancing their needs and intending and expecting that these 
solutions will be repeatedly or continuously used during a certain period by a 
substantial number of the parties for whom they are meant [109]. Standards generally 
consist of rules, guidelines, templates or characteristics for activities, or their results, 
that are provided for common and repeated use [110].   
Innovation involves the development and implementation of a new or 
significantly improved product, service or process, and includes all scientific, 
technological, organisational, financial and commercial steps which are, or are 
intended, to lead to its implementation [54, 111]. Innovation in technology and strategy 
 
 
4 One simple example is that of HbA1c, which is used to monitor glycaemic control in diabetic patients. 
While there have been calls from as early as 2007 [98] for the reporting unit of measurement to be 
standardised. HbA1c is reported by some laboratories as: millimoles per litre (mmol); a percentage (%); 
or an estimation of average glucose (eAG).  
is both a catalyst for modern economic growth [112, 54], and standardisation [113, 
114]; yet standardisation, especially that which is unofficial or voluntary, is believed 
to be something that innately inhibits innovation [54, 115]. It is this last belief which 
has benefited from contemporary reconsideration: growing insight into the role 
standardisation plays in enabling innovation [54, 58, 55-57].     
A variety of approaches have demonstrated the beneficial role standards can 
have in supporting innovation. Interoperability standards describe how different 
components in an ecosystem work together - for example, the hardware and software 
in ICT systems [57]. Anticipatory standards describe the operation and interoperation 
of components of future systems not yet in operation [116]. Formal standards are high-
quality but have a considerable development lead time as they are carefully deliberated 
by standards-writing organisations, such as the International Standards Organisation 
(ISO) and International Engineering Task Force (IETF) [117]. De facto standards 
autonomously stem from processes and interactions within the ecosystem, such as the 
dominance of Microsoft’s operating system in personal computing or resilience of the 
QWERTY keyboard layout which while being originally designed to mitigate adjacent 
keys jamming on early mechanical typewriters, is still seen on devices like 
touchscreens which have no moving parts [117, 57]. Standards can also be described 
in terms of their particularisation or extent to which they are standardised: whether 
the organisation, service or approach is, for example, wholly or only largely 
standardised [118].  
Motor vehicle production and use is constrained by a great many standards: 
directing safety, materials application, pollution, operation and maintenance. The same 
standards governing fuel efficiency and emissions discussed earlier, and which have 
removed many vehicles with inefficient large-bore engines from sale, actually 
stimulated innovation. This innovation includes the recently released homogenous 
charge gasoline compression engines using a system described as Spark Controlled 
Compression Ignition (SCCI). SCCI is claimed to reduce fuel consumption by as much 
as 20% [119, 120]. The standards also produced competition in innovation with 
another major vehicle manufacturer also releasing new technology this year, the 
Variable Compression Turbocharged (VC-T) engine [121]. There were also 
innovations that delivered the fully electric vehicle (fEV) by Tesla - a product that sits 
in a market space that must continue to innovate in order to meet anticipated standards 
requiring all passenger/commuter vehicles to become electric [122, 123]. While the 
standards discussed operate to ensure that motor vehicles marketed today cause less 
pollution, they do not, for example, inhibit a manufacturer’s choice of colour, luxury 
options or the model name that might adorn your next vehicle. And as we have seen, 
far from inhibiting innovation, standards can beneficially support novel innovations. 
While standardisation does not have to inhibit innovation (and can in principle 
lead to greater innovation), in much of the medical profession standardisation is seen 
as an inhibitor to professional expertise and innovation. In part, this is due to clinician 
resistance: with approaches at care standardisation derided as cookbook or cookie-
cutter medicine that some say can only be effective after they have set aside the unique 
needs of individual patients [124-127]. In spite of current issues with clinical overuse 
and the financial crisis pervading healthcare service delivery, standardisation of key 
documentation could help healthcare service providers deliver managed care which is 
seen to reduce incidence of inappropriate care, resource consumption and overall cost 
[128, 129]. Yet healthcare remains one of the slowest industries to adopt process 
standardisation or to demonstrate that it has positive effects on patient safety and 
outcomes [130, 131, 127]. 
The British Medical Association and Royal College of Nursing developed a joint 
guidance stating that use of standardised forms is beneficial in reducing variation in 
healthcare practice [132]. The use of different versions of the same clinical care 
specification in different units within the same care facility, and between different care 
facilities, may not previously have been seen as such an important issue. However, in 
this increasingly digital healthcare environment we are seeing greater amounts of data 
being generated and captured daily, including from diagnostic devices used, or sensors 
worn, by the patient while in the community. Any differences in the documentation 
approach or data recording method results in fragmented data, complicates the 
integration of data about the same patient from different sources, and inhibits health 
information exchange (HIE) [133, 134]. 
When it comes to the practice of medicine, a large array of standards applies to 
almost every action a clinician undertakes. Built on a base of clinical practice 
guidelines, evidence-based medicine is perhaps the most broadly applied and well-
known standardisation in medicine [135, 136]. Current efforts for standardisation in 
health informatics often focus on some element of: (i) how the clinician interacts with 
the system; or, (ii) data entry or composition. Our search for and review of systematic 
reviews of EHR implementations described later at Section 4.2 was unable to identify 
any mention of consideration of the potential for underlying issues to have arisen when 
non-standardised clinical documentation was digitised in the creation of EHR 
solutions, which if mentioned would have been in the context of being a barrier to their 
adoption. While this thesis focuses on standardisation of clinical documentation and 
the benefit this can bring for those seeking to develop and implement LHS, clinical 
documentation should be more thoroughly investigated as a potential source for a 
range of barriers that previously constrained EHR adoption, and which continue to 
prevent LHS from gaining a foothold in clinical practice. 
 
2.3 THE RELATIONSHIP BETWEEN STANDARDISATION AND LHS 
Our underlying assumption that standardisation of CCPS is a necessary and 
beneficial task is certainly not new. Many authors working on CCPS have been making 
the call for standardisation for several decades, as demonstrated by the proposal 
presented at the Conference on Guideline Standardisation (COGS) in 2002 [135]. 
Standardisation of CCPS can have direct implications on how that CCPS document 
could record information capable of supporting LHS. For example, consider the 
recommendation made by authors in the domain of orthopaedics [137, 138]. They 
suggest a call to standardise the methodology, classification, terminology and structure 
of documentation for reporting clinical complications, adverse clinical events and 
deviations from the expected post-treatment healing process would improve the 
accuracy of communication of complication events between clinicians. Moreover, 
where the proposed CCPS standardisation is then inherited into the formal structure 
and data definitions used to construct the EHR, this standardisation approach would 
also make available improved and consistent data capable of reuse in LHS [139]. This 
would enable multiple LHS uses, for example, that could: (i) investigate instances 
where the care provided may have been sub-optimal; or (ii) monitor for, and identify, 
instances of contaminated medicine, faulty or poorly manufactured medical devices or 
highlight clusters of post-surgical infections indicative of a site where sterilisation 
procedures may have broken down (a type of LHS defined as Surveillance).  
We will show (in Chapter 6) that issues of data integrity, integration and 
interoperability are known to be significant barriers to LHS adoption. Standardisation 
of CCPS may represent a significant facilitating factor for mitigating these data-related 
issues. While this thesis is not the first work to propose a relationship between the lack 
of standardisation in CCPS and the heterogeneity in data representation in EHR [139], 
it is the first to draw the direct line from CCPS all the way to LHS and propose that 
resolving the first may be a strong factor in development and adoption of the last.  
 
  
Chapter 3: Methodology 
Selection of the research approach, or methodology, is an important step for 
guiding research development, progression and outcomes, and enables the researcher 
to clearly describe both research and procedure [140, 141]. Many schools of research 
have previously coached students in the tenets of the incompatibility thesis: that 
qualitative and quantitative methodologies were in stark competition and must never 
be mixed in the same research [142, 143]. However, more contemporary proponents 
encourage a mixed approach as the path to becoming a more pragmatic researcher 
[144]. This chapter describes the methodology adopted to achieve the aims and 
objectives of the research. Section 3.1 provides the research design while also defining 
and describing the qualitative and quantitative research methodologies identified in the 
research approach; Section 3.2 discusses the overall research approach used and the 
stages in which the methodologies were implemented; Section 3.3 lists the instruments 
used or created in the study and justifies their use; and, section 3.4 discusses the ethical 
considerations of the research as well as its problems and limitations. 
 
3.1 RESEARCH DESIGN 
This research uses a number of established analytical methods: 
3.1.1 Scoping Review  
The scoping review synthesises and analyses a wide range of literature in order 
to extract evidence and bring greater clarity to a topic of inquiry [145]. The scoping 
study is often used to guide more focused lines of research, such as the systematic 
review [145]. By contrast, the systematic review uses a relatively narrow range of 
quality-assessed studies focused on answering well-defined questions where 
appropriate study designs are identified in advance. The scoping review is less 
interested in the quality and design of included studies that are used to address broader, 
less-specific topics [146]. The scoping review was used in the initial stages of this 
work in the opening literature review which identified many of the works that present 
LHS solutions do not identify within the LHS domain: the community awareness 
challenge described in Section 1.4.2. Knowledge gathered during the scoping review 
informed the search terms and initial concepts at the commencement of the systematic 
review. 
3.1.2 Meta-narrative Review  
For research with a complex and diverse collection of literature it can be difficult 
to understand the problem as a whole and requires exposure of tensions, mapping of 
diversity, and communication of complexity [147]. Meta-narrative review (MNR) 
seeks to explain seemingly disparate and conflicting data encountered in literature 
[148]. MNR attempts to contextualise terms, interpret relationships between different 
concepts, and recognise the impact of assumptions made by authors [148]. Meta-
narrative review was used during the initial reading of EHR systematic reviews in 
order to understand and align the often heterogenous review and reporting methods 
used in each of the 23 works to discuss what was ostensibly the same topic.  
3.1.3 Content Analysis and Thematic Analysis  
Content analysis and thematic analysis are separate but interrelated qualitative 
approaches for descriptive data analysis with low levels of interpretation [149]. 
Content analysis (CA) is an accepted systematic coding and categorisation method for 
investigating texts and resolving a quantitative description of the features [150, 149]. 
CA establishes categories and then records the instances in which that category is 
evident or can be inferred from within the collected texts being analysed [150]. 
Thematic analysis (TA) is a more qualitative method used to identify, analyse and 
report patterns, or themes, that emerge as being important within the material being 
analysed [151, 150, 149]. TA provides the systematic element characteristic of CA, 
while additionally affording the ability to combine analysis of frequency with analysis 
of in context meaning, therefore providing a more truly qualitative analysis [150]. CA 
and TA are established methods regularly used in clinical, nursing and other healthcare 
contexts [151, 150, 152, 149]. 
Authors often represented the same general idea in a variety of ways. While CA 
resolved many common concepts, it is only once TA was applied that these concepts 
could be described by their underlying contextual themes. The following example 
analyses how authors discussed one of the most often-mentioned concepts, cost. 
 
 
EHR: 
1. Reduce RCT cost [153] 
2. Offer low-cost, high-volume nuanced answers [153] 
3. The initial price of the system should not be the overriding 
consideration as the organisation should be willing to avoid purely 
cost-oriented vendors as costs will soon mount [154] 
4. EHR systems come with huge investment costs [154] 
5. HIT improve quality and care coordination and reduce costs [155] 
6. Physicians practices are slow to adopt EHR for a variety of reasons 
including high costs [155] 
 
LHS: 
7. Reduce cost of service delivery [85] 
8. Cost-effective, secure health information exchange represents an 
important interoperability sub-challenge [156] 
9. There were multiple additional systems-based considerations (e.g. 
startup costs) [157] 
10. Integrating [our LHS] into this clinic costs approximately $50,000 
[157] 
11. Reduce costs by providing more efficient care [158] 
12. Initial cost of implementing the registry was high [157] 
13. Reduce the cost of conducting clinical trials [159] 
 
While CA finds that many authors identify the concept cost, TA analyses its 
usage, in this case resolving two contrasting contexts.  
Hence, implementing EHR and LHS: 
1. can reduce the cost of healthcare delivery (1,2,5,7,11,13) 
2. carries a high initial cost burden (3,4,6,8,9,10,12) 
The first contextual theme presents as a benefit that comes from engaging the 
health information system, while the second clearly represents a barrier inhibiting 
adoption of these systems. In this way, common benefits and barriers to the adoption 
and use of EHR and LHS were resolved and analysed across the two collections of 
literature. 
3.1.4 Case Studies  
The case study (CS) is an ideal methodology used in many domains including 
information sciences and comes with a well-developed history and robust qualitative 
procedures for investigation and process validation [160-162]. They are a method for 
conducting and presenting comparative research into subject areas that include 
qualitative and mixed-mode information science inquiry [163]. CS are a valid 
methodology where the rigid approach of experimental research cannot or does not 
apply [160, 162, 164]. Each CS presents with a unique use case and reporting structure, 
and a range of case study types exist, including: exploratory, explanatory, descriptive, 
intrinsic, instrumental and collective [162, 164].  
Computer science, information systems and information science are domains 
characterised by constant change and innovation [165]. All too often, IS researchers 
learn by studying the innovations developed and implemented by practitioners, rather 
than by providing the initial wisdom to underpin these new ideas [165]. Case studies 
allow researchers to capture the knowledge of practitioners, and using a broad variety 
of data sources to ensure the knowledge is looked at through multiple lenses, generalise 
this knowledge in the development and evaluation of new theories and approaches 
learned from it [166, 165].  
The case study examples used in this research draw on knowledge and evidence 
developed from and with the assistance of clinicians in the domains of obstetrics and 
midwifery. Clinical practice guidelines were initially systematically evaluated [167]. 
With the input of clinical experts, novel clinical document standards for development, 
structure and content are evaluated through the conduct of case studies to produce 
compliant clinical documents. 
 
3.2 RESEARCH APPROACH 
This research is divided into the following stages:  
Stage 1: Scoping and meta-narrative review with meta-analysis to: 
1. Identify literature on each clinical documentation type, seeking articles 
that will help: 
a. Describe conception and intended purpose for the 
document type; 
b. Describe the structure, content and development process 
for the document, and; 
c. Demonstrate application of the document in a clinical 
context from inception to today. 
2. Identify literature that presents scoping or systematic reviews of EHR 
implementations on which this research will; 
a. Use Concept Analysis (CA) and Thematic Analysis 
(TA). 
3. Identify literature that proposes or presents an LHS solution, from which 
this research will; 
a. Use CA and TA to develop a classification and 
descriptive taxonomy that will allow those designing 
and implementing health informatics solutions to 
identify their work within the LHS domain. 
b. Use CA and TA to identify: (1) proposed benefits of 
LHS use for clinicians, healthcare organisations and 
consumers, and; (2) barriers that have inhibited adoption 
of LHS specifically. 
Stage 2: Develop and present:  
i. Standardised definitions and nomenclature for each identified 
type of clinical documentation; 
ii. A methodology for standardised development, structure and 
content for those clinical documents where the literature 
demonstrates absence or discordance; 
iii. A taxonomy describing current and foreseeable types of LHS; 
iv. Quantitative presentation of the identified barriers and benefits 
for both EHR and LHS, along with the facilitators identified 
from EHR literature.  
v. A unifying framework that effectively demonstrates the 
application of LHS within the multiple layers of a clinical 
learning organisation. 
Stage 3: Evaluation: 
i. Case study evaluation applying the clinical document 
standardisation method to creating artefacts for clinical 
examples in midwifery and obstetrics.  
ii. Quantification of LHS solutions by classification of all those 
proposed or presented in the LHS literature review. 
iii. Contrast, comparison and analysis of the barriers and benefits 
described for EHR and LHS to identify similarity and 
consistency and identify whether LHS present with similar 
issues and challenges as has been observed for EHR, and 
whether these issues and challenges may have been inherited 
from EHR. 
iv. Quantitative and qualitative assessment of the application of 
facilitators in the domain of EHR, including evaluation of 
whether the type and approach to facilitating EHR may be 
applied successfully to increase the success of LHS 
implementation. 
The above research approach was applied to each of the clinical documentation 
types identified in Section 5.1. For example, for caremaps (which we cover in detail 
in Chapter 8), the approach is summarised in Figure 2.  
 
 Figure 2: Research Process - Consensus formation and evaluation for the standardised caremap 
 
In this example the research focused on the three components listed in Table 1 
whose characteristics would come out of the TA and make up the review framework: 
 
Table 1: Clinical Documentation Components for Standardisation 
Structure What is the representational structure and notation for expressing the 
contemporary clinical document? 
Content What content types are consistently seen in the contemporary clinical 
document? 
Development What are the steps followed by authors to develop this contemporary clinical 
document type? 
 
The literature review is a ground-level consensus-forming function allowing 
researchers to identify implementation techniques and assess the degree of agreement 
within a domain [168, 169]. In this way, the literature pool of the caremaps study was 
used to identify common definition, structure and content elements, and a standard for 
the overall look and feel of caremaps. In addition, process steps that were consistently 
described led to a standardised caremap development process.  
 
3.3 INSTRUMENTS 
3.3.1 Formal Concept Analysis (FCA) Spreadsheets 
The literature review process produced spreadsheets with the details and, for 
LHS papers, a brief description of each paper. CA then data mined the literature to 
inductively populate the spreadsheets initially in the form of formal concept analysis 
charts [170-172]. TA extended these with context, making each concept of interest 
identified from the literature more generic.  
3.3.2 ITPOSMO-BBF 
While many approaches exist for evaluating implementations of new systems, 
services, or the commission of evidence into practice, e.g. [173-175], one was sought 
which had received sufficient attention in the literature to demonstrate robustness and 
flexibility in application. ITPOSMO was originally proposed and developed for 
evaluating the gap between expectation and reality in government IT projects, but has 
also been used to evaluate EHR projects and help explain why health information 
systems have succeeded or failed [176]. In the information systems literature 
ITPOSMO is a widely-used framework for evaluating implementation challenges: for 
understanding critical factors that affected the success or failure of technology projects 
[177]. The ITPOSMO framework identifies seven dimensions for exploring the gap 
between a system’s design and the reality of its implementation: (1) Information; (2) 
Technology; (3) Processes; (4) Objectives; (5) Staffing; (6) Management, and; (7) 
Other factors [178]. The seven dimensions are arranged into four aspects, each 
composed of related dimensions: IT-PO-SM-O.  
Precedent exists for expanding ITPOSMO to enable additional scope and 
functionality, including: service quality analysis [179], survey-based study of 
consumer and public perceptions [180] and Socratic analysis of local e-government 
[181]. This work in Chapter 6 adapts ITPOSMO to identify barriers that have impeded 
implementations of health information technology, and the actions, described as 
facilitating factors, that authors have sought to use in their mitigation.  
 
3.4 ETHICS AND LIMITATIONS 
3.4.1 Ethics 
The conduct of this research does not depend on or require the primary 
participation of human subjects, nor the secondary use of their personal health 
information. 
3.4.2 Limitations 
One key limitation of this work is that it is largely theoretical. While the clinical 
documents that are produced as part of this work can be evaluated and assessed by 
clinicians, the results presented that relate to EHR and LHS can only be properly 
evaluated in the future, and with some benefit of hindsight. This is because while it is 
a relatively simple matter to redevelop CCPS it may be some time before the 
standardisation changes propagate into the next generation of EHR, and before we 
might begin to see any effect on the adoption of LHS solutions in clinical practice.  
 
3.5 SUMMARY 
This chapter has introduced the methods applied generally across the research 
reported in this thesis. The methodologies were selected with close attention to the 
aims and objectives of this research. The research approach was described and two of 
the primary instrument types created during this research were introduced. The ethics 
requirements were then discussed before the chapter closed with discussion of the 
primary limitation arising from the study.  
 
  
 Chapter 4: Scoping Review of Clinical 
Documentation 
While literature on CCPS, EHR and LHS presents each as its own separate and 
isolated domain, we identify the existence of interdependency and, in many ways, 
inheritance between each. In this chapter we apply the methods described in section 
3.1 to undertake a systematic review of each domain. Sections 4.1, 4.2 and 4.3 review 
the current state of CCPS, EHR and LHS respectively. Section 4.4 looks at whether 
other authors have attempted to develop a framework to unify CCPS, EHR and LHS. 
The chapter concludes in section 4.5 with a summary. 
 
4.1 CCPS 
A search was conducted using Scopia, Science Direct, PubMed, EBSCOhost, 
DOAJ and Elsevier for literature discussing the definition, development or use of a 
range of clinical document types including: caremaps (caremap, care map and 
CareMap), pathways (care, clinical and critical pathways), guidelines (clinical 
practice guidelines), plans (care plans), rules (clinical decision rules), and protocols 
(care protocol). In each case literature was sought where authors had attempted to: (a) 
define the document type; (b) detail the inputs used in development (evidence, 
literature, team composition, etc.); (c) identify the intended patients, conditions and 
audience; (d) detail the aim, goals and intended outcomes, and; (e) highlight potential 
benefits and barriers encountered during development and operationalisation of the 
document. To identify the scope of author positions on whether clinical care 
documents were the same or distinct, we collected data on how authors described and 
discussed them in this context as shown in the table presented in Appendix D. Where 
authors described that a document type was also known by or the same as others, these 
were indicated in green. Where they provided narrative that differentiated or 
distinguished different types, this is indicated in red. Separate rows are used to record 
subsequent instances identified in the same text being reviewed. In our primary 
spreadsheet we also collected any definitions authors provided for each document type, 
as well as descriptions of input materials, goals, uses, and whether they provided an 
exemplar document for the reader. 
Many of the CCPS reviewed in this research were developed and refined during 
the 1980’s and 90’s in response to a number of key needs, including: (a) to control 
costs; and, (b) improve the quality of patient care [182, 32, 183]. Using project 
management (PM) and total quality management (TQM) tools more common to 
industry, hospital managers sought to reengineer the processes of patient care with the 
aim of reducing clinical resource overuse and error rates, along with concomitant 
improvements in patient outcomes [16, 17, 183, 19]. In spite of potential for these 
reductions, clinical costs have continued to increase and error rates persist with 
distressing frequency [30]. 
CCPS, also described as care process modelling, arose from a need to evaluate 
the quality of healthcare delivery [184, 185]. Documentation of care processes brings 
healthcare quality improvement as it helps those involved in patient care to develop a 
shared understanding of care to be provided for the patient, and a reference for 
identification of areas for future improvement [186-188]. The intention is to ensure 
that services provided to patients result in the desired health outcomes, consistent with 
current clinical knowledge [185]. Deviation from quality standards established in the 
CCPS is described as variation, and the presence of variation is the driving force 
necessitating adaptation of clinical change described in revised CCPS [189].  
A range of CCPS are in use in clinical practice. However, there is vast 
disagreement in the literature regarding their titles, standard content and construction 
methods. Many terms are used for what are describe collectively in this research as 
CCPS, each of whose remit could generally be described as the documentation of care 
processes for improving healthcare quality and outcomes. These terms include: 
clinical practice guidelines (CPG) [190, 191] which are also known as consensus-
based guidelines (CBG) [192] or local operating procedures (LOP) [193, 194]; 
clinical decision rules (CDR) [195]; clinical pathways [196]; care plans [197]; 
treatment protocols [198]; and caremaps [39]. Some authors describe care pathways, 
clinical pathways, critical pathways, care plans and caremaps as synonymous and 
interchangeable terms [199-202], while others consider them to be representative of 
separate documents [203, 204, 19]. This terminology confusion is further epitomised 
when we observe diagrams that internally describe themselves as one CCPS type, in 
this example [205, 206], caremaps, but which are captioned as one or more other types 
by the author.  
Standardisation of definitions, presentations and development processes for 
most types of clinical documentation is lacking, and while for some a standard has 
been attempted, these attempts are either incomplete or have only further added to the 
confusion [207, 208, 39, 135]. Electronic health record (EHR) software products are 
notorious for their lack of standardisation; in general [209, 210], in process and 
presentation [211], in terminology [212], in structure [213], and in content, format and 
nomenclature [210]. Inconsistency, changes in format between like documents and 
poorly designed materials only increase ambiguity and create greater confusion for 
clinicians [29, 89, 214]. Where clinicians must perform processes and tasks differently 
it is difficult to achieve consistency, and it is only once those processes and tasks 
become better documented and understood that standardisation can occur [215]. It is 
disturbing to note a trend in the literature that recognises that implementation of EHR 
has seen many healthcare organisations neglect the quality of their paper-based 
records: extinguishing all efforts at business process re-engineering that would 
standardise or improve the structure, format and information captured by the clinical 
documentation that their EHR is based on [216, 217]. As one author succinctly puts it:  
 
“…computerising medical records in their current state will 
create more problems than it solves: a mess computerised is a 
computerised mess.” [216]  
 
Caremaps, clinical and critical pathways, clinical flow diagrams and nursing care 
plans are observed with vastly different content and appearance: within the same 
journal, from hospital to hospital, and even from ward to ward within the same 
hospital. While there is much literature presenting examples of each type of clinical 
document, and texts exist describing the development of some traditional and text-
based types, a gap exists in the literature with regards to describing and standardising 
the development, structure and content for contemporary forms of some documents. 
Even though standardisation of healthcare practice, procedure and tools is seen to 
improve healthcare in terms of quality, outcomes and accountability, significant 
resistance persists such that standardisation remains an issue [45, 39, 46]. This should 
not be surprising when the issue of confusion in distinguishing these clinical tools 
persists [39].  
 
4.2 ELECTRONIC HEALTH RECORDS 
An additional literature search was conducted using the terms (“electronic 
healthcare record” along with “barriers” and “benefits” and “facilitating factors”). This 
was followed up by a second search replacing “healthcare” with “health”. Articles 
were included where they presented as a scoping or systematic review of EHR 
implementations and provided analysis and discussion of all three elements: barriers, 
benefits and facilitators. Those not meeting these requirements were rejected. A further 
requirement was to limit the EHR review to articles published during the ten years 
since the IoM’s initial LHS report, in order to align the EHR literature with that 
contemporaneously published for LHS. Figure 3 presents a PRISMA diagram showing 
the outcome of the EHR literature search, which resolved a pool of 26 articles for this 
review. 
 
Figure 3: EHR Literature Selection (PRISMA) 
 
EHR have become ubiquitous in healthcare, yet many hospitals and clinics still 
employ a mix of both digital and paper-based recordkeeping [218-221]. Among those 
EHR implementations in the hospital setting, many offer only limited functionality and 
occur as isolated islands of information, with separate EHRs tied to a particular ward, 
medical specialty or care pathway [222]. There have been some spectacular failures to 
realise the initial promise of EHRs, as seen with the UK’s National Program for IT 
wherein the National Health Service (NHS) failed to deliver effective national hospital 
EHRs [223]. Health services seeking to implement EHR have long complained of slow 
adoption and limited implementation success rates [156, 86, 224, 225].  
The design of many EHR applications, particularly those from the USA, come 
as an extension of health service billing software and often conflict with the needs of 
clinicians, leading to both workflow and information presentation challenges in 
clinical use [226]. The data contained in medical records typically exists within a 
specific context and there can be limitations on applying it for use in another context, 
or significant work needed to support that application [227]. Many commercial EHR 
solutions have proprietary, technological and cost barriers to integration with other 
systems and sources of health data relevant to the individual patient [228, 229]. With 
the best of intentions, many healthcare organisations have self-inflicted these issues 
by layering inflexible new technology over existing processes and procedures in the 
belief that EHR implementation meant simply replacing paper records with digital 
systems [230, 219]. Underlying this has been a lack of understanding about how 
clinicians interact with computers, and general disagreement as to whether such 
interaction enables or inhibits patient-centred care [231]. Successful implementation 
of new EHR requires both clinician- and user-led processes that re-evaluate practices 
and procedures, with a requisite period of adaptation and training for those who will 
use the resulting combination of new IT systems, documentation procedures and 
clinical workflows [232, 233].  
Numerous studies have found that EHR increased efficiency while also 
improving quality of care, accuracy of clinical documentation and access to patient 
information [234-239]. Well implemented EHR also reduced healthcare delivery costs, 
resource use, and clinical errors [240, 234, 235]. Some studies reported improved 
communication between clinicians which acted to increase patient safety [240, 236-
238], while a small number reported EHR increasing or enhancing patient 
confidentiality [241, 238].  
Chapter 6 reports the review of the literature collection identified herein, finding 
that almost every author whose work presents an EHR implementation spoke of 
barriers or challenges. Overcoming these barriers has been a significant challenge to 
implementing EHR [242]. Organisations have invested heavily in efforts to identify 
and engage facilitators they consider could lead to successful implementations [234, 
242, 243]. Some barriers are seen as endemic of, or specific to, the IT industry [243], 
while others are thought to require change in health policy and legislation [241-243].  
 
4.3 LEARNING HEALTH SYSTEMS 
A literature search was performed using the search terms (“LHS” and “learning 
healthcare system”), seeking works that proposed or presented an LHS solution. An 
initial read of abstracts was used to reject duplicates and papers not related to the 
central topic, including those that used the search term in context of learning in the 
academic or education sense [244, 245]. Conclusions and methods were then reviewed, 
seeking to remove papers that did not present or propose an LHS, for example: those 
exploring the medicolegal, ethical or societal aspects of LHS [246-248]  Figure 4 
shows that a total of 230 articles were identified for inclusion in the LHS part of this 
study.  
 
Figure 4: LHS literature selection (PRISMA) 
 
Advancement of evidence-based medicine (EBM) was promoted as the primary 
driver for LHS [59] yet the IoM definition for the concept found in section 1.1.2 fails 
to describe attributes that would contribute to quality, safety, efficiency and efficacy 
of patient care [86, 23]. The four fundamental attributes listed in Table 2 provide 
significantly more tangible metrics for conceptually comprehending the LHS. 
 
Table 2: Four Elements of an LHS (adapted from [249]) 
1 An organisational architecture that facilitates formation of communities of patients, 
families, front-line clinicians, researchers, and health system leaders who collaborate to 
produce and use big data; 
2 Large electronic health record and routinely collected healthcare datasets (big data); 
3 Quality improvement for each patient at the point of care brought about by the integration 
of relevant new knowledge generated through research, and; 
4 Observational research and clinical trials done in routine clinical care settings. 
 
Figure 5 shows that references to LHS in literature were initially quite limited. 
While some much earlier texts including one authored by Florence Nightingale in 1863 
provide methodological references for health outcome monitoring and benchmarking 
suggestive of what would later become LHS [250, 251], the first true use of the term 
comes in 2007 around the time of the IoM’s initial LHS report. However, it wasn’t 
until the IoM’s second LHS report in 2011 [60] that we begin to see a significant 
uptake in publications referring to or about LHS. The primary purpose for their second 
LHS report was to summarise presentations and discussions that had occurred during 
a series of roundtable workshops to identify opportunities, challenges and priorities 
for the development and application of new health information systems (HIS). HIS 
that would constitute one of the various types of LHS [60].   
 
 
Figure 5: LHS Publications (by year) 
 
Coincidentally, and with no reason given, the title for LHS was slightly amended 
in that report. Healthcare was shortened to just health. Figure 5 also shows that while 
use of learning healthcare system had been more prevalent in the years after their first 
LHS report and prior to the second, starting in 2011 and seemingly as a result of the 
title change in the second IoM report, learning health systems became the more 
commonly used nomenclature. It is notable however, that while the nomenclature has 
matured, definitions for LHS have not continued to develop and continue to be largely 
based on the descriptions provided by the two IoM reports [23]. 
LHS are seen to embody the core principles of 4P medicine, which are medical 
information systems that have the ability to be predictive, preventative, personalised 
and participatory [252, 253]. 4P approaches personalise medicine by identifying those 
at greater risk for complications for the purpose of targeting interventions [253, 59], 
but while many 4P approaches present in the literature as clinical decision support 
systems (CDSS) [254-256], CDSS are only one of a number of types of LHS [257, 
86]. In parallel, maturation of technologies such as large datasets, machine learning, 
prediction and decision support, and ongoing increases in processing power will 
further enable development and use of LHS [252, 61, 84]. 
LHS are promoted as bringing numerous benefits for all stakeholders in 
healthcare. For clinicians, these include assessment of which laboratory or imaging 
investigations may be of greater diagnostic value given a particular patient’s 
presentation and symptoms [258], reductions in the risk of causing patient harm from 
prescribing errors [248], and increased awareness of the potential and effects of 
pharmacogenetics [259]. The ability to use LHS technology to record, compare, 
contrast and present information in near real-time enhances the analysis and decision 
phases of the clinical care process. Patients benefit from clinicians having access to 
advanced knowledge developed from the experiences and outcomes of cohorts of past 
patients, the decrease in time taken to arrive at the most appropriate diagnosis, and 
reduced resource use and costs [260, 258, 261]. Others see the financial burden to 
implement and support health information technology (HIT) including LHS [234, 241, 
237], coupled with the persistent need for data and systems standardisation [262, 237, 
238, 263], interoperability [242, 264, 263] and integration [242, 243] as collective 
barriers that prevent broader LHS adoption. 
LHS represent a vision to transform healthcare [265, 60]. It is suggested they 
could be the most significant development in healthcare since the advent of evidence 
based medicine (EBM) in the early 1990’s [266, 23]. The LHS vision requires 
leveraging ongoing developments in EHR by developing new knowledge from the 
ever-increasing amounts of routine clinical data being accumulated [153, 265], 
innovating medicine from the slower population-based process of EBM towards rapid 
near real-time precision medicine [265, 267]. Realisation of some LHS also requires 
access to or development of clinical documentation, for example: development of 
some LHS requires clinical protocols, caremaps and guidelines [248, 268, 269, 39, 
270]. While EHRs have become pervasive in all aspects of healthcare service delivery 
and contain ever-increasing amounts and types of health data [271, 272], they represent 
a rich and underutilised resource demonstrating that the transformational vision LHS 
promises is struggling to be realised [273].   
Review of publications of a number of health informatics conferences held 
during 2017 showed that much of the published work that should naturally fall within 
the domain of LHS fails to be captured under that umbrella term [274]. Review of 28 
papers from Proceedings of the 2017 International Conference on Health Informatics 
(ICHI’17) [275] resolved that 15 (54%) presented works that could be classified using 
the taxonomy presented in Section 6.2.2 as an LHS yet no single author identified their 
efforts as such. A similar review of 60 abstracts from the Medical Informatics Europe 
(MIE) 2017 Informatics for Health conference found that while 41 authors (68%) of 
that conference also present content classifiable as an LHS, only 2 authors (3%) 
actually described their approach thus. It is possible that this failure to identify work 
within the domain of LHS is due to a lack of awareness and understanding of the 
domain. Lacking awareness of the domain results in authors failing to recognise that 
their works are actually LHS. This limits the ability of other researchers to identify all 
relevant works from within the broader field of health informatics (HI) during LHS 
literature searches.  
Presently, there are more than 7000 discoverable publications annually 
discussing topics concerning EHR, while LHS struggles to reach 700. Figure 6 shows 
this dramatic disparity in numbers between EHR and LHS publications when these 
terms are entered into a university library search engine. When considered in the light 
of authors who have described the lack of ontology or classification systems for LHS, 
it is clear that there is a lack of awareness around LHS which may explain why the 
LHS domain is avoided even by authors who are aware of its existence [276, 277, 274].  
 
 
Figure 6: Annual LHS and EHR Publications 
 
4.4 BRINGING CCPS, EHR AND LHS TOGETHER  
We found no papers that had investigated or developed a practical or operational 
framework to unify LHS, the established levels of medicine practice described in 
Section 7.1.1, and common CCPS documentation. While other works have 
characterised subsets of LHS or particular CCPS, no work was located that 
characterised either in the context of medical application. And even though this thesis 
investigates all three, additional effort is required to integrate them into a single unified 
framework that can improve understanding and success in health informatics and LHS 
implementation. 
 
4.5 SUMMARY AND IMPLICATIONS 
In this chapter we have seen that confusion exists in the name, structure and 
content for clinical documents causing vast differences in their quality, applicability 
and usability. We also propose that clinical documentation suffer from a lack of 
standardisation, and that true standardisation in structure, content and development 
processes is beneficial if clinical documentation are to have a positive effect in the 
delivery of effective and safe patient care. This leads to the question: How can clinical 
documentation standardise care, when the clinical documents themselves are not 
standardised? 
EHR were promoted to clinicians as a means to transition healthcare from paper 
to digital recordkeeping. It was asserted that they would deliver improved efficiency, 
accuracy, outcomes and patient safety because they provide easy access to important 
information, treatment orders and a complete, searchable record of all patient 
information. Given their beginnings as an enhancement of hospital billing information 
systems, significant barriers including clinician resistance have resulted in slow 
adoption of EHR. Multiple disparate EHR systems exist and even where two hospitals 
have contracted with the same supplier, variance can be seen in the presentation of 
patient and clinical information at each. Integration between systems is expensive, 
time consuming and has thus remained a major challenge to those seeking a truly 
universal EHR. Therefore, while EHR are now ubiquitous in healthcare settings, we 
must ask: why is it that national health systems have not adopted a standard for EHR? 
We should also consider why it is that after almost four decades of EHR, their adoption 
still represents a significant challenge for health service providers?   
LHS are a natural evolution from EHR. Large collections of EHR are required 
in order to realise operational population-to-evidence-to-precision methods that LHS 
offer. Many LHS also require clinical documentation that is representative of current 
clinical best practice, clinical practice guidelines, and the processes and procedures of 
patient care delivery seen in caremaps and clinical workflows. While there are many 
examples in the literature of proposed LHS solutions, many others do not identify 
within the domain. Adoption rates for LHS in clinical settings remains quite low. This 
research further asks: are LHS simply inheriting the challenges identified from 
research of their underlying antecedents, clinical documentation and EHR? and, is it 
possible to standardise those antecedents and identify facilitators previously employed 
in the mitigation of barriers to EHR that might be beneficial to implementation success 
rates for LHS?  
  
Chapter 5: Standardisation in Clinical 
Documentation 
Appropriate use of CCPS should see patient and clinician actively engage in a 
cycle of healthcare that can be represented as a learning circle as shown in Figure 7, 
in that CCPS in differing amounts and degrees: (1) guide, direct and inform patient 
care; (2) record the care that has been provided; and, (3) capture the present condition 
of the patient and their response to treatment. This last step informs the process that 
guides and directs clinical decisions about the next round of patient care, thus repeating 
the cycle as a continuous process until the patient is restored to their particular version 
of health.  
 
Figure 7: Clinical Documentation Learning Circle and interactions with CCPS 
 
This chapter investigates the broad range of clinical documentation, seeking to 
resolve the aspects lacking standardisation identified in Section 1.1.1. This chapter 
asks: Is it possible to resolve the nomenclature confusion and characterise the content 
and structure of these documents, and in doing so, create a standard for CCPS?  
Section 5.1 seeks to resolve the lack of standardisation in nomenclature for 
CCPS.  Section 5.2 extends an existing approach developed to classify and characterise 
one type of CCPS, the clinical pathway, for application to the broad range of CCPS 
identified in section 4.1. This extended approach is used in development of a taxonomy 
(section 5.3) and characterisation (section 5.4) for CCPS. Section 5.5 demonstrates and 
evaluates this taxonomy and characterisation through application in a case study on 
CCPS for Type 2 Diabetes Mellitus in the United Kingdom. The chapter concludes 
with a discussion (section 0) and summary (section 5.8). 
 
5.1 THE LACK OF STANDARDISATION IN CCPS 
This section seeks to address the lack of standardisation in nomenclature for 
CCPS introduced in Section 1.1.1 and resolved in section 4.5 through a review of the 
literature collected by the search described in section 4.1. 
5.1.1 Policy 
Often seen as the remit of politics, policymaking can be driven or impeded by 
highly charged and competitive ideologies and value systems that mean the resulting 
policies are not always based on clear and convincing scientific evidence [278, 279]. 
International and national organisations can give rise to health policy [280-283] that 
can be applied at both a national and local level, with local policies often being 
representative of aspects of national or regional policy made relevant to specific local 
populations [284, 285, 283]. Policy can be directly determinant of a population’s 
health and health outcomes, especially where it is used to regulate the distribution of 
health services in terms of human and material resource allocation, how healthcare 
services are funded, and the accessibility of services for patients [286, 283]. 
5.1.2 Clinical Practice Guidelines 
It is generally accepted that clinical practice guidelines (CPG) are systematically 
developed  statements based on critical assessment of scientific evidence, experience 
and consensus and they are intended to assist in decision making regarding appropriate 
care for patients in specific clinical circumstances [278, 287-291]. CPG seek to provide 
clinicians with a vital shortcut to identifying the underlying science that informs 
particular clinical decisions [288]. The hierarchy for CPG shown in Figure 8 was 
developed as part of this work. Although the hierarchical view has been adopted, this 
work also established potential for other possible views and perspectives, such as that 
of levels of customisation in which one guideline may exist at each level as a 
customised instance of a version at another level. Furthermore, in such a view a CPG 
may originate at any level in Figure 8 such that customisation may occur as a 
generalisation or specialisation process to suit the population or individual, 
respectively. Thus, a health facility-based CPG may become regionalised, nationalised 
or globalised while global CPG may be nationalised, regionalised or localised at a 
healthcare facility through customisation, i.e., generalisation or specialisation 
respectively.  A key point to note here is that as you move from left to right in Figure 
8, the patient population for which the CPG applies reduces and becomes less 
heterogeneous while the guideline becomes more specific as a direct result of 
customisation. 
 
 
Figure 8: Hierarchy for Clinical Practice Guidelines 
 
At the highest level are global guidelines: international guidelines published by 
organisations such as the World Health Organisation (WHO) [292, 293] and World 
Federation of Haemophilia (WFH) [294], and multinational guidelines from groups 
like the European Society of Cardiologists (ESC) [295]. International and 
multinational guidelines tend toward general or globally-applicable recommendations 
for the diagnosis or management of specific conditions or clinical presentations.  
In combination with local synthesis of evidence, global guidelines are regularly 
used in the production of national guidelines, which are endorsed for and intended to 
inform consistent clinical care across entire countries and health sectors [296, 297].  
Regional guidelines draw on health policy and use national guidelines in the 
production of a more operationalised form of CPG dealing with demographic 
population needs in specific states, counties, or municipalities [298].  
Local guidelines is the term used herein to represent those CPGs developed by 
and for use in hospitals, general practice clinics and other patient-facing locations. 
They provide operationalised, instantiated evidence and clinical knowledge drawn 
from regional, national and global guidelines and are targeted to support and improve 
clinical decision-making and care delivered directly at the patient’s side [298]. It is not 
uncommon for patients with the same condition to receive different treatment at 
different hospitals, and for different healthcare providers to disagree on what the best 
evidence may be in a given situation [299]. For this reason local guidelines may also 
reflect particular elements of organisational culture, and it is not unknown for hospitals 
to manipulate or tweak guideline diagnostic or treatment threshold values either: (a) 
where it may make the guideline more approachable to clinicians and increase 
adherence; (b) as a response to elements previously identified from clinical errors or; 
(c) where based on past experience, senior consultants feel it may aid in the avoidance 
of future poor patient outcomes and potential litigation [299-301, 298]. 
5.1.3 Clinical, Critical and Care Pathways 
While CPGs and clinical pathways both provide a defined approach for a specific 
medical condition or treatment process, clinical pathways were a separate clinical care 
process specification (CCPS) developed in the 1980s and applied to healthcare practice 
with a distinct focus on: (a) the use of benchmarked outcomes; (b) cost containment 
through efficient resource use; and, (c) management of patient care within a structured 
hospitalisation period to produce a reduced length-of-stay (LOS) [302, 287, 303].  
    Clinical pathways was the term most frequently described as being the same 
or synonymous with others studied in this review, primarily caremaps. Clinical 
pathways was also the term most often distinguished as different from others, 
particularly CPGs. Confusion within authors’ narratives as to whether clinical 
pathways, critical pathways and care pathways represented the same [304, 305, 200, 
306] or distinct [278, 307] specifications was identified. An attempt at analysis of the 
definitions provided by authors was made but given broad variance in defining 
elements used across the literature pool this was not probative and had potential to 
increase this confusion. While some authors provided simple and direct statements, 
describing their particular pathway as a paper-based document or blueprint [16, 308, 
309], others gave more comprehensive descriptions discussing systematic use of 
clinical evidence, the types of clinical staff and motivations driving the development 
and use of their pathways [304, 17, 310].  
There was very limited evidence from which to infer the existence of minor 
operational differences between the three terms. In this analysis the term critical 
pathways was observed more often in situations where the care is short, intervention- 
or event-based or requiring of some urgency, i.e. in emergency medicine, surgical or 
intensive care domains [305]. The term care pathways was most often observed in the 
nursing domain describing the day-to-day routine of care provided for patients. And 
clinical pathways appeared to be more broadly applied and more holistic in that 
authors sought to address a wider range of patient issues than just focusing on this 
particular illness or clinical event. They were also observed across a range of care 
domains including: nursing, oncology, community-based care and mental health.  
Despite these merely operational distinctions it would be disingenuous to 
identify pathways as three separate objects. [304] also investigated the nomenclature 
issue for pathways, determining that while critical pathways was the internationally 
accepted term, more than half of all authors in their study had shown a preference for 
clinical pathway. For all these reasons this thesis treats them as the single term, clinical 
pathway. 
5.1.4 Caremaps 
The term caremap refers to a graphical representation of the sequence of patient 
care activities to be performed for a specific medical condition suffered by either a 
patient or a cohort [311-313]. Caremaps have been in use, in one form or another, for 
around forty years [17, 314, 315]. The literature suggests they originated in the nursing 
domain, incorporating and extending the critical pathway method and bringing 
established project management methodologies into healthcare delivery [16, 17, 19]. 
Caremaps aim to standardise health care practice by organising and sequencing care 
workflow, ensuring standard of care, timely interventions and uniform outcomes using 
an appropriate level of resources [316, 207, 314, 311]. Caremaps also help track 
variance in clinical practice, as they provide a simple and effective visual method for 
identifying when care practice has deviated from the routine evidence-based pathway 
[317, 311]. 
Definitions drawn from the literature of the early-mid 1990’s agree in principle 
that the caremap presents as a graph or schedule of care activities described on a 
timeline and performed as part of the patient’s treatment by a multidisciplinary team 
to produce identified outcomes [316, 318, 314, 319, 311-313, 315].  
Caremaps are observed in the literature using three different titles: (1) caremaps; 
(2) CareMaps, and; (3) care maps. The first appears to have been the original title prior 
to a Centre for Case Management (CCM) report and trademarking of the second in the 
early 1990’s [316, 320]. In literature published after 1994 using caremaps it is not 
uncommon to see some mention of CCM or their trademark [321], although this is not 
always the case [322, 323]. It is possible that the use of care maps has come about as 
a defence to any potential issues that might arise from confusion with the trademark, 
as authors did not use this third title in context or reference to CCM [324, 311, 325]. 
Just as the literature presents three different titles for caremaps, it also describes 
three origins for caremaps, with distinct points of intersection between each that make 
it difficult to assess which may be the true history:  
(1) Caremaps were an output of the Centre for Case Management (CCM) in 
1991 [320]. CCM’s CareMaps were similar in form and function to existing 
clinical pathways and were applied to specific patient populations that were 
commonly treated in many hospitals [320]. CCM went on to trademark the 
double-capitalised version CareMap but had not within the first decade 
undertaken any research to demonstrate the effectiveness of the concept 
whose invention they claimed [326]. 
(2) Caremaps naturally evolved as an expansion of earlier case management and 
care plans [315].  
(3) Caremaps were developed during the 1980’s at the New England Medical 
Centre (NEMC) [327, 313]. 
Caremaps arose in nursing where they incorporate and extend the critical 
pathways and bring established project management methodologies into healthcare 
delivery [202, 111, 328]. Indeed, from the early 1980’s nurses were the primary users 
of caremaps [125]. 
Early caremaps were text-based and holistic. Rather than centring on only the 
immediate primary diagnosis or intervention, nurses developed these early caremaps 
to focus on the entire scope of care that might be necessary for the patient during 
hospitalisation. Traditional caremaps considered elements such as anxiety, 
rehabilitation, education, prevention and coping strategies and were intended to restore 
the patient to a normal quality of life [329, 330, 311-313].  
In the second half of the 1990’s clinicians began to realise that creating caremaps 
was easier for surgical procedures than other in-hospital care scenarios [331]. That 
caremaps would evolve in form and function had been expected as information 
technology and EBM developed [313]. From 1999 examples can be found of 
transitional caremaps: caremaps that whilst still being text-based, have reduced their 
focus to interventions that are part of the primary diagnosis [207, 208, 321]. 
Caremaps continued to evolve as graphical representations. Contemporary 
caremaps emerged as separate but complimentary components to clinical pathways 
and clinical practice guidelines (CPG) [320, 323]. Recent caremaps come linked to or 
provide graphical flow representation for the clinical practice guideline (CPG) or 
surgical event [332, 317, 325]. While retaining the purpose and flow and still 
conforming to the general principles of the caremap definition, many that are found 
annexed to CPGs have begun dropping the caremap title [333-336]. A summary and 
comparison of caremap evolution stages is shown in Table 3. 
There were numerous examples of contemporary caremaps in the literature and 
annexed to hospital-based CPGs. Contemporary caremap literature tended towards 
focusing on establishing the clinical condition that justified creation of the caremap, 
such as: determination of incidence, risk factors and patient outcomes [332]; diagnosis 
and stabilisation of patients with an acute presentation [337], and; protocolising of 
ongoing treatment [325]. Presentation or discussion of the development process and 
elements for construction were rare, and more often had to be inferred from a thorough 
reading of each paper. 
We found a single article written by a veterinarian and a lawyer which attempted 
a systematic description of the process for contemporary caremap development [338]. 
This article primarily focused on standardisation for the purpose of cost containment, 
and provides an example of mapping for a surgical procedure [338]. Given their focus 
and particular caremap construction model which, through their own exemplar 
application, only includes a temporally-ordered single-path representation of the gross 
steps of patient care, their paper was at best, merely formative. By their own admission, 
they deliberately limited relevant data analysed during the input design phase to what 
they felt was truly critical for identifying and understanding outliers. This results in a 
model lacking clinical applicability and a distinct lack of detail surrounding each care 
process. Their method requires significant work to adequately support true 
standardised clinical caremap development. 
 
Table 3: Summary and comparison of caremap evolution stages 
 Traditional  
(1980’s to mid-1990’s) * 
Transitional  
(Mid-1990’s to mid 2000’s) * 
Contemporary 
(2004 onwards) * 
Primary Author Nurses Nurses and Doctors Doctors 
Context Holistic Primary condition Single diagnostic, screening 
and/or intervention event. 
Foci Restoring the patient to 
normal life 
Outcomes, cost and resource 
consumption 
Efficiency of care delivery and 
outcomes, reduction of practice 
variation, bridge gap between 
evidence and practice 
Presentation Text-based Text-based with some early flow 
examples 
Flow diagram or graph 
Status Independent document Independent or sometimes 
incorporated with CP document 
Self-contained but often found 
appended to/contained in CPG 
CP = Clinical Pathway, CPG = Clinical Practice Guide 
*All dates are approximate ranges 
 
5.1.5 Clinical Decision Rule 
Clinical Decision Rules (CDR) assist clinicians in their decision-making role by 
providing a link between published clinical evidence, best practice, and the clinical 
decision under consideration [278, 339, 340]. CDRs draw on evidence from guidelines 
to provide operationalised and efficient approaches to assessing probabilities for 
diagnostic, treatment, and prognostic decisions integrated into the clinical pathway 
[287, 339-341]. Rules guide clinicians in their clinical decision-making role, helping 
to establish pre-test probability, providing simple screening tests for common 
problems, and aiding in the estimation of risk [278, 342]. 
5.1.6 Care Plan 
A Care plan is an organised multidisciplinary day-by-day list of care activities 
that healthcare providers will undertake to support identified patient problems along  
with intermediate outcome-based goals for assessing performance [343, 344]. While a 
ward or care unit may have a care plan template for patients with particular clinical 
presentations, such as for post-caesarean section [343], patients diagnosed with 
community-acquired pneumonia [345], or stroke [308]; being as care plans are specific 
to the patient they can only be defined once the nurse or clinician has assessed that 
patient’s particular deficits and needs [310]. An implied relationship exists whereby 
the care plan may draw knowledge of the condition from the CPG however, in practice 
care plans include no supporting literature or knowledge gained from retrospective 
chart or patient record reviews that would justify the practices used as part of the plan 
[345]. Care plans are a constituent component of the clinical pathway [305, 346, 344], 
and due to their prescriptive and scheduled nature are credited as the component used 
to achieve reduced LOS [345]. 
5.1.7 Treatment Protocol 
Known variously as clinical, care or treatment protocols (TP), these are standard 
descriptors of clinical care activities developed on the basis of guideline-based 
evidence, and usually found incorporated into clinical pathways and described against 
a timeline [16, 347]. Examples of TPs for severe acute respiratory syndrome [348], 
post resuscitation care [349], lung donor treatment [350] and rhabdomyolysis-based 
renal failure [347] show the structure of these to treatment steps arranged in sequence 
for a particular clinical presentation. Some also include outcome assessment factors 
for evaluating the success of protocol application or for consideration of whether to 
move the patient onto more aggressive treatment options [348, 349]. Given the 
structure and presentation of TPs, many have potential for description using the 
graphical formalisation of the caremap. 
 
5.2 THE EXPANDED DE BLESER APPROACH 
Clinical care process specification (CCPS) documents have been viewed from 
the perspective that they consist of elements that can be represented along continuums 
describing either their degree of prescriptiveness or input to healthcare quality 
improvement [304]. Both continuums and elements were applied in development of a 
characterisation framework, but in De Bleser et al’s case, applied to clinical pathways 
only [304]. The continuum and elements were represented on two axes: the x-axis 
having elements ranking the pathway from descriptive to prescriptive, and the y-axis 
using elements that describe levels from current practice to healthcare quality 
improvement [304]. However, it was necessary to extend De Bleser’s framework in 
two ways. The first adds an additional dimension to De Bleser’s coordinate system 
approach by describing CCPS documents’ evidential and practical applicability: that 
is, the addition of a z-axis describing the hierarchy of evidential strength contained 
within the CCPS document and how applicable or useable the document is in the 
delivery of clinical care to the individual patient. This is illustrated in Figure 9, where 
the newly applied axis is represented horizontally. The second extension applied the 
resulting extended framework to the hierarchy of six care process specifications and 
thus provides a standard for comparison and accurate characterisation of each clinical 
care process specification. 
 
Figure 9: The expanded De Bleser approach 
 
5.3 TAXONOMY FOR CLINICAL DOCUMENTATION 
In developing the taxonomy shown in Figure 10, the literature collected in 
section 4.1 was reviewed using the CA, TA and meta-narrative methods described in 
section 3.1. All instances identified in the table in appendix D were considered, along 
with authors’ definitions and descriptions of each document type and input from our 
clinical experts. The taxonomy presented identifies the categories of clinical 
RCD: Routine Collected Data 
RCT: Randomised Control Trial 
documents we determined from our review as being unique or distinct, as well as a 
hierarchy for how authors described each as being derived from, dependant on, or 
acting as a component of another. A solid connecting line, or arc, represents where a 
strong and direct, almost parent-child relationship was resolved from the literature. A 
dashed connecting arc represents those instances where an indirect relationship was 
inferred from authors’ narratives. Each document type and their described 
interrelationships are discussed in the following section. 
 
 
Figure 10: Taxonomy and hierarchy for clinical documentation 
 
The relationship between this taxonomy and the expanded De Bleser model in Figure 
9, especially in the hierarchy of systematically developed evidence described on the z-
axis, is notable. In both cases the clinical care specifications naturally fall in order of 
clinical, or operational, usability. 
 
 
5.4 CHARACTERISATION OF CLINICAL DOCUMENTATION 
Table 4 provides a characterisation for CCPS based on their presentation, 
structure, the population they effect and their clinical intention. It also positions each 
document with reference to De-Bleser et al’s continuums, or axes. The x-axis 
(descriptive / prescriptive) and the y-axis (healthcare quality improvement). And 
finally, it aligns the six clinical CCPS on a continuum in order of operational usability.  
 
Table 4: Characterisation of Clinical Documentation 
  CPG Clinical 
Pathway 
Care Plan CDR Caremap Treatment
Protocol 
Presentation Primarily Free 
text Ensemble Free text 
Structured text 
Columnar   
   (day-to-day) 
Graphical 
description 
Columnar 
Temporal flow 
(day-to-day) 
Structured text 
(If this, do that) Contemporary Graphical 
Flow diagram 
Cyclic 
 
Temporal or 
sequential 
Structured text 
  
step-by-
step   instruction
s 
Application Cohort 
(condition/ 
intervention) 
Generic 
Cohort 
(condition/interve
ntion) Generic 
Pt Specific Condition 
investigation or 
intervention 
Specific 
Event or 
condition specific Intervention specific  
Grounding Evidence 
based 
Graded 
evidence 
Consensus 
based 
  
Do not usually 
include 
discussion of 
evidence 
Do not usually 
include 
discussion of 
evidence 
Do not usually 
include 
discussion of 
evidence. May 
refer reader to 
CPG 
Do not usually 
include 
discussion of 
evidence 
Do not usually 
include 
discussion of 
evidence 
Contextual 
Domain 
All domains More common in 
nursing 
Nursing Medicine Traditional: 
nursing 
Transitional: 
mostly nursing 
Contemporary: 
more common in 
medicine, less 
common in 
nursing 
All domains 
Aim/Goal Reduce 
variation from 
evidence-
based practice 
Define outcomes 
Cost 
containment 
Resource 
containment 
 Provide day-to-
today evidence-
based care 
schedule for a 
particular patient  
 Provide 
algorithm/rules to 
support clinical 
decision making  
Reduce variation 
while expediting 
decisions by 
providing defined 
care and 
treatment paths 
 Operationalise 
particular 
treatment steps 
of the CPG  
Usability Least 
operational Þ 
  
Most 
operational 
 Descriptive/ 
Prescriptive 
Plan Care Plan Care Plan Care Strategy/ 
Method/ Tool 
Strategy/ 
Method/ Tool 
Strategy/ 
Method/ Tool 
Healthcare 
Quality 
Improvement 
Approach/ 
Plan 
Approach/ 
Plan 
Approach/ 
Plan 
Procedure Procedure Procedure 
 
This characterisation is robust in the sense that in addition to De Bleser’s 
elements it also incorporates aspects that allow CCPS to be analysed more 
comprehensively in terms of their content, structure and target patient cohort. This 
table would be useful in tasks seeking to identify or design particular CCPS 
documentation and ensure that it covers all of the aspects incorporated in Table 4. 
 
5.5 CCPS: CASE STUDY 
This section applies the CCPS taxonomy and characterisations to clinical 
documentation from England on the topic of Type 2 Diabetes (T2D) and Diabetes in 
Pregnancy. In each of the following, any reference to a section identifies a section so 
labelled within the identified CCPS document being described. Each of the 
specifications cited includes a URL in the reference so that the reader may access and 
assess the source document. 
5.5.1 Policy 
Three related documents were identified within England that describe policy 
regarding diabetes, and more specifically Type 2 Diabetes (T2D). These include 
government, health and clinical policies and are listed in Table 5. 
 
Table 5: Policy Documents for Type 2 Diabetes 
Government Health Policy Health Matters: Preventing Type 2 Diabetes [351] 
National Health Policy National Strategy and policy to prevent Type 2 Diabetes [352] 
National Clinical Policy NHS England: Action for Diabetes (NHS, 2014) [353] 
 
Government policies generally open by expounding on the scope and scale of a 
public health issue. This information, which centres around the community and 
resource impact of the medical condition tends to be followed by pronouncements that 
are so simplified that they lose the proper meaning and efficacy they are intended to 
convey. In effect, they miss their goal and become more like promotional material 
intended for the media. An example from the Government Health Policy identified in 
Table 5 is shown in Figure 11, where, at the time of writing, the government set the 
goal of delivering weight loss, which was achieved in a very small subset of cherry-
picked and highly motivated volunteers. As with all such experiments, caution should 
be used when claiming these results will be transferrable to the general population. 
Success in such situations is rarely achievable. 
 
 
Figure 11: Clinical Practice Guidelines for T2D (UK Government, 2018) [351] 
 
One component of this same policy which has become enshrined in UK taxation 
legislation, is the laudable challenge to remove 20% of the caloric content comprised 
by sugar from all products produced across the food and drinks industry. Whilst put in 
holistic context, this caloric-reduction policy carries over in section 4 of the identified 
National Health Policy. However, this policy approach has resulted in manufacturers 
finding it necessary to replace sugar primarily with artificial sweeteners like aspartame 
and saccharin. Both these non-nutritive sweeteners have received sufficient research 
to suggest that the health dangers of frequent or daily use may also be harmful [354-
356]. This example demonstrates our claims regarding policy: (a) that it is politically 
motivated; (b) that it is often not based on established scientific evidence; and (c) that 
it tends towards having been constructed by politicians from many small sound bites 
seeking air time to expound the virtues of their policy and elicit support from the 
ordinary citizen.    
5.5.2 Clinical Practice Guidelines 
CPGs range from those that broadly present considered recommendations of best 
practice suitable internationally, through to hospital guidelines that are customised by 
consultants based on the characteristics they observe in the local population. A 
selection, again relevant to diabetes care in England, are shown in Table 6. 
Table 6: Clinical Practice Guidelines for Type 2 Diabetes 
International CPG IDF Clinical Practice recommendations for managing T2D in 
primary care [357] 
Management of hyperglycaemia in Type 2 Diabetes (ADA & 
EASD) [358] 
National CPG Type 2 diabetes in adults: Management [359] 
Pharmacological management of glycaemic control in 
people with Type 2 Diabetes [360] 
Local CPG Barts Health NHS Trust CPG: Diabetes in Pregnancy [361] 
Type 2 Diabetes: Reducing hypoglycaemia [362] 
 
Similar to the government policy which claimed it had, or would, deliver weight 
loss, the IDF international guideline at section 1.2 recommends weight loss as the key 
tool for preventing T2D. It also presents more responsible with regards to its scientific 
and evidentiary basis than the government policy, in that it recommends avoidance of 
sugar and sugar-sweetened drinks rather than replacement with artificially sweetened 
versions. 
The international guideline at section 1.3 also provides for a regimen of testing 
and thresholds to be used in diagnosing the diabetic patient. In this case the IDF 
guideline follows a diagnostic standard from another international guideline, that of 
the World Health Organisation (WHO). Similar diagnostic testing and threshold 
recommendations carry through in the first National CPG at section 1.6, and Barts 
Health Local CPG at section 4.3.  
At each level the recommendations in CPGs are seen to become more capable 
of application to patient care. While the international and national guidelines are 
written from a best-practice perspective, hospital guidelines tend towards being more 
pragmatic and patient-centred. The international and national guidelines present the 
perfect scenario or perfect model for treatment, while local guidelines recognise that 
there are non-compliant patients and not everything will go according to plan. The 
contrast is as one might expect, and not dissimilar to that between fiction and reality. 
5.5.3 Clinical Decision Rule 
In many cases CDR can be identified and isolated from within the content of 
local CPGs. The diagnostic threshold rule for glycaemic control in pregnancy for 
diabetic mothers who were treated only with diet control in Table 7 is drawn from 
within the Barts Health NHS Trust Local CPG referenced in Table 6 comes: 
Table 7: Clinical Decision Rule for Diabetes in Pregnancy 
10.1 Monitor blood glucose 4 hourly.  
 
If blood glucose >7.0mmol/L on 2 consecutive occasions, start IV insulin/glucose 
infusion. 
 
If the woman requires a Caesarean section and the blood glucose >7.0 mmol/L, 
start IV insulin/glucose regime. 
 
5.5.4 Clinical Pathway 
Two English diabetes clinical pathways are referenced in Table 8. Each presents 
an approach to screening and patient assessment, care planning, patient support and 
education that includes lifestyle changes in diet, weight, exercise and insulin/glucose 
control. Each also makes reference to, and recommendations regarding, potential 
complications that may arise in future for these patients and advises the signs and 
symptoms that clinicians and patients should be mindful of. These pathways present 
as a generic blueprint for care of patients with diabetes. 
Table 8: Clinical Pathway for Diabetes 
Clinical Pathway Clinical Management: Optimal pathway [363] 
Clinical Pathway New Patient Clinic Pathway [364] 
 
5.5.5 Care Plan 
Care plans are the first of the clinical care specifications that present with 
customisation for the immediate patient. Each of the example care plans in Table 9 
presents with information and contact details for services the patient may require. 
More importantly however, each provides space and tables for recording the day-to-
day condition, treatment and care recommendations specific to that patient.   
Table 9: Care Plan for Diabetes 
Care Plan  My Personal Diabetes Health Care Plan and Record [365] 
Care Plan My Personal Diabetes handheld record and care plan [366] 
 
5.5.6 Caremaps 
Caremaps provide a visual roadmap of care for a specific condition or treatment 
process. Caremaps can aid in treatment selection, understanding of disease 
progression, and can also provide the base knowledge that, together with clinical 
expertise, may be used in other forms of health research. The EPSRC-funded 
PAMBAYESIAN project has demonstrated that caremaps can be used in the 
development of Bayesian-based LHS [367]. PAMBAYESIAN developed the 
caremaps listed in Table 10 for diabetes in pregnancy as part of research and 
development of clinical decision support LHS for use by both clinicians and patients. 
Table 10: Caremaps for Diabetes in Pregnancy 
Midwifery Booking Visit  GDM Booking Visit [368] 
Diagnostic Caremap GDM Diagnostic Decisions 2.0 [369] 
Management Caremap GDM Management Decisions 2.0 [370] 
 
Caremaps can be further instructive with the addition of decision points. This 
addition provides detail at the points where clinicians are called to make diagnostic or 
treatment decisions for the instant patient. With the input of experienced clinicians, the 
PAMBAYESIAN caremaps include decision points and diagnostic criteria, as shown 
in Figure 12. 
 
Figure 12: GDM Booking Visit Caremap with Decision Points 
 
5.6 STANDARDISATION BEFORE COMPUTERISATION 
CCPS Computerisation: Various types of CCPS such as caremaps, clinical 
practice guidelines and clinical protocols are increasingly becoming the subject of 
computerisation [371]. For computerisation to be easily achievable, CCPS need to be 
formalised in order to render them computer-interpretable [372]. Formalisation of 
CCPS refers to specification using precise and unambiguous terms and structures, 
usually using computational or mathematical formalisms, rendering the resulting 
CCPS as computer interpretable. 
Standardisation as a Prerequisite to Computerisation: CCPS 
computerisation is enabled by CCPS formalisation which in turn is enabled by CCPS 
standardisation. Consequently, computerising CCPS that have not first been 
standardised creates more problems than it solves. While this research has referred to 
the need to standardise the structure and presentation of CCPS, there is also a need to 
standardise the content captured within the CCPS by standardising the underlying 
language. This is crucial to the challenge of formalisation to attain computer 
interpretability and hence computerisation. 
Role of Data and Information Standardisation in CCPS Computerisation: 
Data standardisation is needed to resolve the Data Triple-I Issues of integrity, 
integration and interoperability identified in a 2019 literature review as significant 
barriers to adoption of health information technology [373]. The use of standardised 
clinical terminology and approaches to eliciting and reporting routine clinical data is 
necessary to improving clinical practice and communication and enabling accurate 
computerisation of health record data [374]. In our experience there are many existing 
healthcare provider projects in the United Kingdom, Australia and New Zealand that 
seek to standardise coding of data as it is captured. The issue observed is that they do 
this more often without considering whether the underlying CCPS was standardised 
first. Where standards are considered there tends to be disagreement as to which 
underlying methodology, terminology, data standard or data exchange protocol should 
prevail: SNOMED, ICD-10, METeOR, FHIR or some other.   
The Benefits of Standardisation in the Context of CCS Computerisation: 
Standardisation of CCPS has been observed to improve data collection, data quality, 
and to enable automated coding and analysis [375, 376]. Standardisation of CCPS 
using approaches that include: (1) defined data definitions; and (2) attention to built-
in computer interpretability [377] supports data standardisation, mitigating the Data 
Triple-I issues and increasing the chances for successful creation and adoption of LHS. 
  
5.7 DISCUSSION 
The confusion arising out of the absence of standardised definitions and 
nomenclature for clinical documents has been known since at least 2006 [378, 208, 
304, 379]. Resulting from this lack of standard terminology and taxonomy have been 
successive and discordant attempts at defining and describing structures and 
development processes for some clinical documents [378, 304, 379]. These have only 
served to exacerbate the lack of standardisation. This is further intensified when we 
observe examples of authors who identified multiple document types as synonymous 
in name or structure [378, 208, 16, 343], only to differentiate them in the same research 
by describing one as a single or multi-component item of the other [16, 343], or a 
translation of the other represented in different structural form [378]. In [39] we 
reported examples where authors’ described a clinical document in-text using one label 
listed in the CCPS taxonomy, only to find that the author’s included clinical document 
titled or described itself using another e.g.: [205] and [206]. Such instances exemplify 
this issue and its potential to create lasting confusion. 
While authors have attempted to define or present approaches to the 
development of different clinical care process specifications during the last two 
decades, significant variance in the complexity level, design approach, content and 
representational structures for the majority has persisted [207, 39]. As a result of this 
lack of standard and formal care process specifications, differences in communication 
and information transfer between clinicians providing care for the same patient can be 
substantial and ubiquitous, affecting the quality of care and introducing additional risk 
of harm for as many as 25% of all patients [380-382]. Error reporting documentation 
is similarly, and more often, not standardised. However, even where some effort has 
been made to standardise, clinical decision and treatment errors remain underreported. 
While clinicians and clinical researchers are encouraged to be honest and transparent 
in such situations, we can never be absolutely certain whether reported error figures 
quoted are representative of the entire scope of the problem [383-386]. 
Standardised approaches, especially in clinical documentation, ensure that each 
time a healthcare provider approaches that type of document, the format and content 
are consistent with expectation [39]. Standardised documentation ensures sufficient 
higher quality information is recorded and reported, enabling documents to be read 
quicker and content within to be better retained, all with the effect of improving overall 
patient safety and outcomes [380, 88, 381, 39, 89]. Standardisation of specifications 
also brings benefits that go beyond being operational or purely clinical. The data triple-
I issue represents the biggest single barrier to learning health systems (LHS) [373, 
387]. Standardisation of clinical care specifications can enable computer 
interpretability, which in turn supports data standardisation and increases the chances 
for successful LHS implementation. 
 5.8 SUMMARY 
Since the early 2000’s there has been a significant shift towards standardisation 
of healthcare and healthcare practice. Efforts to standardise healthcare can be held 
back by many things, one of which may be the lack of consistent nomenclature and 
definitions for CCPS documents, many of which are used every day in hospitals and 
general practice clinics. This research has addressed the challenge by presenting a 4-
layer taxonomy for clinical care process specification documents that begins with 
those documents that are least able to be applied in clinical care and moves towards 
those which are most capable of use in the clinical setting, and evaluating this 
taxonomy through a case study looking at a range of clinical care process specification 
documents from the UK concerning diagnosis and treatment of patients with Type 2 
Diabetes and diabetes in pregnancy. It is intended that the results and discussion should 
stimulate those in healthcare and healthcare service management to consider the 
potential benefits of standardising clinical documentation in the same way that 
evidence-based medicine aims to standardise healthcare. Standardising the way patient 
care is documented and reported will reduce significant data integration and 
interoperability issues as national health services continue to move towards 
implementing centralised electronic shared care records. 
 
  
Chapter 6: The Heimdall Framework  
Using comprehensive analysis of literature for LHS collected by the search 
discussed in Chapter 4, this chapter initially seeks to characterise and present the first 
complete taxonomy for LHS, and position the identified types within the wider 
healthcare domain. Then, with addition of the EHR literature collection from Chapter 
4, this chapter seeks to: (i) identify challenges that have inhibited adoption of health 
information systems for clinical practice; and (ii) ascertain whether there is a 
relationship between those factors that previously inhibited EHR adoption, and those 
that authors believe currently restrain acceptance of LHS.  
Section 6.1 extends our general understanding of the issues that inhibited EHR 
through an analysis of the barriers and facilitating factors of EHR implementation. 
Section 6.2 identifies the concepts that define and characterise LHS, as well as 
presenting and validating a taxonomy for LHS. How LHS may integrate into the 
learning health organisation and draw efforts at EBM towards precision medicine is 
depicted in section 6.3 with presentation of a novel framework, the Heimdall 
framework. Section 6.4 extends the established ITPOSMO methodology, resulting in 
a new approach named ITPOSMO-BBF. ITPOSMO-BBF is then applied to analyse 
and compare the current state for EHR and LHS implementations and the results are 
discussed in section 6.5. Section 6.6 summarises the chapter.  
 
6.1 EHR: BARRIERS AND FACILITATORS 
The CA and TA methods discussed in section 3.1.3 were used on the literature 
collected at section 4.2 to identify barriers, benefits and facilitating factors, and 
examine the frequency and context within which authors described these themes. It 
was possible to categorise many identified themes within a key theme: a grouping of 
related themes. Key barrier and facilitator themes are listed in Table 11, which also 
lists the literature in which each theme was identified and whether the authors 
discussed it in the context of: (a) a barrier inhibiting implementation or use of EHR, 
or (b) if appropriately engaged, a potential facilitating factor increasing the likelihood 
of success for a new EHR implementation. 
 Table 11: EHR literature categorised into key themes by TA 
 Key Themes  
 Barriers Facilitators 
1 Willingness, interest or motivation to adopt new HIS 
and frameworks 
[240, 235, 242, 237, 263] [388] 
2 Training and skills with computer systems and HIS [389, 390] [234, 243, 264, 237-
239] 
3 Data standardisation, interoperability and integration [391, 392, 258, 393, 388, 
394, 395, 224, 225, 396, 
397] 
[234, 84, 394, 238, 398] 
4 Changes to legislation, policy and government-
mandated financial factors (incentives or penalties)   
[156, 258, 393, 394, 390, 
399] 
[388, 241, 400, 395, 
224, 225, 401, 399, 402] 
5 Capital investment, implementation, maintenance and 
support costs 
[154, 240, 234, 393, 235, 
241, 403, 242, 243, 262, 
264, 390, 225, 237, 238, 
398] 
[154, 393, 235, 241, 
262, 238, 263, 398] 
6 Impact of EHR on health outcomes and patient-clinician 
encounter within the patient care workflow 
[154, 240, 234, 241-243, 
262, 237, 238, 263, 239, 
398] 
 
7 Privacy, security, data integrity and accuracy [404, 154, 240, 234, 235, 
242, 264, 390, 225, 405, 
237, 399, 238, 263] 
[241, 238, 406] 
8 Approvals and ethics oversight for use of digital health 
data 
[236, 397]  
9 Organisational culture, management and clinician 
attitudes to change  
[404, 154, 234, 242, 262, 
237, 407] 
[154, 234, 408] 
10 Identifying and involving all relevant stakeholders  [409, 410, 263] [154, 240, 237, 263, 
397] 
 
6.2 A TAXONOMY AND CHARACTERISATION FOR LHS 
By drawing on the literature collected in section 4.3, this section seeks to resolve 
the research community awareness challenge introduced in section 1.5.2 to develop a 
characterisation, taxonomy and unifying framework for LHS. 
6.2.1 Characterisation and Conceptualisation of LHS 
The IoM definition cited at section 1.1.2 which states that a Learning Health 
System (LHS) is one in which progress in science, informatics and care culture 
converges to continuously create new knowledge as a natural by-product of a care 
process in which best practice is applied for continuous improvement [60] is repeated 
and relied upon by most authors. However, that definition both fails to contemplate 
what it means for something to be an LHS, and fails to describe attributes that would 
contribute to aspects of patient care that LHS systems should target. Namely: quality, 
safety, efficiency and efficacy of patient care. The domain has seen little development 
of these aspects [274, 23]. Similarly, the IoM definition does little to develop an 
understanding of the attributes, or concepts, underpinning implementation and usage 
of LHS in clinical practice [23], with those that are observed, like those quoted in Table 
2 of Chapter 4, being limited to the naive idea that an LHS is made up of an 
organisation forming communities who collaborate to learn new knowledge from big 
data for the purpose of quality improvement [411].  
This work synthesises the unified conceptualisation and framework for 
systematically characterising LHS from various strands of investigations undertaken 
by the author. These strands are as follows: 
• Concept: The problem of lack of understanding of the concept of LHS is 
described as the research community awareness challenge [274]. 
• Taxonomy: Development of a taxonomy describing the entire scope of LHS 
as observed in the current literature and showing how each type positions 
within the larger learning health organisation [23]. 
• Framework: Development of a unifying framework showing the role and 
context for LHS and its integration into the learning healthcare organisation 
[23]. 
• Implementation: Identification of the benefits, barriers and potential 
facilitators for LHS, and comparative analysis of how these may have arisen 
from, or be related to, those that have impacted EHR implementation during 
the preceding thirty years [387]. 
• Realisation: Demonstrating how the taxonomy, framework and factors for 
successful LHS implementation can be applied to a contemporary project to 
identify those aspects that constitute LHS, the type of LHS, the barriers to 
which facilitators may be applied and the benefits that may result. 
 
The accumulation of this research found that the concepts that define or are 
associated with LHS (conceptual composition of LHS) as shown in Figure 13 are: 
• Patient data: Collections of patient data in the form of EHR are seen as 
a near-inexhaustible source from which to learn new knowledge [61, 62].  
• Computing System: Not limited to the computers used to access or store 
patient data, but also includes those which contain the programs and 
perform the machine learning, prediction and other computing necessary 
to learning and applying knowledge [248, 62].  
• Learning: The concept of learning as it relates to LHS is the processes 
that analyse data to derive or generate new knowledge [248, 61, 102, 62].  
• New knowledge: The new knowledge learned from patient data can 
advance our understanding of the underlying mechanisms of disease and 
patients’ response to treatment [249, 62].  
• Near real-time: The current driving ambition for LHS is to expedite the 
process, often described in terms of a seventeen-year lag, of getting 
knowledge to inform clinical decisions from scientific discovery to 
clinical use [249, 61, 87, 62]. 
 
 
Figure 13: Five Concepts that define Learning Health Systems 
 
6.2.2 Taxonomy for LHS 
Only three papers could be identified that proposed classification systems for 
LHS [257, 86, 87]. Surveillance and Comparative Effectiveness Research were the 
only types common to all three. Figure 14 unifies the knowledge identified from all 
three papers into a taxonomy of nine LHS classification types, indicating abbreviations 
(initials) and the primary reference for each.  
Cohort Identification (CI) seeks patients with similar attributes, used to 
determine the feasibility of studies and quantify numbers of potential patients that may 
be helped [87]. CI is also the first operational step of most other LHS types. 
Positive Deviance (PD) uses outcome data to benchmark clinical care. PD 
identifies elements of safer, more effective, timely and patient-centred care, 
recognising beneficial behaviours for incorporation into another clinician’s practice 
[412]. PD can also identify common traits of patients benefiting from a treatment, 
using these to identify others who may benefit from the same intervention [87]. 
Negative Deviance (ND) identifies instances of sub-optimal care. ND 
presupposes some particular clinical behaviour negatively impacted patient care and 
the resulting outcome. The clinician critically evaluates the care provided, 
investigating causes for sub-optimal results [257]. 
 
Figure 14: LHS Taxonomy 
 
Predictive Patient Risk Modelling (PPRM) uses patterns discovered in patient 
datasets to identify cohorts at higher risk for future adverse events. PPRM can also use 
routine health data to identify ‘triple fail’ events; where treatment fails to improve 
patient care experiences, population health, or lower healthcare costs [413]. 
Predictive Care Risk and Outcome Models (PCROM) algorithms identify 
situations of high risk for ‘unsafe,’ ‘delayed,’ or ‘inefficient’ care, providing estimates 
of the effectiveness of different interventions [86]. Geisinger Health Systems have 
incorporated PCROM approaches into clinical software, identifying when spikes in 
hospital activity or patient non-attendance may occur [414]. 
Clinical Decision Support Systems (CDSS) are active knowledge systems 
where two or more characteristics of the patient are matched to computerised 
knowledge bases with algorithms generating patient-specific treatment 
recommendations [415-417]. 
Comparative Effectiveness Research (CER) compares interventions and 
outcomes within an EHR dataset to determine the most effective treatment; using a 
method considered more efficient than randomised control trials [86]. CER isolates 
patients with similar attributes to the current patient, returning knowledge on 
treatments that deliver optimum health outcomes [418]. 
Intelligent Assistance (IA) uses data sources to automate routine processes such 
as prepopulating pathology orders and clinical notes, or summarising patient case notes 
prior to consultations [86]. 
Surveillance (S) monitors EHR data for outbreaks of disease (e.g. measles) or 
treatment issues (e.g. contaminated medicines or increased frequency for post-surgical 
infections). Examples observed include Health and Demographic Surveillance 
Systems (HDSS) used in sub-Saharan Africa [419]. 
6.2.3 Validation of the LHS Taxonomy 
To validate that the LHS taxonomy included all currently classifiable types of 
LHS, proposed or presented solutions from the LHS literature collection described in 
Chapter 4 were reviewed and classified using the taxonomic descriptions. Some 
proposed solutions were incompletely described; but it was observed that the intention 
of the authors was always clear from the information presented. All LHS solutions 
conformed easily to one of the identified taxonomic types. It is proposed that this 
validates the taxonomy as it has been presented. This validation of the taxonomy also 
found CER were the most prevalent type of LHS presented in the literature, as 
identified in Table 12. CER was followed at some distance by stand-alone CI, although 
it should be noted that this classification type had not been identified by either [257] 
or [86]. 
 
 Table 12: Distribution of LHS Solutions (per 100 publications) 
Comparative Effectiveness Research (CER) 44 
Cohort Identification (CI) 14 
Clinical Decision Support System (CDSS) 13 
Predictive Patient Risk Modelling (PPRM) 10 
Positive Deviance (PD) 8 
Intelligent Assistance (IA) 3 
Negative Deviance (ND) 3 
Surveillance (S) 3 
Predictive Care Risk and Outcome Models (PCROM) 2 
 
6.3 HEIMDALL: THE INTEGRATED LHS FRAMEWORK 
Just as the Norse God Heimdall was said to be the son of nine mothers, the 
Heimdall framework starts from the nine LHS classifications to develop the integrated 
LHS framework in Figure 15. The diagram’s conical structure demonstrates how the 
use of technology (large datasets and processing systems) to record, store, index and 
present information, flowing into and improving the learning processes used in EBM, 
can focus clinical practice towards delivery of precision medicine (PM). This enables 
the learning healthcare organisation to engage in decisions individualised to match 
unique patient characteristics. 
PM results from enhancing the generalised population health approach using 
attributes in the EHR to constrain analysis for diagnosis and treatment options to 
cohorts predominately matching the presenting patient’s profile. As the clinician enters 
attributes about the current patient, the speed and accuracy of decisions increase as 
illustrated by arrows in Figure 15. LHS draw knowledge from a reducing cohort whose 
attributes predominately match the current patient as illustrated by the circular design. 
In examining a cross-section of Figure 15, the larger white circle represents the entire 
population used to select the most effective common treatment. The light grey circle 
reduces that population to those who share some basic attributes with the patient that 
would normally be identified in the slower learning organisation approach of EBM. 
The inner dark circle further reduces the population to a significant cohort with 
clinical, genetic and socioeconomic attributes predominately matching the patient at 
the centre. The interrelationship between the Heimdall framework and the LHS 
taxonomy is shown down the right side of the conical portion of the diagram. While 
LHS are technology solutions, the majority operate in the context of either the 
treatment provider’s learning organisation, or the clinician’s primary patient-facing 
role. 
 
Figure 15: The Heimdall LHS Unifying Framework 
 
Incorporated within this framework is the concept of the clinical lifecycle as 
shown in Figure 16 and adapted from multiple works in this review, including [418, 
257, 414]. The right side of the diagram represents largely clinician driven aspects, 
while the left side identifies those aspects where LHS technology delivers 
improvements. The more challenging barriers to LHS regarding data quality, 
interoperability and standardisation all result from activities on the right side of the 
lifecycle. 
 Figure 16: A generalisation of the clinical knowledge translation lifecycle 
 
This cycle is repeated, both for surveilling the proposed transformation, and to 
seek further items of knowledge [418, 257, 414]. LHS engender a close relationship 
between care, research and knowledge translation, aimed at providing a platform for 
integrating various data to better understand patients [420]. LHS are commonly 
described using an iterative lifecycle similar to many other EBM processes where: (a) 
patient data is collected by clinicians, (b) aligned, transformed, and amalgamated into 
larger data sets; (c) a problem is defined and, (d) analysis performed; (e) with evidence 
data returned, and; (f) made into new knowledge, that is; (g) used to transform clinical 
practice. 
The taxonomy and Heimdall framework together provide a toolkit for 
characterising LHS literature in terms of the following thematic and analytical aspects 
to assess whether the LHS demonstrates: 
• Taxonomic Consistency – conforms to the taxonomy. 
• Patient Focused – ensures personalised health care, known as PM.  
• Technology Usage – uses health IT with big data, machine learning 
algorithms and automation. 
• Decision Support – near real-time support to clinicians, bringing recent 
scientific advances, machine learning and EBM together at point-of-care. 
• Application of LHS – goes beyond selecting ‘most likely treatment for a 
population’, to selecting the ‘most applicable treatment for an 
individual’. 
• Barriers and Further Observations – challenges limiting 
implementation. 
 
As for EHR, CA and TA were used to identify barriers and facilitators for LHS. 
These were grouped using the same process and key themes and are shown in Table 
13.  
Table 13: LHS literature categorised into key themes using TA 
 Key Themes  
 Barriers Facilitators 
1 Willingness, interest or motivation to adopt new HIS 
and frameworks 
[156, 260, 392, 421, 86, 393, 
422, 62, 405] 
[418, 156, 157, 423, 
392, 87] 
2 Training and skills with computer systems and HIS [244, 246, 62, 396, 406] [424, 425] 
3 Data standardisation, interoperability and integration [156, 426, 391, 427, 159, 
421, 86, 428, 225, 405, 429, 
430, 406, 397, 425] 
[418, 158, 427, 159, 
431, 428, 402] 
4 Changes to legislation, policy and government-
mandated financial factors (incentives or penalties)   
[156, 246, 391, 392, 257, 
431, 432, 421, 87, 433, 388, 
434, 390, 435] 
[158, 392, 432, 433, 
388, 394, 436-439] 
5 Capital investment, implementation, maintenance and 
support costs 
[156, 157, 427, 421, 268, 
440, 400, 26, 441, 442] 
[153, 244, 158, 252, 86, 
84, 389, 268, 396, 441] 
6 Impact of LHS on health outcomes and patient-clinician 
encounter within the patient care workflow 
[391, 392, 258, 388, 400, 
390, 405, 397, 402] 
[428, 405] 
7 Privacy, security, data integrity and accuracy [418, 156, 246, 391, 260, 
392, 257, 248, 421, 84, 388, 
62, 428, 400, 395, 401, 26, 
429, 397, 402, 443] 
[158, 159] 
8 Approvals and ethics oversight for use of digital health 
data 
[247, 248, 444, 434, 400, 
445, 396, 270, 446, 399, 
406] 
[400, 399] 
9 Organisational culture, management and clinician 
attitudes to change  
[418, 158, 431, 86, 447, 433, 
265, 62, 396, 430, 406] 
[431, 84, 448, 430, 425] 
10 Identifying and involving all relevant stakeholders  [418, 449, 424, 246, 158, 
427, 260, 392, 431, 421, 
422, 444, 436, 450, 448, 
400, 401, 26, 441, 451, 452, 
397] 
[157, 431, 453, 84, 448, 
440, 26, 446] 
 
6.4 ITPOSMO-BBF ANALYSIS  
This research extended the ITPOSMO framework to support comparative 
analysis of barriers, benefits and facilitators that are identified from the literature for 
both EHR and LHS: naming the resulting new framework ITPOSMO-BBF.  
ITPOSMO-BBF adopts the aspects and dimensions of the original ITPOSMO 
framework [178], and combines these with the concept of a framework for analysing 
barriers and facilitators from [454]. The resulting new framework developed for this 
research is then used to identify related benefits that authors identify as resulting, 
whether directly from mitigating the barriers or simply from applying the identified 
facilitators. Figure 17 provides an example of the ITPOSMO-BBF diagrammatic 
structure that: (1) identifies barriers and facilitators to the implementation of EHR and 
LHS and the frequency with which they were discussed in the literature; (2) quantifies 
the relationships between facilitators and barriers, and; (3) identifies potential benefits 
authors expect from resolving the listed barriers.  
 
 
Figure 17: ITPOSMO-BBF diagram structure 
 
Each of the four ITPOSMO-BBF diagrams presented in the Results chapter 
provide key data, including the percentage of EHR and LHS literature identifying a 
particular barrier or facilitator, the contextual relationships observed in authors’ 
discussions of barriers and facilitators, and the corresponding benefits ascribed to 
resolving the barriers or engaging with the facilitators. The frequency of attention 
drawn by authors to the relationship between a barrier and a facilitator is shown using 
a weighted line. Figure 18 identifies the relationship between the number of authors 
discussing a relationship and the thickness or weight of the line identifying that 
relationship in the ITPOSMO-BBF diagrams.  
 
 Figure 18: Line weight and number of authors 
 
While ITPOSMO was developed as a retrospective analysis of projects that have 
already been completed, ITPOSMO-BBF can be used with data on barriers and 
facilitators to understand, plan for and mitigate potential barriers prior to a new EHR 
or LHS implementation. 
Except for the fourth and seventh themes from Table 11 and Table 13, which 
were found to fall equally across the boundaries of two aspects, Figure 19 shows that 
each of the key themes could be located within a single ITPOSMO aspect. Themes are 
distributed outwards from the centre based on the strength of their heterogeneity from 
other aspects – that is, the more a theme identified within a particular aspect and apart 
from other aspects, the further out from the middle it is located.  
 
Figure 19: Linking the key themes to ITPOSMO aspects 
 
6.4.1 Barriers 
Every author presenting an HIS implementation spoke of barriers or challenges. 
Some presented as barriers to entry, such as the high cost to implement and support 
EHR  and other health information systems (HIS) [234, 241, 237] or issues resulting 
from complicated and inconsistent legislation [240, 235, 263]. Others presented as 
barriers to success, including the need for data and systems standardisation [237, 238, 
263], interoperability [242, 264, 263] or integration [242, 243]. Finally, there were 
barriers to organisational culture [455] such as clinical users and patients who 
expressed reticence or negative attitudes towards the use of computing systems and 
resistance to potential changes in workflow that it was claimed would disrupt the flow 
of patient care [241-243] or impact time management [264, 238, 398], and opposition 
to the requirement for staff development and training in information systems use [234, 
241, 243]. Issues of data accuracy and integrity which could have lasting impact on 
patient care and health outcomes were also claimed to arise from using health 
information technology [237, 238, 263, 398]. Concerns were expressed that systems 
producing, storing, exchanging or amalgamating health data could negatively impact 
patient privacy and confidentiality [234, 242, 262, 264], with adequate data security 
remaining as an unresolved primary challenge [154, 234, 238].  
Appendix A provides detail of the individual authors and frequency with which 
each barrier was discussed. Figure 20 presents the EHR barriers grouped within the 
referential thematic context in which each author discussed them. Barriers naturally 
presented from the literature in the context of four archetypal themes (shown in blue): 
(1) Human Factors issues; (2) Technological/ IT Issues; (3) Policy issues, and; (4) 
Finance issues. Sub-themes (shown in black) were identified that further 
contextualised small groups of identified barriers. Authors gave greater attention to 
human factors barriers affecting staff and clinicians. These barriers including clinician 
resistance, the need for training, support and user champions, and the potential for 
disruption to patient care and increased clinical workload. Further analysis was 
performed to separately identify who authors described as being primarily affected by 
some of the more frequently identified barriers. Figure 21 displays these lines of effect 
in red. While most of the attention in the literature is being directed towards barriers 
arising from staff and clinicians, this shows that it may be patients who are more 
frequently impacted.  
 Figure 20: EHR Barriers 
 
 
Figure 21: EHR Barriers indicating ‘barrier directly affects’ 
 
Finally, Figure 22 indicates how the identified barriers distribute within the four 
ITPOSMO aspects that will be used later in this chapter to contrast barriers and 
facilitators.  
6.4.2 Facilitators of EHR Adoption 
The literature demonstrates that patience [243], committed leadership [242, 
262], systematically planned incremental implementations [234, 262] all have 
considerably positive effects. Early collaboration with clinical users [234, 242], 
provision of both general computer and EHR-specific training [234, 243, 237], and 
engaging user champions to drive acceptance and reduce user frustration [404, 234, 
239] were identified as substantial human factor facilitators that counter resistance. 
Resistance is considered significant enough that some medical schools have 
recommended or even mandated specific training for doctors in the implementation 
and use of health information systems [456-458]. Appendix A shows that a total of 
fourteen facilitators were identified. These were described by authors as falling within 
eight of the ten key themes as shown in Table 11.  
 
 
Figure 22: EHR Barriers within the ITPOSMO aspects 
 
6.4.3 Benefits 
Organisations contemplating HIS implementation do so with some intention of 
realising benefits [459]. While it could be argued that any benefit improves the health 
of patients, even indirectly, this research found that benefits fall broadly into two 
categories. First, there are those that have a direct positive effect on health outcomes 
for patients. These include any that increase patient safety [234, 263], reduce harm 
from treatment or medication errors [234, 238], or improve the overall quality of 
healthcare [241, 237, 238]. Second, there are those seeking to improve some metric of 
healthcare delivery: increasing efficiency and accountability [234, 241, 237], or 
reducing waste or overconsumption of resources, which accordingly increases the 
overall capacity of healthcare systems [234, 241, 262].  
6.4.4 ITPOSMO-BBF: Information and Technology 
A number of Information and Technology barriers were described by authors in 
Table 11 and Table 13. These were most often issues resulting from the stand-alone 
and bespoke nature of health systems, coupled with a lack of ability to combine 
systems or data in any simple, inexpensive or meaningful way. Little effort has been 
expended in devising facilitators to resolving these barriers, even though there are 
important benefits that could be realised. Figure 23 shows that the most frequently 
discussed facilitator that authors considered would realise a number of the listed 
benefits was the seemingly simple act of integrating historic patient data so that any 
new system presented a complete picture of the patient. 
6.4.5 ITPOSMO-BBF: Process and Objectives 
Many of the Process and Objectives (PO) barriers might reasonably appear to 
fall within the remit of ethicists. The small number remaining were raised by clinicians 
who work closest with patients, namely nurses and general practitioners. Many of the 
potential benefits authors felt would result from resolving the PO barriers would 
appear to deal directly with issues of patient safety and confidence with health services, 
yet surprisingly no single facilitator was directly attributable to resolving one of the 
PO barriers and realising the benefits presented in Figure 24. 
 
 Figure 23: Information and Technology (ITPOSMO-BBF) 
 
 
 
 
Figure 24: Process and Objectives (ITPOSMO-BBF) 
 
6.4.6 ITPOSMO-BBF: Skills and Management 
Most effort aimed at facilitating EHR has gone towards resolving ‘human factor’ 
barriers. This, in spite of the fact that authors only made reference to one benefit arising 
from facilitators in the Skills and Management (SM) element of ITPOSMO, as shown 
in Figure 25. Even in the case of technical support and training, these were described 
by authors in the context of developing skills and managing staff resistance, yet no 
single author reported that any of these facilitators was actually reducing staff 
resistance to technology or improving adoption rates for EHR. While there is strong 
interest directed towards resolving adoption issues, the facilitators presently being 
employed do not appear to have substantially resolved these issues, as the EHR 
adoption problem persists. 
 
Figure 25: Skills and Management (ITPOSMO-BBF) 
 
(ERB/IRB: Ethics Review Board/Institutional Review Board) 
 
6.4.7 ITPOSMO-BBF: Other Resources and Constraints 
The other resources and constraints (O) element shown in Figure 10 reviews 
those attributes not falling within the first three ITPOSMO elements, including 
finance, maintenance, and user and systems support. While financial incentives that 
had been enshrined in the laws of countries like the U.S. was discussed by more than 
half of all EHR papers, only three mentioned the potential for penalties for non-
adoption contained in the same legislation to be a facilitator. Note however, that none 
of the three led to the belief that the threat of penalties had helped an implementation 
of HIS. 
 Figure 26: Other Resources and Constraints (ITPOSMO-BBF) 
 
6.5 DISCUSSION 
6.5.1 EHR in the context of HIS Adoption 
A strong undertone was observed in the EHR literature, consistent with the idea 
that strong barriers still impede acceptance of EHR even when they are now largely 
ubiquitous at all levels of healthcare service delivery. One novel causal factor 
receiving attention is digital disruption. Digital disruption is a catch-all term for a 
range of related issues, described as the changes facilitated by the introduction of 
digital technologies that occur at a pace and magnitude that disrupt established ways 
of value creation, social interactions, doing business and, more generally, our way of 
thinking [460]. One group in Australia have attributed the failure of more than half of 
all EHR system implementations to poor understanding and management of digital 
disruption, failure to understand and manage disruption to clinical workflows, the 
anxiety this engenders in staff, staff dissatisfaction, and the concerns for the quality 
and safety of care being delivered during the digital transformation [461]. Elements of 
digital disruption are seen in almost all the barriers identified in this work. Facilitators, 
such as those which stipulate early staff involvement, staff training, and user 
championing have been promoted for many years as mitigants for these barriers. If the 
issues raised by [461] as elements of digital disruption are still evident, it is possibly 
because the selected facilitators do not adequately deal with the barriers identified, or 
they were not successfully employed by the authors during their hospital’s 
implementation project. Policymakers and clinicians still struggle with barriers that 
only serve to limit widespread acceptance and adoption of HIS [462-464]. 
6.5.2 Analysis of LHS Themes  
Several themes emerged during this work which are discussed in this section, 
which also includes topical analysis to investigate their effect on the LHS domain.  
Patient Focused: While clinicians argue they always practiced patient-focused 
medicine, normal clinical practice follows population medicine-based EBM [465]. 
Precision Medicine (PM) extends diagnostic practices with profiling techniques and 
therapies tailored to the individual [466, 467]. Patient focus is a key dimension that 
LHS improve [86]. PM approaches can be retrospective, as in CER, and prospective, 
when genotyping for treatment selection [466, 467]. Patient-centred care encourages 
data use in optimising care for individuals [422]. Aggregated patient records enable 
LHS to identify cohorts similar to the patient [468]. [76]. LHS is an efficient tool for 
integrating PM into practice. As the clinician enters attributes about the patient, the 
LHS refines a cohort of prior similar patients. It assesses the treatments they received 
to recommend one most likely to produce an optimal outcome. 
Technology Usage: The focus for health IT has shifted from issues of adoption 
to identifying how to best use technology to improve healthcare delivery and outcomes 
[442]. This shift is significant in creating LHS, and elevates issues in EMR/EHR 
interoperability, data standardisation and quality that must be resolved if LHS are to 
be truly practical and ubiquitous [469, 470, 442]. Health IT’s ability to improve 
healthcare service delivery quality and efficiency is recognised [471, 472]. Enabling 
necessary data flow and integration of data sources are key abilities technology can 
deliver, representing core requirements to enabling LHS [473, 420]. Integration of 
learning into technology is observed in every LHS solution reviewed. Technology is 
fundamental to LHS. As EBM evolves from paper-based roots, clinicians and 
healthcare providers will realise benefits from coupling technology to Learning Health 
Organisations, thus realising LHS [469, 474].  
Decision Support: Healthcare providers evolved from considering health IT as 
a billing and documentation facilitator, to contemplating its active participation and 
capabilities to answer complex questions in care delivery [475]. LHS bring 
opportunities for improving speed and efficiency of clinical decision support [473, 
476, 475]. LHS solutions are context-sensitive, incorporating cohort identification and 
risk modelling in real time to identify interventions for improving individual patient 
outcomes [432, 477]. LHS have potential to rapidly perform retrospective comparative 
effectiveness trials, evaluating treatment options against each other where they have 
been provided to similar patients [153, 477]. In contrast with Randomised Clinical 
Trials (RCTs), LHS is considered safer, and engenders greater confidence in accuracy 
of the treatment choice [153, 477].  
Application of LHS: Clinical epidemiology is an example of learning 
healthcare. EBM evolved from clinical epidemiology: statistically identifying the 
optimal treatment which becomes best practice for that condition [478, 479]. 
Conversely, the focus for PM is selecting from the available interventions the 
treatment that will best serve the individual. The primary driver towards population 
medicine was economic: maximising benefit while minimising cost, harm and waste 
[478]. While meant for benefiting the individual patient, population medicine has 
disadvantages in that the individual’s best interests may conflict with those of the 
population and it is difficult to reconcile the two [478, 422]. Individual patients may 
be denied higher priced precision interventions in favour of lower cost population-
optimised interventions [478]. The Heimdall framework demonstrates that LHS focus 
healthcare using population medicine and EBM directly onto the presenting patient. 
While EBM selects one treatment for all patients, LHS produces a cohort with 
attributes similar to the presenting patient, identifying the treatment most likely to be 
effective for this individual patient. LHS in this way delivers PM. 
LHS Barriers and Further Observations: Most authors discuss barriers to 
implementation. The most common are: cost [404, 480, 288]; data interoperability and 
standardisation [481, 392, 482]; poor data quality and integrity [257, 483, 435]; 
informed consent and ethics review complications [484, 485, 400]; privacy and 
security issues [418, 481];  and slow technology adoption [481, 421, 486]. These issues 
are discussed in the same context as they were for adopting EHR/EMR. This suggests 
LHS are inheriting challenges from the EHR/EMR on which they depend. 
6.5.3 ITPOSMO-BBF 
While the benefits of LHS build and significantly expand on those put forward 
for EHR, the barriers described for both were similar. This tends towards confirming 
LHS are inheriting unresolved challenges from EHR. For this reason, this research also 
investigated the factors identified as facilitating EHR implementation to assess 
whether it is possible that these may aid in resolving LHS implementation challenges. 
This is discussed next.  
6.5.4 Enabling LHS 
The barriers identified by this study represent the substantive issues impeding 
implementation and adoption of LHS. However, few authors are asking the right 
questions, such as: how can health departments achieve subject matter expertise in all 
technology, legal, compliance and privacy aspects? Nor are they recognising that these 
issues must be resolved in order to achieve a secure data repository to support LHS 
[392, 84]. The literature contains abundant discussion of requirements or elements of 
a solution to one or more of the barriers, mostly revolving around calls for a new and 
common set of standards [392, 259]. Another key point is that while LHS are seen to 
have potential to significantly benefit the conduct of many types of clinical trial 
research, EHR were not discussed by any author as being beneficial in that same 
context. This, in spite of the fact that EHR are the constituent components for all LHS 
and are often where the patient data from clinical trials is recorded. However, we 
conclude that the absence of universal and effective LHS shows these barriers remain 
unresolved. While LHS have been developed that are intended to learn from evidence-
based literatures, patents, genomics and other non-patient data, LHS can only be 
successful in their ultimate goal of delivering ubiquitous individualised or personalised 
healthcare when data from EHR are made available. Data sharing to create large-scale 
data warehouses will only occur when clinicians and patients can trust that methods 
and systems used are protecting their privacy. Even then, ethics review processes may 
still impede the realisation of knowledge that can come from LHS. 
It became clear during this study that the majority of facilitation efforts are 
focused on human factors, and more specifically the mitigation of negative aspects 
arising from a general resistance to change. More facilitators fell within the Skills and 
Management aspect of ITPOSMO-BBF than any other: an aspect domain that 
primarily deals with staff, the skills they possess, whether these are sufficient to using 
the HIS being implemented, and the structure and style of management within the 
healthcare organisation [178, 179]. While many of these facilitators should lead 
towards a smoother and more successful implementation it is notable that while so 
much effort goes towards mitigation of barriers in this aspect domain, authors only 
ascribed the one benefit as arising from it: staff retention. This strongly suggests that 
the greatest mitigation effort results in the least amount of tangible benefit. Other areas 
described with benefits bringing more significant impact on patient safety, health 
outcomes and efficiency, such as those of the Process and Objectives aspects are left 
unresolved. Further research is needed to provide those implementing HIS with a more 
focused toolkit capable of mitigating a wider range of barriers and enabling delivery 
of the broadest possible benefits.  
It is for those involved in developing HIS to actively participate in counteracting 
the barriers and changing negative perceptions. The barriers and issues for LHS 
identified in this research were largely similar to those previously ascribed to EHR, 
with addition of the key issue that good quality EHRs are a necessity to enable LHS 
[23]. Variations on Meaningful Use legislation seen in the USA, UK and Australia are 
aimed at supporting use of EHR in LHS, motivating expensive government-operated 
national solutions like Care.data (UK), Shared Care Records (NZ) and MyHealth 
(AUS). While the cost to implement and maintain standardised EHR repositories in 
support of LHS may seem substantial, the cost savings promoted as justification for 
engaging LHS are potentially many times more significant [487]. Many government, 
academic and private organisations are funding research into novel health technologies 
aimed at realising the benefits identified by this study. A key theme within the 
facilitating factors for EHRs is clinician involvement, whether it be through early 
involvement, or ongoing as HIS are integrated into the patient care environment. Many 
health technology implementations have lacked the input and involvement of 
appropriate stakeholder group members. Seeking input from all stakeholders who will 
impact and be impacted by the HIS is a significant factor in reducing resistance and 
increasing adoption of technology that has the potential to help many [488]. While 
there has been a call for clinicians and their training organisations to engage with 
technologists, those working in the technology sector must be similarly called to seek 
clinician involvement [488, 489]. Clinicians and technologists must work as co-
investigators and leaders in the research and implementation of health technologies. 
Engaging each other as leaders and stakeholders to influence HIS design and 
implementation [489, 490].  
While this thesis starts from the premise that comparative review of the EHR 
implementation literature can provide a framework for analysis of LHS 
implementation, with the potential to increase the number of successful 
implementations, future work to extend this might also include comparison through 
analysis using other established quality improvement and change management 
frameworks. Such analysis was outside the scope of this particular work. 
 
6.6 SUMMARY 
EHR lack standardisation in many areas including content, structure and process. 
This lack of standardisation was clear in several key themes arising out of our 
investigation of the barriers, benefits and facilitators of EHR implementations. This is 
not only true for the processes and forms that are the structure of EHR, and which EHR 
inherit from CCPS, but especially true where it concerns the content, or data, that the 
EHR is used to collect, and the inability of most EHR software products to integrate 
and interoperate with other HIS. Prior to this research no similar effort had been made 
to collectively identify the barriers, benefits and facilitators of LHS. Comparative 
analysis of these for EHR and LHS produced two significant findings: (1) LHS are 
inheriting many barriers from EHR; and, (2) much of the work supporting EHR and 
LHS is targeted at human factors barriers, and given there was no suggestion that 
facilitators in one domain created benefits in another, little effort has gone towards 
facilitators that would resolve barriers leading to improved healthcare service 
efficiency, patient safety and health outcomes.  
LHS were conceived to capitalise on the large datasets of EHR held by many 
healthcare provider networks and state and federal health departments. While most 
potential LHS have been proposed or tested by researchers and healthcare services, it 
is possible that the lack of a standard terminology, nomenclature and definitions may 
have restrained many authors from identifying their health-AI/ML solutions as LHS. 
The proposed taxonomy can help researchers to standardise naming and presentation 
of LHS solutions, and was significant in developing the Heimdall Framework that 
identifies within the healthcare organisation the standard application for each LHS 
type. This supports the contention raised in the introduction of this chapter that as a 
concept becomes better documented and understood, standardisation can occur. 
 
Chapter 7: LAGOS Framework to guide 
integration of new healthcare 
tools 
When we have developed and implemented a new tool, and that tool has become 
established, and even after we have re-evaluated and standardised that tool, effectively 
integrating it with the other tools and processes currently in use can still prove 
exceedingly difficult [491-493]. In these situations it is common to investigate a 
framework that can inform and assist integration [492, 493]. This thesis has presented 
a number of new tools. However, on reflection, an additional framework is necessary 
to inform integration of these tools into healthcare practice. This chapter presents 
LAGOS, a pathway-based framework that uses the established levels of medical 
practice to guide integration and application of each of the primarily clinically-focused 
tools of this thesis. 
Section 7.1 introduces Pathway Theory and the LAGOS framework and 
describes the construction of each of LAGOS’ five pathways. Section 7.2 presents an 
instructional case study in the application of LAGOS in three key areas of 
contemporary health research: (1) the creation of realistic synthetic data for secondary 
uses; (2) patient risk and clinical decision modelling; and, (3) approaches to 
empowering patients as active participants in their own healthcare. 
 
7.1 LAGOS: BRINGING CCPS, EHR AND LHS TOGETHER  
7.1.1 Pathway Theory 
The use of a pathway theory and analytical framework helps highlight 
underlying values and fundamental relationships between otherwise fragmented 
concepts [494]. Different to the clinical or treatment pathways common to medicine 
and nursing, an application of pathway theory is designed around a consistent value or 
belief set [494]. In this case, we use the established levels of medical practice 
application [63, 495, 496] which are described on the Application Pathway. We start 
with this application pathway and use it as the basis for ordering all other pathways, 
bringing together the domains of LHS and CCPS and arranging them on the basis of 
how each function in the delivery of population, evidence-based or precision medicine. 
7.1.2 The LAGOS Framework 
LAGOS is an acronym drawn from the first initial of each of the five pathways 
shown in Figure 27. These pathways, described below, are Learning Health Systems, 
Applications, Guidance, Operational and Systems. They focus and converge on the 
individual patient presenting to the clinician, and broadly define the domain map 
covered by the LAGOS Framework. Each pathway radiates from the most general, or 
broadest application of that pathway’s scope, toward the centre, which represents the 
most specific application. Thus, within LAGOS, as the viewer moves along each 
pathway toward the patient in the centre, the focus of elements at each layer shift from 
a population-based focus that seeks interventions or approaches applicable to an entire 
population, to a precision medicine focus that can identify the most appropriate and 
curative intervention for the individual patient.  
 
Figure 27: The LAGOS Framework 
 
 The Application Pathway 
The pathway of medical practice and its ongoing shift from population medicine 
through evidence-based medicine (EBM) and on towards precision medicine, is best 
described in the title of Horowitz et al’s [495] paper From Evidence-Based Medicine 
to Medicine-Based Evidence. Population medicine effectively promotes those 
activities that will improve general health for an entire population [497], and may be 
impacted and influenced by policy and financial concerns [497] that are not always 
informed by clear or convincing scientific evidence [278, 279]. EBM focuses on 
informing clinicians’ practice with scientifically-proven current best treatment options 
for a particular condition. This has sometimes been characterised as a one-size-fits-all 
approach to medicine [63, 496]. EBM identifies the treatment or intervention that cures 
the largest number of patients with a given medical condition. Finally, precision 
medicine is an approach to customising medical treatment, basing the treatment 
decision on patient-specific factors [63]. Just as EBM is the scientific basis for and 
epidemiological application of population medicine [498, 495], precision medicine is 
seen to be the natural scientific evolution of EBM [63]. 
The System Pathway 
The system pathway supports our need for technology and learning in the 
provision and improvement of healthcare. In the outer arc is the computing technology 
on which everything else, including patient EHR, operate. On the next level the 
learning healthcare organisation employ learning approaches, research and trial 
approaches and stored EHRs in their goal of identifying new evidence-based 
knowledge and treatments. Proximal to the patient on this pathway are the LHS which 
are those systems presenting customised treatments for individual patients. 
The LHS Pathway 
The complete LHS taxonomy shown in Figure 14 is represented in the LHS 
pathway of LAGOS. At the outer edge is Surveillance, which operates as an automated 
alert process within Health IT systems that: (a) monitors the entire population’s EHR 
for diagnosis or clinical coding of a range of communicable disease; and, (b) can also 
be programmed to monitor for adverse treatment outcomes or drug reactions. Those 
LHS types at the second layer primarily work with or on the basis of EBM, or are used 
by clinicians in review of their, or other clinicians, treatment outcomes. This includes 
Cohort Identification which is most often used within learning health organisations to 
identify groups of patients who share one or more similar characteristics of interest. In 
the smallest circle are those LHS proximal to the patient which can be engaged by the 
clinician in the direct conduct of patient care. These models support personalised 
clinical decision making and predict risks and outcomes for an individual patient 
receiving the clinician-selected treatment. It is these LHS that meet the true definition 
of precision medicine. 
The Guidance and Operational Pathways 
CCPS are documents that define healthcare policy and procedure. They are 
arranged in the hierarchy shown previously in Figure 10 which describes both their 
distance from the patient and inherent operational nature. For example, policy is 
furthest from the individual patient in that it is set by governments to guide health 
services for entire populations. Policy also possesses the quality of being the least 
operational as they are the most general and least likely to be grounded on scientific 
evidence. CCPS may also be described based on their inherent nature; that is, whether 
their primary intention is only to provide guidance, or be operational and therefore 
engaged in clinical practice. Policy, and the levels of CPG discussed in Section 5.1.2, 
operate primarily in the guidance space and are presented on the Guidance Pathway 
based on their proximity to the patient. Policy is population-based while local CPGs 
are closest to the individual patient. There is overlap between the guidance and 
operational pathways in that local CPGs can also be seen with an operational content. 
On the Operational Pathway, local CPGs are observed at the population end as they 
would be applied to the general population of the health service or district who are 
diagnosed with that particular condition. Care plans, clinical pathways and clinical 
decision rules are found centrally along the pathway as they primarily focus on the 
diagnosis or condition and present with templated, general or recommended 
interventions applicable to the entire cohort. Caremaps and treatment protocols that 
have options that are selected based on individual patient need or treatment response, 
are accordingly are found closest to the patient. 
 
7.2 LAGOS: CASE STUDY 
7.2.1 LHS in the context of generating the Realistic Synthetic Electronic Health 
Record  
Accessing EHR for secondary use purposes such as non-clinical research, patient 
or disease modelling or AI training presents with challenges: (i) the challenge of 
achieving ethics approval for access to collections of EHR; (ii) a practical difficulty 
when consent is required from each individual patient; and (iii) over-reliance on 
anonymisation as a privacy-protection mechanism can reduce or remove important 
contextual detail. The CoMSER Realistic Synthetic Electronic Health Record (RS-
EHR) [269] and ATEN Realism in Synthetic Data [499] projects operate following the 
approach described in Figure 28 and focus on satisfying the need for access to EHR 
for secondary uses relying on a privacy-preserving knowledge-intensive method to 
generate locally realistic, but not real, synthetic EHR without needing access to the 
real EHR. 
The relationship between LHS and RS-EHR can be two-way. LHS can help to 
provide the aggregated statistical data and knowledge described as rules and 
relationships that exist in EHR datasets. In this way, RS-EHR generation need never 
be exposed to real EHR during the definition or generation of synthetic EHR. 
Conversely, LHS can be built, trained and validated by projects like PAMBAYESIAN 
using collections of RS-EHR, prior to being productionised to work from real patient 
data for patients and clinicians. 
 
Figure 28: The ATEN Approach to RS-EHR Generation [499] 
 
The LHS paradigm allowed us to fully exploit the routinely collected data from 
the healthcare system. This made development of knowledge-intensive methods for 
generating synthetic EHR successful, making it easy to create collections of realistic 
synthetic EHR for use in secondary uses where privacy concerns prevent release of 
real data. Further, development of knowledge-intensive models enables prediction of 
patient risk for particular negative outcomes and the recommending of appropriate and 
more effective treatments based on patient characteristics, history and current 
symptomatology possible. 
To fulfil RS-EHR’s aims the following LHS types from the LHS pathway, which 
apply to the levels of medical practice from the application pathway (in brackets) are 
needed:  
1. CI - learning evidence (EBM) and operating within the context of the 
Learning Healthcare Organisation level of the System Pathway to 
identify a prescribed cohort of patients with similar health conditions or 
characteristics such as demographics and symptomatology consistent 
with the disease to be modelled and generated; 
2. PD and ND - learning evidence (EBM) and operating within the context 
of the Learning Healthcare Organisation level of the System Pathway; 
of commonly used treatments, both effective and ineffective to ensure 
synthetic patients receive realistic treatments and outcomes. 
3. PPRM - specific to patient (Precision Medicine) and operating within the 
Learning Health System level of the System Pathway to identify patterns 
and model risk factors consistent with adverse events; 
4. CDSS - specific to patient (Precision Medicine) and operating within the 
Learning Health System level of the System Pathway to identify 
characteristics of synthetic patients that make them compatible for 
generation of specific disease or treatment outcomes; 
7.2.2 LHS in the context of Patient Risk and Decision Modelling 
There are numerous intelligent systems that may be capable of supporting 
clinical decision making for diagnosis, prognosis or treatment selection. Bayesian 
networks (BNs) are one such system [500]. BNs model uncertainty and allow the user 
to update prior belief, such as when assessing the probability for presence of a medical 
condition in light of new evidence (additional symptoms, risk factors and test results). 
However, the process of building these intelligent systems for chronic conditions is 
not yet fully explored and understood. The chronic condition presents as a particularly 
challenging clinical scenario as the patient’s condition must be monitored for extended 
periods during which many decisions may be undertaken. Ideally, doctors and nurses 
should be able to monitor patients without the resource-intensive, expense and 
inconvenience of clinic visits, except when such visits are necessary. Current clinical 
records and care processes do not easily receive, integrate or enable patients in the 
home to collect and transmit self-monitoring data from inexpensive sensor-based 
devices like the Apple watch and continuous glucose monitors. 
PAMBAYESIAN [367] is developing a new framework for distributed 
probabilistic decision-support systems. As shown in Figure 29, PAMBAYESIAN 
combines patient data with clinical expertise and patient input, for use in developing 
intelligent systems. The novelty of this framework is the use of “conventional” EHR 
(e.g. blood tests, imaging results) combined with near real-time continuous data from 
local sensors for learning and providing new knowledge. This allows for autonomy in 
a collaborative decision-making environment that includes clinicians and patients, 
enabling avoidance of unnecessary visits to a clinic or hospital. Referring to the 
Thresholds box in the top right corner of the figure, once the patient’s condition crosses 
the diagnostic threshold (in green), the clinician prescribes the treatment (in yellow) 
and treatment review (in red) thresholds. The patient self-monitors the parameters of 
their condition and enters these into the LHS application. If assessment and prediction 
of their condition rises above the treatment threshold, the patient receives treatment, 
be it medication or otherwise. If it rises above the treatment review threshold, the 
clinician is alerted that the patient requires review so that an appointment can be 
offered. 
 
 Figure 29: The PAMBAYESIAN Project as an LHS 
 
To fulfil PAMBAYESIAN’s aims the following LHS types from the LHS 
pathway, which apply to the levels of medical practice from the application pathway 
(in brackets) are needed:  
1. CI - learning evidence (EBM) and operating within the context of the 
Learning Healthcare Organisation of the System Pathway to identify 
patients with similar demographic and clinical characteristics; 
2. A CDSS - specific to patient (Precision Medicine) to collect and analyse 
daily data and operating within the Learning Health System level of the 
System Pathway to provide relevant patient feedback; 
3. A PPRM - specific to patient (Precision Medicine) and operating within 
the Learning Health System level of the System Pathway to predict 
potential future adverse events, for example, where treatment may fail to 
improve the patient’s experience. 
 
7.2.3 LHS in the context of Empowering Patient Participation in Healthcare 
Despite advances in modern medicine, many chronic conditions have generally 
proven incurable. The daily life of patients with chronic conditions is highly affected 
by disease progression; over time disease symptoms exacerbate until they overwhelm 
the patient. Patients must constantly evaluate their condition, making day-to-day 
decisions regarding care and relying on advice from their treating clinicians to guide 
those decisions. Again, despite medical advances, access to healthcare remains a 
significant issue for all patients. Regular appointments with doctors or nurses are time 
consuming, expensive, inconvenient and in many cases cannot be scheduled to 
coincide with times when the worst symptomatology may present. 
PAMBAYESIAN aims to empower patients to undertake day-to-day self-care 
within boundaries; diagnostic, treatment and treatment review thresholds that are 
defined by the patient’s clinician. As shown on the right side of Figure 30, home health 
monitoring devices and applications will be used to gather patient symptoms, 
measurements and reports about their condition, and with BN intelligence will tailor 
clinical knowledge and generate patient advices. In this way, PAMBAYESIAN will 
promote continuous monitoring of the patient's condition while supporting patient self-
management and engagement of timely interventions. PAMBAYESIAN also 
promotes a more effective and efficient interaction model between patients and 
clinicians whereby expensive and time-consuming clinic visits need only occur when 
a patient’s monitoring shows that their symptomatology has escalated and surpassed 
the treatment review threshold as discussed in the previous section.   
 
Figure 30: Using PAMBAYESIAN to Promote Patient Empowerment 
 
To fulfil PAMBAYESIAN’s aims the following LHS types from the LHS 
pathway, which apply to the levels of medical practice from the application pathway 
(in brackets) are needed: 
1. CI - learning evidence (EBM) and operating within the context of the 
Learning Healthcare Organisation of the System Pathway to identify 
patients with similar demographic and clinical characteristics; 
2. A CDSS - specific to patient (Precision Medicine) to collect and analyse 
daily data and operating within the Learning Health System level of the 
System Pathway to provide relevant patient feedback; 
3. A PPRM - specific to patient (Precision Medicine) and operating within 
the Learning Health System level of the System Pathway to predict and 
identify potential future adverse events. 
 
7.3 SUMMARY 
Medical practice has focused on health and wellness recommendations for the 
entire population (population medicine), and identifying the treatment that positively 
benefits the largest number of patients with a particular condition (evidence-based 
medicine). However, clinicians have recently realised that with the added insight of 
modern genomics and data science, these approaches are no longer sufficient. LHS are 
a recent concept with little more than a decade of research but limited exposure. LHS 
have the potential to completely change the way medicine is practiced by guiding 
treatment selection on characteristics of the individual patient (precision medicine) 
instead of focusing on the disease (EBM). This chapter set out with the aim of unifying 
LHS with the domains of medicine, clinical care, health informatics and decision 
science. The LAGOS framework successfully incorporates these domains within five 
pathways, each with three levels corresponding to how the elements within that level 
relate to the three application levels of medicine: population medicine, evidence-based 
medicine and precision medicine. This chapter also introduced the work of the 
EPSRC-funded PAMBAYESIAN project and shows aspects of PAMBAYESIAN as 
a case study demonstrating how such health informatics and decision science projects 
are and should be regarded as LHS. LAGOS is further grounded through application 
to three LHS examples, demonstrating that it describes the interaction between LHS, 
CCPS and medical practice. We believe that LAGOS can help those standardising 
healthcare services by identifying related elements on the other pathways. This can 
help when seeking the appropriate system or documentation on which to base an LHS, 
or an LHS that can help deliver a particular level of medical practice.  
  
 Chapter 8: TaSC: Towards a Standard for 
Caremaps 
This Chapter presents a standardised method, model and notation for caremap 
content, structure and development. Section 8.1 presents TaSC, the standardised model 
for caremap structure and content and a development lifecycle approach to 
standardising the process by which caremaps are developed. Section 8.3 discusses the 
background and basis for clinical decisions, and extends the TaSC model with decision 
points (DP) that graphically represent clinical decisions. Section 8.4 summarises and 
concludes the chapter. The TaSC model is evaluated later in Chapter 9.  
 
8.1 TASC: STANDARDISING CAREMAPS 
A search using the three terms observed across clinical documentation literature: 
‘caremap’, ‘CareMap’, and ‘care map’ was conducted using a range of databases. This 
search was supplemented using a citation search of the selected caremap papers. Once 
duplicates, papers not based in the nursing, medical or healthcare domains and those 
papers using the term ‘care map’ in other contexts were removed a core pool of 1215 
papers remained for this review. Initially, each paper was reviewed using CA and TA 
to identify and classify terminology, construction and content elements, and to infer 
the development process.  
8.1.1 Data Visualisation 
Graphically modelling the process of patient care for a given medical condition 
or hospitalisation event is not new, and approaches have been proposed utilising a 
variety of presentation styles, including: UML process modelling to represent the 
ongoing clinical management of a chronic condition [501]; business process modelling 
notation (BPMN) to visually map the treatment flow encapsulated in clinical pathways 
[502]; and, influence diagrams to model the structure of complex clinical problems, 
identifying decisions to be made, the sequence in which those decisions may arise, the 
information available to make the decision and the probability of uncertain events 
[503]. Caremaps model patient care, and while their presentation style and content has 
changed markedly since conception in the 1980’s, contemporary caremaps present as 
one example of an underdeveloped information visualisation approach currently used 
in clinical medicine [39]. Existing caremap visual modelling systems, in addition to 
lacking standardisation, generally lack comprehensive representation of all types of 
clinical decision points within the caremap. 
Graphical modelling, termed Information visualisation, is the study of 
transforming data, information and knowledge into visual representations that can 
more easily convey meaningful patterns and trends hidden within large and otherwise 
abstract datasets [504-507]. Depending on the style or information presentation 
approach used, information visualisation can provide the reader with an ability to 
immediately comprehend vast datasets and perceive emergent properties, patterns, 
new insights, causation, and problems within the data and the methodology used to 
collect it [505-507]. A 2011 report by the US Institute of Medicine (IoM) described 
information visualisation in clinical medicine as underdeveloped when compared and 
contrasted with other scientific disciplines [508]. 
8.1.2 Structure  
As discussed in Table 3, caremaps were transformed through the years from 
holistic and wordy texts [330, 318, 200] to illustrative graphs [16, 317]. This transition 
is shown in Figure 31, where the traditional caremap on the left requires completion 
of a large number of text-based fields, while the contemporary caremap on the right 
presents as a flow diagram of the care process for the clinician to follow.  
 
 Figure 31: Traditional text-based [330] and Contemporary flow-based [509] caremap comparison 
 
The vast majority of contemporary caremaps present either: (a) monochromatic 
like the right-hand example in Figure 31 [332, 320, 510], or; (b) as a full colour flow 
diagram like those shown in Figure 32 [511, 323]. The flow diagram represents a well-
known and long established process modelling tool [512].  
 
Figure 32: Colour caremap examples from [511] left and [323] right 
 
In general, each of these caremaps has its own set of boxes and notations, with 
the most common box presenting as a rectangle representing a care process usually 
described as an activity. Contemporary caremaps contain a set of activities that 
represent medical care processes; however, the literature shows that there is no 
consistency in the way an activity is represented. Different shapes such as rectangular 
boxes with rounded [205] or square [16, 325] corners, or even arrows [513] have been 
used. In some cases, activities that lead to multiple mutually exclusive pathways are 
represented by a diamond [201, 514, 510]. The flow from one activity to another is 
sometimes illustrated with arrows [332, 317] or simple lines [320, 201]. The literature 
lacks a clear description as to whether the caremap should present with clear entry and 
exit points. For some, neither is present [317, 325], while for others these points are 
an implicit [201, 514] or explicit [509] part of the diagram. Finally, most of the 
contemporary caremaps reviewed in this review contain multiple pathways and are 
often presented as multi-level flow charts [16, 509, 510]. 
Contemporary caremaps lack a consistent structure. A problem that is amplified 
by the absence of an established formal representational model for caremap elements. 
To begin resolving these problems the entity relationship diagram (ERD) in Figure 33 
was prepared to describe the relationship between structural elements of the caremap.  
 
Figure 33: Entity relationship diagram for the caremap 
 
Guided by the ERD and adapting the activity diagram representation from 
Unified Modelling Language (UML) version 1.0, which itself was an adaptation of 
Harel’s statechart [515, 516], Table 14 presents the representational notation for 
caremap elements, while Figure 34 presents the standardised structural model for the 
caremap. 
 
 
Table 14: Representational notation for structural elements of caremap 
 Element Description Notation 
1 Entry point Beginning of the caremap  
2 Exit point End of the caremap 
 
3 Exclusion 
point 
Exclusion from the caremap, 
as the patient does not belong 
to the targeted population 
 
4 Activity A care or medical 
intervention that is associated 
with a medical content type 
(see Table X in next section) 
 
5 Nested 
Activity 
An activity that has an 
underlying caremap  
6 Flow Transition from one activity 
to another  
7 Multiple 
pathways 
Flow from an antecedent 
activity to a number of 
successors from which the 
clinician must choose the 
most appropriate ongoing 
path 
 
8 Nested 
caremap 
connection 
Connection between an 
activity and its nested 
caremap 
 
9 Multi-level 
caremap 
connection 
Connection between a series 
of linked caremaps  
 
 
 
Figure 34: Structural model for caremaps 
 
8.1.3 Content 
Each node in the caremap represents a specific medical activity. Diagnosis, 
initial and ongoing treatment/monitoring are three archetypal medical activities most 
often represented in caremaps [310, 205, 514]. It is common for the caremap to contain 
a set of targeted outcomes, that is, points at which the patient exits the caremap (exit 
points) [16, 509, 325] with activities along a time scale, described either as a duration 
or inferred from the step-by-step ordered nature of the care process [323, 514, 510]. 
Finally, an explanation associated with the nodes (activities) or edges (arrows or paths) 
may be provided [317, 511, 325, 510]. This explanation serves to better describe the 
care being provided during the particular activity (node) or provides justification for 
the clinical decision to prefer one path (edge) over an alternative path. 
The three archetypal contemporary caremap activity types relate to a set of 
specifically ordered medical activities that may also collect related patient health data, 
as described in Table 15. The caremap content model demonstrating how the three 
archetypes relate, and the temporal nature of the activities is shown in Figure 35. The 
three types are represented on different caremap levels, while described medical 
activities are shown as the components of the caremap. This proposed standard content 
model represents the information that should be captured by the caremap.  
Table 15: Content type, activities and information captured in the caremap 
Content 
Type 
Activity  
 
Data/Information 
Captured 
  
  
 
 
  
  
Diagnosis 
Review patient 
records 
Demographics 
Medical history 
Collect patient 
history 
Family history 
Comorbidities 
Ask personal, 
lifestyle questions 
Habits (risk factors) 
Clinical 
examination 
Signs 
Symptoms 
Targeted exam Diagnostic test results 
Disease 
assessment 
Diagnosis 
  
 
  
  
Treatment 
Set goals Expected Outcomes 
Consider different 
interventions 
Possible treatments 
Consider potential 
complications 
Variances from 
expected outcomes 
Write prescription Selected treatment 
Treatment details 
  
  
 
  
Monitoring 
Review patient 
records 
Previous test results 
Previous symptoms 
Clinical exam Signs/Symptoms 
Targeted exam Diagnostic test results 
Evaluate goals Progression 
 
  
Figure 35: Content model templates for caremaps 
 
8.2 DEVELOPMENT PROCESS 
Despite the importance of standardising clinical processes, standardising the 
development process for contemporary caremaps has received very little attention in 
the literature. This review found that only one from every six caremap papers in the 
literature pool provides any detail regarding the development process. Some (n = 5) 
discussed their development process with some degree of deliberateness [125, 310, 
308, 517, 205]. From the others, the development process could only be inferred [320, 
319, 509, 325].  
Appendix C lists the caremap development steps described in the literature, and 
which authors described each step. The development steps have been clustered into 
three primary groups: (a) those undertaken before actual caremap development 
commenced; (b) those undertaken during development and refinement of the caremap, 
and; (c) those that come after the caremap has been refined and approved for 
implementation. The steps described have also been clustered into groups of fourteen 
like steps, those that appear similar or that may represent part of the same process step. 
The table also shows the order in which the particular author described undertaking 
each step, and from this the overall number of steps described or inferred from each. 
The proposed caremap development process presents with six distinct phases, as 
shown in Figure 36. During the initial preparation phase the conceptual framework is 
decided, the multidisciplinary team assembled, and training should be conducted 
covering the overall caremap development process. The next phase clarifies current 
practice for the condition or patient cohort and seeks to identify any existing or 
anticipated variance issues that may exist. A review of the available evidence is the 
final step prior to development of the draft caremap. Once developed, the caremap 
should be evaluated and with consensus, implemented into practice. As Figure 36 
shows, caremap development should operate as a lifecycle learning process. As new 
variance or evidence are identified, the process continues and the caremap is re-
evaluated and updated as necessary.  
 
Figure 36: Caremap development lifecycle 
 
8.3 EXTENDING TASC WITH CLINICAL DECISION POINTS 
The standard in TaSC for nodes within the caremap is that they represent 
activities conducted in the performance of patient care. However, nodes are often also 
seen to represent within their perspective one or more latent clinical decisions, 
described in this paper as decision points (DP), that the clinician may consider as part 
of selecting the treatment path for the individual patient. The existence of these latent 
DPs within caremaps, and the lack of an approach to identifying and representing them 
has already been noted [39]. This section explores these issues and presents an 
extension to TaSC for identifying and representing DPs along with decision criterion. 
The term allopathic medicine was coined by homeopathist Samuel Hahnemann 
in the 1800’s to describe with his own personal degree of disdain what he saw as the 
growing practice of science-based medicine: a practice that as early as the 1850’s was 
already being described as modern medicine [518, 519]. For as long as doctors have 
practiced modern medicine they have sought approaches, even graphical ones, for 
making quick, accurate and confident clinical decisions [520-523]. The diverse clinical 
presentation of disease, ever-increasing variety of potential treatment options, 
constantly changing opinions regarding those treatment options, and unlimited scope 
for patient response to treatment all complicate the clinical decision-making process 
[524, 525]. Patient care involves making a series of clinical decisions to determine the 
next treatment activity after consideration of all information available for this patient 
up to that point [526]. The more accurate, detailed and current that information can be, 
the more reliable the resulting clinical decision is and the closer the clinician comes to 
providing precision, rather than just population or evidence-based medicine [527, 
528]. 
Medical decision-making is inevitably performed under conditions of 
uncertainty. Where diagnostic tests are used to guide decisions, differences are often 
observed between the diagnostic and treatment threshold values being applied for a 
particular test result [529, 530]. The diagnostic threshold assists the clinician to 
estimate the probability that the patient has the disease, and evaluate whether further 
tests are required [530]. The treatment threshold is the point where the probability of 
disease is so high that treatment can no longer be withheld [529, 530]. Application of 
these threshold models in clinical practice guidelines (CPGs) and care pathways is 
often represented similarly to the if/then/else statements common to software 
programming. However, graphical presentation in a caremap requires multiple 
potential paths, some leading to different treatment options and others toward 
continued diagnostic evaluation. In every case, all outcome options for a diagnostic 
test must be represented. 
While not specifically describing an intention to do so, prior examples have 
attempted in part to address the need for contextualising the inherent, or latent, DPs in 
caremaps. Some provided the clinician with a graphical cue representing where a 
clinical decision needs to be made, while failing to provide the justification or 
necessary criteria that would help them to easily identify the best path for their patient, 
for example: Figure 37 from [509] which identifies decision nodes as a diamond but 
fails to provide detail to assist the clinician to know why a particular path must be 
followed.  
 
Figure 37: Example from [509] 
 
Others present quite granular justification for the threshold values or criteria to 
be considered when making clinical decisions, but they lack any visual cue for simple 
differentiation of DPs from standard activity nodes, such as the examples shown in 
Figure 38 from [531, 511, 323].  
 
 
Figure 38: Examples from [528] (left) and [508] (right)  
This work proposes that the way forward for integrating DPs into the TaSC 
caremap model is a combination of both approaches: (1) a visual cue for clinicians to 
easily identify when a clinical decision needs to be made combined with (2) easy to 
identify criteria that enables easy selection of the appropriate treatment path based on 
the accumulated knowledge regarding the current patient. We suggest that caremaps 
are more useful when the latent decisions that exist within the caremap, along with the 
criteria to support clinical decision making, are presented graphically as a standard 
component of the caremap model. 
8.3.1 Clinical Decisions 
There are many clinical decisions that might inhabit a particular caremap node. 
For example, a treatment activity may require the clinician to consider whether aseptic 
technique is required, which dressing to use or the selection of a clinical resource to 
assist during treatment. The majority of these decisions do not impact directly on the 
flow of care or the pathway of the patient within the caremap. In identifying DPs to be 
defined within the caremap we are concerned with those decisions that have an impact 
on the path to be taken by the patient: DPs that are critical to patient flow.  
Clinical decisions that may give rise to DPs in a caremap result from six aspects 
of clinical work identified by [532] as follows: 
 
Clinical Evidence: The identification and selection of clinical evidence from 
clinical trials and clinical practice guidelines for use in the creation of 
tools like caremaps necessitates decisions regarding how to gather the 
right clinical findings properly and interpret them soundly.  
Diagnosis: During diagnosis decisions are made regarding the selection and 
interpretation of diagnostic tests.  
Prognosis: Prognosis requires decisions of how to anticipate a given patient’s 
likely course.  
Therapy: Therapy decisions consider how to select treatments that do more good 
than harm.  
Prevention: Screening and reducing a patient’s risk for disease are prevention 
decisions.  
Education: Consideration of how to teach the clinician, patient or patient’s 
family what is needed fall within the remit of education decisions. 
 
8.3.2 Extending TaSC with Clinical Decisions 
Structure: Caremaps with DPs present as flow diagrams. The e-TaSC entity 
relationship model (ERM) that describes the relationship among structural elements of 
a caremap with DPs is shown in Figure 39. The extended TaSC structural elements 
and notation are presented in Table 16. The elements are inspired by the standardised 
pictorial elements seen in UML and hard state chart notations. The additional elements 
related to extending TaSC with DPs are shaded in grey. The standardised structural 
model of the caremap with DPs can be drawn from the updated content model shown 
in Figure 40. 
 
Figure 39: The TaSC ERM for the caremap with decision points 
 
Content: The same three main content types are captured in the extended TaSC 
model; diagnosis, treatment, and management/monitoring. As shown in Table 17, 
these broad content types are related to a set of specific medical activities and DPs. 
The additional DPs related to e-TaSC are shaded with grey. The supporting exemplar 
content model is shown in Figure 40. Each content type represents a different caremap 
level, while the activities and decisions are components of the caremap.   
 
Table 16: The extended TaSC representative notation 
  Element Description Notation 
1 Entry point Beginning of the caremap 
 
2 Exit point End of the caremap 
 
3 Exclusion point Exclusion from the caremap, as the patient does not belong to the 
targeted population  
4 Activity A care or medical intervention that is associated with a medical 
content type (see Table X in next section) 
 
5 Nested Activity An activity that has an underlying caremap 
 
6 Decision A cognitive process of selecting a course of action that is 
associated with a medical content type (see Table X in next 
section)  
7 Nested Decision A decision that has an underlying caremap 
 
8 Flow Transition from one activity to another along the pathway 
 
9 Multiple pathways Flow from an antecedent activity to a number of successors from 
which a decision point arises 
 
10 Decision Criterion Conditional values used to identify the path to be taken based on 
the clinical decision being made  
11 Nested caremap 
connection 
Connection between an activity and its nested caremap 
 
12 Multi-level caremap 
connection 
Connection between a series of linked caremaps 
 
 
 
 
  
Figure 40: The updated TaSC content model for caremaps with decision points 
 
 
Table 17: Caremap content 
Content 
Type 
Activity 
 (associated with Content Type) 
Decision  
(associated with Content Type) 
  
  
 
  
  
Diagnosis 
Review patient records     
 
Is there a suspicion of the targeted 
disease? 
Collect patient history 
Ask personal, lifestyle questions 
Clinical examination 
Targeted examination Has the initial suspicion been 
confirmed? 
Disease assessment 
  
 
  
  
Treatment 
Set goals  
 
Is the considered treatment going to 
be beneficial? 
Consider different interventions 
Consider potential complications 
Write prescription 
  
  
 
  
Monitoring 
Review patient records  
Have the goals been achieved? 
 
Is there a need to change the current 
treatment? 
Clinical examination 
Targeted examination 
Evaluative goals 
8.4 SUMMARY 
This chapter presented a solution for standardising caremap structure and 
content, and an approach for caremap development distilled directly from analysis of 
the CCPS literature. During the course of refining and evaluating TaSC the presence 
of DPs undescribed in the original caremaps specification and that can assist clinicians 
in identify the appropriate treatment path for patients, was realised. As a result, an 
extension to TaSC was developed to incorporate a standard approach to describing 
DPs relevant to path selection, and based around the six aspects of clinical work.  
If used consistently, the methods presented in this chapter will bring 
standardisation to caremaps and ensure that as clinical staff move between busy units 
in a tertiary care setting, they are not distracted from the patient in effort to understand 
the care flow model. Every caremap would be familiar and time can be given over to 
treating their patient, not trying to understand the document. Using TaSC and its 
extension as the example, standardisation is evaluated in the following chapter.  
 
  
Chapter 9: Evaluating TaSC: Studies in 
Caremap Development 
This chapter presents four case studies directly applying the TaSC standardised 
structure and development approach for caremaps proposed in Section 8.1. The first, 
a caremap for the labour and birth event, presents a simple and direct example that 
occurred prior to development of the TaSC approach. However, in development of the 
second case study in Gestational Diabetes Mellitus it was discovered that caremaps 
become more useful when the latent decisions that exist as divergences in the flow 
diagram, along with the decision criteria that identify the path to be taken, are 
presented. It was during development of this case study that the DPs extension 
presented in Section 8.3.2 was formalised. The third case study in Rheumatoid 
Arthritis was the first to be developed using the complete TaSC model. Finally, the 
fourth case study in trauma care proved to be the most complicated of the three, and a 
fine test case for more complex evaluation of caremaps generally, as well as of the 
refined TaSC approach. Each case study is evaluated quantitatively through recording 
and comparative reflection of a number of metrics, including the number of clinicians 
and information scientists involved and the total hours of each resource that were 
required to complete the caremap. As the fourth case study was also to play a structural 
part in the work presented in the clinical fellow’s own research, the opportunity 
presented for it to also be qualitatively assessed using a short convenience survey of a 
small number of experienced trauma clinicians. The resulting caremaps with decision 
points were seen to become an invaluable tool in the development of Bayesian 
Networks (BNs) for use as clinical decision support learning health systems. 
 
9.1 STUDY I: THE LABOUR AND BIRTH CAREMAP 
The labour and birth process represents an excellent example for a first-pass 
evaluation case study to assess the development process for caremaps. Labour and 
birth have easily defined start and end points, limited temporal variance, and a small 
number of easily identified treatment paths. 
9.1.1 Inputs 
Inputs for the labour and birth caremap were: (a) clinical practice guidelines for 
intrapartum care at Middlemore Hospital, Counties Manukau District Health Board of 
New Zealand (NZ); (b) clinical expertise and consensus from midwives and 
obstetricians who practice in that facility; and, (c) publicly available incidence and 
treatment statistics for that facility published annually by the Ministry of Health in NZ. 
9.1.2 Development 
An iterative development process was used wherein we created an initial version 
of the caremap based on the clinical practice guideline (CPG) and evidence derived 
from the treatment statistics. The initial caremap was revised and refined during a 
number of sessions with the clinicians. The resulting labour and birth caremap based 
on the Middlemore Hospital CPG is shown in Figure 41. 
 
 
Figure 41: Labour and Birth Caremap 
 
9.1.3 Validation 
The Ministry of Health in NZ annually publish aggregated and anonymised 
maternity and newborn data and statistics for each of the country’s birthing units and 
hospitals. These statistics are presented as a set of contingency tables whereby the 
possible birthing outcomes and clinical interventions are correlated with a whole range 
of demographic and clinical variables (maternal age at birth, ethnicity, deprivation, 
maternal BMI, obstetric interventions and so on). Using the 2014 data, we calculated 
the most likely treatment paths and care experiences for all birthing mothers at the 
Middlemore Hospital birthing unit. A state transition machine was developed and 
computerised, and realistic synthetic electronic health records (RS-EHR) for all 8,731 
mothers were synthetically generated [269]. The synthetic treatment paths for each 
woman were digitally compared against the caremap in Figure 41 to ensure a valid 
path solution could be resolved for every recorded birth. In this way we demonstrated 
that the caremap is representative of the entire range of patient presentations and 
treatment options as undertaken by clinicians and experienced by delivering mothers. 
9.1.4 Evaluation 
Evaluation metrics for development of the labour and birth caremap are provided 
in Table 18.  
Table 18: Evaluation Metrics for Caremap Development 
Metric No. Description 
Clinicians 3 Senior Practicing Obstetric Clinician  
Two Senior Midwives 
Hours with Clinicians 30 Over 24 weeks 
Hours without Clinicians 60 Over 24 weeks 
Iterations 7  
 
 
9.2 STUDY II: THE GESTATIONAL DIABETES MELLITUS CAREMAPS 
As part of PAMBAYESIAN [367] we are creating a Bayesian Network (BN) 
model [533] to predict treatment needs for individual mothers with gestational diabetes 
mellitus (GDM). The process initially required three caremaps, for: (1) the midwifery 
booking visit; (2) GDM diagnosis; and, (3) clinical management of the patient’s 
condition. Later, a fourth sequela caremap was developed for postnatal assessment and 
prediction of the likelihood of: (a) the mother going on to develop Type 2 Diabetes5 
(T2D) [534]; and, (b) the child going on to develop some form of diabetes6, either 
Type 1 Diabetes (T1D) or early-onset T2D [535, 536]. 
 
 
5 Women diagnosed with GDM have a seven-times greater risk of developing T2D postnatally (Lie, 
Hayes, Lewis-Barned et al, 2013).  
6 The prevalence of impaired glucose tolerance (IGT) is as high as 20% in some studies of children of 
GDM mothers (Plagemann, Harder, Kohler et al, 1997). 
9.2.1 Background 
GDM occurs in 2-25% of pregnancies [537, 538] and, depending on the 
diagnostic criteria used, rates across the United Kingdom (UK) may be as high as 17% 
[539, 538]. While the original definition for GDM was based on maternal risk for 
developing diabetes postpartum, newer glucose criteria have been developed based on 
risk of maternal and neonatal complications [540, 541]. While a number of 
international standards provide diagnostic thresholds for GDM, in 2015 the National 
Institute for Health and Care Excellence (NICE) published an updated guidance for 
diabetes in pregnancy [542]. The Barts Health Trust (BHT) CPG used in development 
of the GDM caremaps was based on this 2015 NICE guideline. 
9.2.2 Inputs 
Inputs for the gestational diabetes caremaps were: (a) a clinical practice 
guideline from Barts and The London Hospital in East London that is currently in use 
for the care of women with diabetes in pregnancy; and, (b) clinical expertise and 
consensus from midwives and diabetologists of the same facility. 
As part of the work undertaken on the PAMBAYESIAN project’s GDM case 
study, this author assisted another PhD student to undertake an AGREE II protocol 
review undertaken to assess the quality of CPGs that would contribute to 
PAMBAYESIAN’s CDSS [167]. AGREE II is a widely accepted and validated tool 
for assessing the methodological quality of CPGs [543]; however, it should be noted 
that it does not assess the implementation of that guideline. The AGREE II instrument  
[544] comprises 23 items arranged in 6 domains: (1) scope and purpose, (2) 
stakeholder involvement, (3) rigor of development, (4) clarity and presentation, (5) 
applicability, and (6) editorial independence. Responses are scored on a Likert scale 
from 1 to 7 (1 = strongly disagree, 7 = strongly agree). The AGREE II study’s primary 
focus, therefore, is less on the focus and more on the form of the guideline: who wrote 
the guideline, conflicts of interest, the processes used for evaluation of evidence, the 
quality and referencing of that evidence, and so on. The AGREE II committee cite 
these as primary issues that affect the quality and reliability of CPGs and their effect 
on the care delivered in hospitals. It has been observed that low CPG usage rates 
coupled with increased clinical resource wastage conflict with the CPGs primary 
purpose to such degree that issues of who wrote or funded its development and the 
processes they relied upon to select and evaluate evidence may not actually be 
impacting on the quality of care to any significant degree [545, 546]. It does not matter 
how well a guideline scores on the AGREE II protocol, AGREE studies are silent as 
to how well the guideline is being applied in clinical practice. 
Rather than seeking guidelines or guideline reviews from the literature, which in 
many cases only consider ideal guidelines from national or international non-clinical 
organisations (as well as those from medical associations, professional colleges, health 
insurance providers, government health departments, and so on), this guideline review 
sought a representative selection of local CPGs developed by, or required to be used 
by, clinicians in English-speaking western hospitals. The criteria for inclusion were 
that the document: (1) was explicitly identified as a guideline; (2) was produced by or 
for the hospital in an English-speaking country; (3) included diagnostic criteria and 
recommendations concerning gestational diabetes; (4) demonstrated some evaluation 
or inclusion of evidence; and, (5) was easily accessible over the internet to health 
service consumers. In addition, it was required that: (6) two CPGs from each country 
were identified. Where more than two from any one country met these requirements, 
those most recently updated were used. Given that all Canadian hospitals searched 
(n=11) referred to the same nationally developed Canadian Diabetes Association 
(CDA) CPG, its singular inclusion was allowed in order to assess the reason for its 
clinical popularity. The resulting CPG collection included two from each of AUS, NZ 
and the UK, and the single CDA CPG from Canada. These are listed in Table 19. 
All of the CPGs were assessed as having some deficiencies, most notably a lack 
of user involvement, assessment of resource implications and conflicts of interests, and 
an across the board lack of external review. It was positively noted that none of the 
CPG significantly deviated from recommendations of the national or international 
advising bodies on which their recommendations were based. The UK local CPGs 
broadly adhered to NICE recommendations, with minor refinements, or tweaks, in the 
BHT one which the CPG states is due to a patient population predominately classified 
as high-risk.  
Table 19: Reviewed Guidelines and URLs 
  Author Organisation Year Title 
1 AUS Royal Women’s Hospital (RWH) 2017 Management of Gestational Diabetes 
2 AUS King Edward Memorial Hospital (KEMH) 2017 Diabetes in Pregnancy 
3 NZ Auckland DHB (ADHB) 2013 Diabetes in Pregnancy 
4  NZ Hutt Valley DHB (HVDHB) 2015 Diabetes: Pre-existing and Gestational 
5 CA Canadian Diabetic Assoc. (CDA) 2013 Diabetes and Pregnancy 
6 UK Nottingham University Hospital (NUH) 2016 Management of pregnant women with diabetes 
7 UK Barts Health Trust (BHT) 2015 Diabetes - Pregnancy, Labour and Puerperium 
 
 URL 
1 https://bit.ly/2OcMFFJ 
2 https://bit.ly/2N1cAeJ 
3 https://bit.ly/2Iemf0J 
4  https://bit.ly/2xBuakU 
5 https://bit.ly/2IdXoud 
6 http://bit.do/exsYa 
7 http://bit.do/exsXy 
 
While the PAMBAYESIAN AGREE II study rated the Canadian CPG best 
overall [167], it lacked usability for application in daily care. Development of a 
practical care pathway and caremap would be necessary in order for midwives and 
obstetricians to consistently apply it in practice. The second-highest ranked CPG was 
from NZ ADHB. It provided simple and clear clinical pathway diagrams, but its use 
of URL links to other hospital documentation meant those sections could only be 
followed and understood by someone working within the hospital computer network. 
And while it provided detailed instructions for post-natal follow-up, it failed to provide 
appropriately detailed recommendations for foetal surveillance during the pregnancy. 
The UK CPGs were produced to be generally consistent with the recommendations of 
the NICE guidelines. As the NICE guidelines are already considered rigorous in their 
investigation and assessment of evidence, the UK guidelines scores were not impacted 
so much by the lack of evidence, but by the presentation, style and lack of adherence 
to the format prescribed by AGREE II and other CPG development protocols.  
The primary goal of this AGREE II assessment was to comparatively evaluate 
adequacy and appropriateness of the BHT guideline that would be used in production 
of the caremaps presented later in this section. The AGREE II outcomes showed that 
while it was due for updating, the BHT CPG was still of sufficient quality and recency 
to be highly suitable for this purpose [167].  
9.2.3 Development 
An iterative development process was used wherein the health informatician, 
decision scientist and midwifery fellow all worked together to deliver an initial version 
of the caremap based on CPG and clinical expertise. The initial caremap was revised 
and refined during a small number of sessions with the midwife and clinicians. As an 
example of the output of this process, Figure 42 presents the resulting caremap for 
clinical management of the patient diagnosed with GDM. 
9.2.4 Extending the Caremaps 
While using the caremaps to develop of BNs to support diagnostic and treatment 
decisions for GDM we found that the process was significantly easier and more 
efficient when the latent decisions embedded in each caremap were identified and 
included in the caremap. The GDM caremaps were redeveloped as caremaps with 
decision points. Figure 43 shows the resulting caremap with decision points for the 
midwifery booking visit, Figure 44 shows diagnosing GDM, and Figure 45 shows 
management of the diagnosed patient. 
 
 Figure 42: GDM Management Caremap 
 
 
 
 Figure 43: GDM Booking Visit Caremap with Decision Points 
 
 Figure 44: GDM Diagnostic Caremap with Decision Points 
 Figure 45: GDM Management Caremap with Decision Points 
9.2.5 Validation 
Validation was performed through consultation seeking consensus from three 
participating diabetologists with tertiary care experience treating obstetric patients 
under the CPGs used in development of the caremaps. The caremaps shown in Figures 
43-45 are those which expert assessment found to be correctly representative of the 
overall care process for these patients.  
9.2.6 Evaluation 
Evaluation metrics for development of the gestational diabetes caremaps are 
provided in Table 20. 
Table 20: Evaluation Metrics for Caremap Development 
Metric No. Description 
Clinicians 2 Senior Practicing Clinician  
Clinical Research Midwife 
Hours with Clinicians 14 Over 16 weeks 
Hours without Clinicians 27 Over 16 weeks 
Iterations 4  
 
9.3 STUDY III: THE RHEUMATOID ARTHRITIS CAREMAPS 
PAMBAYESIAN’s second, but this thesis’ third case study focuses on the 
diagnosis, initial treatment and ongoing management of Rheumatoid Arthritis (RA).  
9.3.1 Background 
RA is a chronic disease and presently the most common autoimmune 
inflammatory disorder in adults [547, 548]. The condition is characterised by 
progressive damage to the articular cartilage at the end of the bones, where they come 
together to form joints [547]. RA has a gradual but significantly detrimental effect on 
the patient’s ability to perform normal activities of daily living (ADLs), reduces 
quality of life (QoL), and increases mortality [548]. While there is significant year-on-
year development of new knowledge and treatments for the condition, a cure has thus 
far eluded clinicians [547, 548]. RA was therefore a suitable case study condition for 
PAMBAYESIAN as: (a) it is a long-term chronic condition; (b) has a large number of 
pharmaceutical treatment strategies that include steroids, non-steroidal anti-
inflammatories, disease modifying antirheumatic drugs (DMARDs), biologics, and 
vaccines; (c) it has patients with a large number of therapeutic, non-therapeutic and 
psychosocial needs that must be addressed in a community setting; and, (d) there is 
considerable day-to-day variability in the condition that must be modelled and 
understood in order for any potential intervention to be beneficial. 
9.3.2 Inputs 
Inputs for the RA caremaps were: (a) a current clinical practice guideline from 
Barts and the London Hospital in East London; (b) literature, including systematic 
reviews, for the condition and common treatment options published during the last 
three years; and, (c) clinical expertise and consensus from a senior rheumatologist and 
her practicing clinical research fellow.  
9.3.3 Development 
While development of the RA caremaps was also an iterative process, where the 
process differed from the GDM case study was that the information scientist performed 
considerably more self-directed research and used this to develop much larger portions 
of the caremap that were presented and reviewed regularly with the clinicians. Figure 
46 presents the diagnostic caremap, Figure 47 presents the initial management 
caremap, and Figure 48 provides the approach for ongoing management of RA. 
 
 Figure 46: RA Diagnosis Caremap with Decision Points 
 
 
 Figure 47: RA Initial Management Caremap with Decision Points 
 
  
Figure 48: RA Ongoing Management Caremap with Decision Points 
 
9.3.4 Validation 
As with the GDM caremap, validation was achieved through consultation and 
consensus of the participating treating clinicians.  
9.3.5 Evaluation 
Evaluation metrics for development of the RA caremaps are provided in Table 
21. 
Table 21: Evaluation Metrics for Caremap Development 
Metric No. Description 
Clinicians 2 Senior Practicing Clinician  
Clinical Research Fellow 
Hours with Clinicians 9 Over 16 weeks 
Hours without Clinicians 23 Over 16 weeks 
Iterations 3  
 
9.4 STUDY IV: THE HEMS TRAUMA ASSESSMENT CAREMAPS 
The Helicopter Emergency Medical Service (HEMS) is a physician-led and 
well-established component of trauma systems in most first-world countries [549, 
550]. Helicopters are capable of transporting the major trauma patient significantly 
faster than ground-based services, and while costly, this mode of transport is seen to 
have a significant impact on reducing mortality [551-553]. HEMS clinicians have a 
history of seeking algorithms to make critical life-and-death medical decisions (such 
as whether or not to amputate) in trauma care situations: these range from simple score-
based systems like MESS [554] which is based on observable symptoms and patient 
responses, through to complex CDSS built on medical AI or Bayesian Networks [555-
558]. HEMS crews are literally at the bleeding edge of critical care practice, and as a 
result, are often on the forefront of any new research that could make an appreciable 
difference in outcomes for their patients. 
9.4.1 Background 
When HEMS clinicians arrive on-scene a range of triage and treatment processes 
developed during the last several decades and refined into an ever-growing collection 
of mnemonic terms are engaged. Mnemonics are a memory-aid learning strategy: 
catchy phrases to prompt recall of a process or subject [559, 560]. Over the years 
simple mnemonics like ABC, which stands for airway, breathing and circulation 
[561], have been extended and enhanced by a variety of first responder and trauma 
care organisations. St John Ambulance first responder manuals added danger and 
response to create DRABC [562]. Military medics preferred the addition of a prefix 
for catastrophic haemorrhage [561], and later appended disability and exposure, 
resulting in the more comprehensive cABCDE [563]. Given that any effort to sequence 
prehospital care must faithfully report the activities of clinicians, and those activities 
are guided directly by these mnemonics, this case study set out to develop caremaps 
based on a number of prehospital care mnemonics.  
9.4.2 Inputs 
Inputs for the trauma care maps included: (a) a clinical reference textbook 
prescribed for prehospital emergency medical training [564]; (b) clinical practice 
guidelines issued by state or federal health authorities and intended for use by 
paramedics and ambulance personnel; (c) current literature on prehospital emergency 
care; and, (d) clinical expertise from a practicing trauma fellow.  
9.4.3 Development 
The trauma fellow determined which current prehospital care plans could be 
targeted. Two primary targets most commonly used in HEMS practice were resolved 
from his ongoing survey and interviews with prehospital emergency care clinicians. 
They were: (i) SCREAMER – Scene survey, Communicate, Read the scene, Everyone 
accounted for, Assess patients, Method of extraction, Evacuation route and Right 
facility; and, (ii) cABCDE – Catastrophic haemorrhage, Airway, Breathing, 
Circulation, Disability and Environment and Exposure.  
A textbook was located that described SCREAMER [564]. According to several 
clinicians interviewed by the trauma fellow, the nomenclature used in SCREAMER 
had been influenced by its authors’ experiences attending motor vehicle traffic 
accidents. Encouraged by the clinical experts, the caremap adapted from SCREAMER 
uses adapted language intended to ensure application in a much wider range of 
prehospital emergency care scenarios. The same textbook [564], along with a range of 
clinical literature [565-567], described the cABCDE primary survey approach. An 
initial overview caremap was created for each, and was refined during short 
consultations with the trauma fellow.  
 
 
The complete SCREAMER caremap can be viewed at:  
http://www.mclachlandigital.com/screamer.png 
The complete cABCDE caremap can be viewed at: 
http://www.mclachlandigital.com/cabcde.png 
 
9.4.4 Validation 
Initial review and validation was conducted with the trauma fellow and an 
experienced HEMS clinician. Once they agreed on the content of each caremap, 
extended validation was performed by the trauma fellow through a process of sending 
out the caremaps and inviting review by a select number of the prehospital emergency 
care clinicians who had been interviewed prior to and during the caremaps creation. 
Some minor modifications and ‘fine tuning’ was performed on the basis of these 
reviews that included the addition of clinical factors and symptomatology for a number 
of decision nodes, and a process loop for triage and treatment in situations involving 
multiple casualties.  
9.4.5 Evaluation 
Evaluation metrics for development of the trauma caremaps are provided in 
Table 22. 
Table 22: Evaluation Metrics for Caremap Development 
Metric No. Description 
Clinicians 1 Senior Practicing Trauma Clinician  
Hours with Clinician 7 Over 6 weeks 
Hours without Clinicians 25 Over 10 weeks 
Iterations 8  
 
 
9.5 TASC EVALUATION AND DISCUSSION 
9.5.1 Caremaps Resource Evaluation 
One approach to evaluating the effect of standardisation on caremaps is 
quantitative: we assess the time taken to develop the caremap and achieve consensus, 
and the overall cost of development. Table 23 brings together the metrics recorded for 
each case study, as well as the number of individual caremaps or caremap segments 
produced by each case study.  
Table 23: Evaluation Metrics Combined 
Case 
Study 
Clinicians Clinician 
Hrs 
InfSc  
Hrs 
Clinician 
Wks 
InfSc  
Wks 
Iterations Total 
Caremaps 
1 3 30 60 24 24 7 1 
2 2 14 27 16 16 4 3 
3 2 9 23 16 16 3 3 
4 1 7 25 6 10 9 12 
 
The initial caremap standard, TaSC, was developed during the period between 
case studies one and two. As TaSC was refined and familiarity increased, and even as 
the standard was extended with DPs, the time taken to deliver each individual caremap 
reduced. Table 24 shows that each component of the final case study’s two large 
amalgamated caremaps was developed with a per-caremap labour time of just 2.7 
hours. Similarly, when compared to the first case study, the final case study’s cost-per-
caremap reduced by almost 2700%. 
Table 24: Individual Caremap Cost and Labour 
Case 
Study 
Clinician 
Rate/  
Hr (£) 
Clinician 
Hrs 
Clinician 
Total  
(£) 
InfSci 
Rate/ 
Hr (£) 
InfSci 
Hrs 
InfSci 
Total  
(£) 
Total 
(£) 
Total  
£ Per 
Caremap 
Hrs  
Per 
Caremap 
1 84 30 2520.00 65 60 3900.00 6420.00 6420.00 90.0 
2 104 14 1456.00 80 27 2160.00 3616.00 1205.33 13.7 
3 104 9   936.00 80 23 1840.00 2776.00   925.33 10.7 
4 123 7   861.00 80 25 2000.00 2861.00   238.42   2.7 
 
9.5.2 Trauma Caremaps Evaluation Survey 
Modelling of clinical work flow processes, sometimes confusingly described as 
patient flow, is common, especially for emergency care, and serves an initial step in 
development of simulations that can assist clinicians and provider organisations to 
address problems [568-570]. While developing the trauma caremaps, the trauma 
fellow visited the offices of Kent Surrey Sussex Air Ambulance (KSSAA) and 
observed that their staff were engaged in an ostensibly similar work flow modelling 
process using post-it notes arranged in sequence across a large whiteboard to represent 
activity nodes. Their process flow focused on the clinician role: on ordering activities 
the HEMS clinician undertakes to prepare for, travel to, attend and care for the trauma 
patient. They included nodes for activities like dressing in their flight suits and 
checking and refilling medical equipment packs. In contrast, the caremaps presented 
in this thesis focus on care of the patient: on identifying the health issues, treatment 
and clinical response of the patient from arrival at the patient’s location through to 
transport of the patient to hospital. We preferred to focus on patient care because, while 
planning and training to get to the patient expediently is no doubt beneficial, there are 
only limited gains to be made here. We believe there are greater improvements to be 
found in understanding the processes and procedures that clinicians undertake in 
evaluating the patient’s condition and providing first-line care during what is described 
as the golden hour. 
Another approach to evaluating TaSC is qualitative: evaluation through 
responses to a convenience survey on the accuracy characteristics of the delivered 
caremaps and their decision points. The mnemonic caremaps from the fourth case 
study were evaluated through the operation of a survey instrument using a forced-
choice Likert scale. The survey questions posed to clinicians are found in Table 25. 
 
Table 25: Questionnaire for evaluating Trauma Caremaps 
Q Survey Response Prompt 
After viewing the caremap… 
Aspect Evaluated 
1 I find that the caremap faithfully reproduces the necessary 
structure represented in the mnemonic. 
Accuracy of caremap structure to 
mnemonic. 
2 I find that the caremap path progression is similar to the path a 
clinician would take in applying the mnemonic during 
assessment and treatment of the trauma patient. 
Accuracy of caremap path 
progression to actual treatment. 
3 I find that the placement and purpose of decision points within 
the caremap are similar to the decisions a clinician would make 
during each stage of the caremap. 
Accuracy of decision points in 
placement and purpose. 
4 I find that the criterion associated with the paths away from each 
decision point are similar to the diagnostic and treatment 
thresholds and other criteria clinicians would expect to find in 
the CPG used in the caremap’s development. 
Accuracy of decision point 
criterion to the CPG. 
5 I find that the caremap structure and path progression, and the 
placement and purpose and criterion for decision points when 
read together has neither conflicts nor inconsistencies as would 
be expected in the actual trauma patient treatment process. 
Accuracy and realism for the entire 
caremap with decision points and 
hence for the entire clinical logic 
flow. 
6 I find the caremap to be simpler and easier to use in practice 
than the CPGs and clinical literature its development was based 
on. 
Accuracy of claim that the caremap 
has utility in clinical practice 
 
   Participating in the survey were seven self-identifying experienced emergency 
and trauma clinicians. None of the survey respondents had any involved in 
development of the trauma caremaps. Similarly. none were exposed to the caremaps 
prior to completing the survey. In each case the clinician examined the SCREAMER 
and cABCDE trauma caremaps in answering whether the caremap possessed qualities 
similar to the CPGs, mnemonic sequence and actual care process flow. The results of 
the survey demonstrates that the caremap structure and path, when examined 
independently, are considered by clinicians to have accuracy 88% (Q1) and 76% (Q2) 
respectively, while the placement and purpose and criterion used to describe decision 
points were 86% (Q3) and 95% (Q4) accurate. The caremaps were assessed overall to 
be 93% accurate when all elements were examined jointly, and 95% (Q6) easier to use 
than the clinical documentation they were based on. Hence, this survey indicates that, 
for caremaps developed using the extended TaSC approach, practicing clinicians 
found a high degree of accuracy when examining the caremaps both independently 
and jointly. While the conclusion cannot be generalised due to the limited number of 
participants, it does provide support for the potential clinical utility of using the 
extended TaSC approach to deliver accurate caremaps. The survey response legend 
and individual responses are provided in Appendix E. 
9.5.3  TaSC Benefits, Limitations and Significance 
The TaSC approach is promising for efficient and standardised production of 
caremaps with high clinical accuracy. An important benefit is that TaSC is generic: it 
can be applied to any medical condition or practice. Extending TaSC with DPs 
increased the caremap’s utility, providing clinicians with a visual prompt for when 
significant clinical decisions must be made, as well as the evidence-based criteria to 
support selection of the appropriate treatment path for the current patient.  
The TaSC caremap is as robust, applicable and accurate as the CPG, medical 
literature and expert guidance allows. Different local health districts develop their own 
CPGs with diagnostic and treatment thresholds customised for the local population. 
One issue for application is that even when the caremap with DPs is based on a national 
CPG and evidence-based literature, the aspect of local CPGs and clinical expertise 
may colour the caremap and DP criteria with local influence that limits the resulting 
caremap’s general applicability. 
Of significance to TaSC is visual simplicity and standard appearance. We 
propose that if the range of caremaps appended to CPGs and in use within a facility 
were to be standardised using TaSC, clinicians could engage with TaSC caremaps in 
clinical practice without the effort that adapting to different presentation styles and 
notations as they move between units within the hospital must require. The presence 
of decision criteria acts as a simple CDSS, prompting the clinician with the path to be 
taken and next treatment activity required while still being entirely grounded in the 
CPG and evidence-based medical literature they would normally refer to. TaSC may 
have the potential to expedite treatment, improve treatment consistency and save time 
for both the patient and clinician. All of which reduces healthcare cost and resource 
consumption and improves the patient’s quality of life.  
9.6 SUMMARY 
This chapter has described four case studies in the development of caremaps. 
While the first case study provides a pre-standardisation baseline example, the latter 
three apply TaSC in assessment of the aims and objectives of standardisation of 
clinical documentation. The latter three were also developed within the context of the 
PAMBAYESIAN project: used as a formal approach to elicit expert information and 
validate the LHS designer’s understanding of clinical information prior to use in 
development of Bayesian-based CDSS LHS.  
Quantitative assessment showed that TaSC reduced the resources, significantly 
time and cost, required to produce the clinical caremap. Qualitative assessment with 
experienced clinicians found that the structure, care path, and DP in caremaps 
developed using TaSC were highly accurate and significantly easier to use than the 
CPGs the caremap was based on. TaSC-based Caremaps imbued with DP can be 
applied in clinical care as one type of LHS: a CDSS – prompting the clinical decision-
making processes with criteria for consideration and using the existing evidence to 
direct treatment.  
Developing caremaps with clinical experts along with the responses received 
from clinicians during the survey supports the research hypothesis that through 
standardisation of clinical documentation, we can support development and 
implementation of LHS.  
 
  
Chapter 10: Discussion and Conclusions 
The hypothesis for this research was that by understanding the ongoing barriers 
that have inhibited health IT implementation, it is possible to develop models to 
achieve the standardisation necessary for development and implementation of LHS 
with a new approach to standardising CCPS.  
Rather than approaching the hypothesis from the perspective of LHS alone, we 
began by investigating the primary source which EHR, the building blocks of LHS, 
were designed to replace: clinical documentation. While many healthcare 
organisations focused standardisation efforts on the stored data format or data entry 
method, these approaches have failed to deal with the original lack of standardisation 
at the source. Clinical documentation lacked standardisation. This is a flaw inherited 
by EHR that has been a significant barrier to adoption. The thesis has shown that 
understanding the barriers enabled development of models that can help integrate new 
technology tools into clinical practice, and that standardisation of the caremap in 
particular provides insight into a new approach that could truly lead to implementation 
and adoption of LHS. 
This chapter summarises why the thesis has provided strong support for the 
research hypothesis. It reviews the content and contributions and relates them back to 
the objectives defined in Chapter 1. It also describes how the chapters and 
contributions relate to the academic literature drawn from this thesis. The majority of 
these papers have, as at the time of submission, been peer reviewed and are, or are in 
the process of being, published. Chapter 3 described in detail the common 
methodologies applied throughout this research. Within each chapter the application 
of these methods is described, along with any methodology unique to the needs of that 
chapter’s research. Examples include the development and application of ITPOSMO-
BBF in Chapter 6, and the use of Pathway Theory in Chapter 7.  
 
 
10.1 REVIEW OF RESEARCH OBJECTIVES 
Objective 1: The Lack of Standardisation 
 
In chapter 4 we saw that research established a lack of awareness as to what 
constituted, and how to classify solutions as, LHS. It was also observed that only 
around half of the self-identified LHS literature reported on a developed solution, and 
of those, none were found to be in clinical use. In order to investigate standardisation 
as a causal issue or potential mitigant, it was first necessary to understand the 
fundamental elements of LHS, being EHR. We investigated their purpose and the role 
standardisation had, or should have had historically, in development of the clinical 
documentation underpinning EHR. In chapter 2 we established that EHR were 
originally intended to be digital replacements for much of the clinical documentation 
commonly used in healthcare. A review of literature in chapter 4 identified a lack of 
standardisation in the CCPS which EHR were developed to replace. This discovery 
underpinned the rest of the research.  
 
Objective 2: The relationships between CCPS, EHR and LHS 
This objective had four parts: (a) qualification of the relationship between CCPS, 
EHR and the more recent invention, LHS; (b) the role for standardisation in this 
relationship; (c) the role, or application, of each in clinical practice; and, (d) 
investigation of a unifying model that integrates CCPS, EHR and LHS and describes 
their relationship to the levels of medical application and treatment of individual 
patients.  
The direct relationship between CCPS and EHR was established in literature 
which showed that an important motivation for the development of EHR had been to 
create CCPS and capture patient data in digital form. Chapter 4 showed that the direct 
relationship between EHR and LHS was also already well understood as EHR are 
widely described as the basic building block necessary for LHS, which by definition 
seek to expose new knowledge from large datasets of EHR. The literature review in 
chapter 4 was the first comprehensive literature review of EHR and LHS. It also 
established that interdependent relationships and similar issues, suggesting inheritance 
of issues, exist between CCPS, EHR and LHS. As the relationships between CCPS, 
EHR and LHS were established, resolving the first branch of Objective 2. 
Determining the role standardisation plays in the relationships between CCPS, 
EHR and LHS first required investigation of the degree of standardisation currently 
present in each: a lack of standardisation in all was established in chapter 4. This lack 
of standardisation could also have been established through the gathering and analysis 
of CCPS and EHR implementation documentation directly from a range of hospitals. 
However, this additional step was unnecessary as much of the collected literature 
reproduced either extracts from or entire copies of exemplar clinical documents. From 
these it was possible to establish the vast differences in structure and content between 
examples of the same document type, supporting this thesis’ contention that 
standardisation was an issue.   
Resolving the remaining two branches of Objective 2 occurred 
contemporaneously, with each becoming apparent as the LAGOS framework 
presented in chapter 7 was developed. Investigation and identification of the 
relationships between CCPS, EHR and LHS clarified their connection to 
corresponding levels of medical practice.  
Objective 3: Standardisation as A basis for Learning Health Systems 
Meeting this objective required us to investigate, develop and evaluate an 
approach to standardising CCPS. Given the range of CCPS identified in chapter 5, it 
became clear that seeking to standardise all types would far exceed the thesis scope. It 
was therefore necessary to identify a single CCPS type that could serve as an example. 
Caremaps were chosen and an approach to their standardisation was developed and 
evaluated through several case studies. 
During work on the second case study presented in chapter 8 it became apparent 
that caremaps not only contain latent DP, but that identification and rendering of those 
DP would improve clinical understanding and overall utility of the resulting caremap. 
Six aspects of clinical practice from which clinical decisions arise had previously been 
identified [532]. Different approaches were observed for presenting criterion for 
clinical decisions on caremaps. However, activities identifiable as DPs were not 
always evident and no previous standard describing DP identification and presentation 
in clinical documentation of a graphical form was identified. 
 
10.2 CONTRIBUTIONS 
The novel contributions of this thesis can be summarised as follows: 
• Identification and characterisation for each type of CCPS identified from the 
literature, along with a taxonomy for CCPS incorporating a hierarchy and 
describing the relationship and heritance between each. The taxonomy and 
characterisation are applied through a case study examination of clinical 
documents for Type 2 Diabetes.  
• A taxonomy identifying the nine types of LHS, with validity demonstrated through 
classification of the self-identified LHS solutions identified during the literature 
review. 
• A unified framework, Heimdall, that describes how the nine types of LHS situate 
within the learning healthcare organisation and how LHS focus clinical practice 
toward delivery of precision medicine. 
• A new approach, ITPOSMO-BBF, that extends on the established ITPOSMO tool 
used in IT implementation gap and failure analysis, for comparing and contrasting 
the benefits, barriers and facilitating factors. A case study that applies ITPOSMO-
BBF to EHR and LHS implementations. 
• A unifying framework, LAGOS, using pathway theory for aligning the domains of 
medicine, clinical care, health informatics and decision science. These are 
incorporated within five pathways, each with three levels corresponding to how 
the elements of these domains relate to the three applications of medical practice: 
population, evidence-based and precision medicine. 
• A new approach, TaSC, for standardising the structure, content and development 
of caremaps. TaSC is used as a demonstration that standardisation of clinical 
documents can have both a beneficial effect on the application and use of the 
clinical document, and development and engagement with LHS. 
• A case study that applies the standardisation approach, TaSC, to a selection of 
caremaps developed and used in conjunction with clinical expertise to develop 
CDSS for the EPSRC-funded PAMBAYESIAN project. The results demonstrated 
great potential for clinical benefit as the standardised approach efficiently 
produced caremaps that clinicians found to be highly accurate and, due to their 
standard appearance, easy to engage with.  
 
10.3 FUTURE DIRECTIONS 
This thesis presents the TaSC approach and demonstrates it is repeatable. 
However, the method described is limited in application because it requires 
information scientists to lead the process and information technology tools that are 
non-intuitive for most clinicians. Future work should create online tools for developing 
caremaps that can be used in clinical research and patient care. Such tools would need 
to provide a user interface and intuitive approach that would allow clinicians to self-
create and validate caremaps adhering to TaSC. 
The TaSC approach presented in this thesis draws on CPGs and other clinical 
documentation to develop accurate caremaps. Caremaps have previously been used to 
create state transition machines (STMs) that, with the addition of incidence and 
treatment statistics, can be used to generate synthetic data described as the realistic 
synthetic electronic health record (RS-EHR). Populating the caremap is time 
consuming, as it requires locating and aggregating large sets of statistics for each node 
and arc of the caremap. These statistics describe the likelihood that a given treatment 
will be applied to the patient, the probability that this treatment will resolve the 
patient’s condition, and the likely path along the caremap that the clinician will select 
to progress treatment. Future work should investigate an accelerated solution to locate, 
aggregate and populate caremap nodes with knowledge from RCTs, systematic 
reviews and publicly available incidence and treatment statistics. Such a solution 
would represent a significant precision medicine LHS that could be used to position 
the patient within the caremap, and efficiently fine tune DPs in near real-time to 
demographic, risk and treatment response factors relevant to the individual patient.  
The work described in this thesis developed an approach to standardising one 
clinical document type and discussed its application in the creation of Bayesian-based 
CDSS; this is one type of LHS. While accuracy and engagement of the TaSC approach 
was assessed non-clinically with a small number of clinicians, future work in this area 
should involve assessment in the conduct of pre-clinical and clinical trials that evaluate 
the research outputs of projects that have used standardised caremaps as the foundation 
for developing LHS, like the EPSRC-funded PAMBAYESIAN. Such a study has been 
proposed under the title Accelerating Development of Improved Clinical Decision 
Support Applications for Diabetes (ADiCAD). This funding application was 
successful in its initial evaluation with Barts and The London Charity (BLC), and was 
invited to proceed to a full funding submission that the charity will evaluate late in 
2019.  
 
10.4 CONCLUSION 
The research and frameworks presented in this thesis have supported the research 
hypothesis by showing that, through understanding the barriers inhibiting health IT 
implementation, it is possible to develop models to achieve standardisation, mitigate 
the barriers, and increase acceptance of LHS.  
LHS could revolutionise healthcare through the potential of precision medicine 
to deliver advanced decision-making and predictive solutions; assisting health systems 
to reduce resource expenditure and improve patient experience and outcomes. 
However, like EHR before them, healthcare providers and clinicians have been slow 
to adopt LHS.  
A lack of awareness persists within the LHS domain which inhibits creation of 
a critical mass of researchers. While the number of proposed and published LHS 
solutions continues to rise, very few LHS have been used in clinical practice. The 
public failings of systems considered to be LHS, including IBM Watson and Google 
DeepMind, have made clinicians and patients wary of LHS solutions. Many also 
continue to express concern over potential privacy implications arising from the 
secondary use of personal medical data. LHS can only ever be as good as the EHR 
they data-mine for new knowledge, and the Triple-I issues of data integrity, integration 
and interoperability are another significant factor that presently restrain our ability to 
accurately develop new knowledge from EHR. 
While standardisation has been a successful approach used in a wide range of 
business applications, its application in healthcare has not always been accepted nor 
has it been entirely successful. Much of the focus of standardisation has been on the 
management of healthcare services and the approach to clinical practice through 
evidence-based medicine. However, directing standardisation towards those items that 
affect and record patient care, namely the clinical documentation, may be one way in 
which hospital management and clinicians can bring about the advantages of 
standardisation, successfully implement and engage with learning health systems, and 
realise the benefits precision medicine has to offer.   
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LHS: Benefits and Barriers 
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Enhanced collaboration with patients
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Improved communication between clinicians (sharing info)
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Unpredictable clinical course
Refusal to adopt/use (resistance)
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Caremap: Development Process Analysis 
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Identify Group of patients/condition/public health issue
Assess Viability of patients/disease for improvement
Decide conceptual framework
Assemble a multidisciplinary team
Challenge traditional practice
Clarify current practice/ situation
Common understanding on CPGs and knowledge among experts
Review and evaluate current data (benchmarks)
Anticipate potential complications
Identify key variances
Literature review
Identify patterns found in the literature
International Delphi studt: content validity
Grading of evidence
Assess the evidence (strength, availability)
Train nurses on how to develop care maps
Identify and manage Conflicts of Interest (CoI)
Transform evidence into policy
Add HPIP knowledge (care guidlines)
Translate into computer interpretable care guidlines 
Make artefact Organization-Specific (i.e. revising different Dx standards)
Add patient specific knowledge (instances of different OSCs)
CPGs are graphically represented through an authoring tool and a relational database
CPGs are translated into the workflow process definition language
WPDL code is used to build a Petri net -like structure
Develop an ideal pathway
Create discipline specific pathways
Create draft pathway based on experienced multidiciplinary team
detailed description of each intervention
Translate into a set of process
Reach consensus on the content and flow
Refine pathway using different multidisciplinary team from initial
Refine artefact using two or more voting rounds (Delphi Panel)
Refine pathway using external stakeholders
Multi-disciplinary consultation prior to implementation
Training before implementation
Piloting by multidisciplinary teams in different organisations
Put pathway to the test
Assess care map's usability principles
Identify problem areas based on the documented variances
Modifications based on observed viariations
Period of public comment and review
Assess long term information system needs
Revise CPGs
Implementation of care map /guideline
Assessment, revision and full implementation
IN-Practice (post implementation) evaluation and review
Periodic review of variance reports
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Appendix D 
Clinical Documentation Terminology Use (1993-2016) 
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Author (year) 
Goode (1993)     £  £ £    
Goode (1993) p5            
Goode (1993) p17    £ £       
Goode (1993) p215            
Giffin (1994)            
Giffin (1994)      £   £    
Seaberg (1994)            
Hydo (1995)      £ £     
Hydo (1995)            
Hydo (1995)            
Stiell (1995)  £  £        
Gordon (1996)     £   £    
Gordon (1996)            
Gordon (1996)            
Holocek et al (1997)   £  £ £  £    
Morreale (1997)     £ £  £    
Morreale (1997)            
Morreale (1997)     £     £  
Hill (1998)     £ £      
Chu et al (1998)            
Chu et al (1998)            
Denton (1999)   £  £ £ £ £    
Dickinson (2000)            
Dickinson (2000)            
Philie (2001)            
Philie (2001)     £   £    
Quaglini (2001)            
Lanzieri (2001)     £   £    
Trowbridge et al (2001)            
Micik (2002)      £  £    
Panzarasa (2002)            
Powell (2003)            
Jones (2003)            
Jones (2003)            
Li (2004)            
Li (2004)     £ £    £  
Beaupre (2004)     £ £      
Beaupre (2004)            
Van Herck (2004)     £ £ £ £    
Agrawal et al (2009)            
Agrawal et al (2009)            
Brehaut (2005)            
Repasky (2005)     £  £     
Ducharme (2005)            
Ducharme (2005)            
Dunning (2006)            
De Blesser et al (2006)     £ £ £     
Vanhaecht (2006)     £ £ £ £    
Tay (2006)     £  £ £    
Gaddis (2007)            
Sternberg (2007)            
Sternberg (2007)      £   £   
Mackey (2007)            
Kwan (2007)     £ £ £ £    
Richman (2008)  £  £        
Rotter (2008)     £ £ £ £ £   
Rotter (2008)            
Rotter (2008)            
Lougheed (2008)            
Lougheed (2008)            
Gemmel et al (2008)     £ £  £    
Isern (2008)            
Ebell (2010)            
Nakanishi (2010)            
Kinsman et al (2010)    £ £ £      
Kinsman et al (2010)            
Kinsman et al (2010)            
Kinsman et al (2010)            
Lodewijckx (2012)            
Tastan et al (2012)            
Tastan et al (2012)            
Huang et al (2012)            
Huang et al (2012)    £     £   
Huang et al (2012)            
Lockie et al (2013)            
Jarayaj (2013)            
Jabbour (2013)            
Jabbour (2013)            
Morrow (2013)     £ £      
Yu (2014)             
Yu (2014)            
Li et al (2014)            
Royall (2014)            
Carter (2015)            
Carter (2015)      £ £     
Wang et al (2015)            
Wang et al (2015)            
Roopsawang (2015)    £ £ £      
Buchert et al (2016)    £ £ £ £ £ £   
Buchert et al (2016)            
Dagliati et al (2017)            
Dagliati et al (2017)            
Gopalakrishna (2016)            
Gopalakrishna (2016)     £ £      
Solsky et al (2016)            
Alonso-Coello (2016)            
 
LEGEND: 
 = Narrative provided by the authors identified that these items were distinct/different 
£ = Narrative provided by the authors identified these items as the same or synonymous 
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Appendix E 
Trauma Caremap Survey 
 
 
 
Table 26: Survey Response Legend 
Value Text Description 
6 Strongly Agree 
5 Agree 
4 Moderately Agree 
3 Moderately Disagree 
2 Disagree 
1 Strongly Disagree 
 
 
 
Table 27: Survey Responses and Totals 
Clinician Q1 Q2 Q3 Q4 Q5 Q6 
1 5 4 5 6 6 6 
2 6 6 6 5 6 6 
3 5 4 4 6 5 6 
4 5 5 6 6 6 6 
5 6 5 5 5 5 5 
6 6 5 5 6 6 6 
7 4 3 5 6 5 5 
Potential 
Score 
42 42 42 42 42 42 
Actual 
Score 
37 32 36 40 39 40 
Percentage 88 76 86 95 93 95 
 
 
 
 
 
 
 
 
  
Appendix F 
Thesis Relationship to Published Works   
 
 
During the conduct of this research, much of the contributions contained herein 
have been presented and/or published in the academic literature. Figure 49 identifies 
the relationship between contributions presented in this thesis, and their publication in 
the academic literature. A given paper’s contributions may have been drawn from one 
or more chapters of the thesis. This often occurred because the research question and 
literature review that formed the basis of a published paper were contained in one 
chapter, and the new framework or research result are presented in another.   
 
Figure 49: Papers to Chapters Relational Diagram 
 
Paper 1: The Community Awareness Challenge identified that many authors 
were unaware that their health informatics solutions represented LHS, and that this, 
along with the lack of a complete taxonomy that would allow authors to identify their 
solutions within the LHS domain, was inhibiting development of a critical mass of 
researchers within the domain. This paper was published in the Journal of Innovation 
in Health Informatics (JIHI) in January 2018 and Google Scholar reports it has 
achieved five citations and currently has an Altmetric score of 7.  
 Paper 2: The Taxonomy and Hierarchy for CCPS reports on a literature review 
of CCPS nomenclature, types, content and usage. It presents the expanded De Bleser 
approach, a research methodology that was used to develop a taxonomy of the most 
common and necessary types of CCPS in contemporary use. It also presents an 
exemplar case study of CCPS for Type 2 Diabetes. This paper has been submitted to 
the Sage Health Informatics Journal (HIJ) and is currently in the review stage. 
Paper 3: The Heimdall Framework used an extensive literature review to resolve 
a taxonomy for LHS, and presented the unifying Heimdall Framework showing how 
the nine LHS types integrate with healthcare delivery and the learning health 
organisation in order to focus medical practice towards precision medicine. The 
taxonomy was validated through classification of all presented or proposed solutions 
self-identified as LHS in the literature. Heimdall was published in the 25th issue of the 
Journal of Innovation in Health Informatics (JIHI) in 2018 and Google Scholar reports 
it has already garnered five citations while Researchgate shows an additional citation 
bringing the total to six. Heimdall currently has an Altmetric score of 15. 
Paper 4: LHS Barriers, Benefits and Facilitators expands on the well-known 
ITPOSMO methodology for evaluating Information Technology projects, using it as 
the basis for ITPOSMO-BBF: a new approach to analysing barriers, benefits and 
facilitators for HIT implementations. ITPOSMO-BBF is applied to a comparison and 
analysis of barriers, benefits and facilitators identified during EHR and LHS 
implementations. The expansion on ITPOSMO presented in the paper was published 
with only minor changes by the Journal of Learning Health Systems (LHS) in early 
2019 and in only a few months has already achieved an Altmetric score of 15.  
Paper 5: Integrating LHS with Patient Care begins by providing a 
characterisation and conceptualisation for LHS and describing the LHS learning 
lifecycle. The paper goes on to present the LAGOS framework, which unifies LHS 
with the domains of medicine, clinical care, health informatics and decision science 
across five pathways. The relationships between each pathway are demonstrated and 
evaluated through three case studies related to the EPSRC-funded PAMBAYESIAN 
project. In October 2019 this paper was accepted for publication in the British Medical 
Journal of Health and Care Informatics (BMJHCI). 
Paper 6: Towards a Standard for Caremaps presents a standardised approach to 
caremap creation focusing on three key elements: structure, content and development 
process. The name of this approach has been abbreviated following the capitalisations 
in the italicised heading above, resolving to the acronym TaSC. The caremaps paper 
was presented at the 12th International Joint Conference on Biomedical Systems and 
Technologies (BIOSTEC) in Prague during February 2019. 
Paper 7: Incorporating Clinical Decisions provides a rational and description for 
resolving the latent decision points that inhabit activity nodes in the caremap.  
 
 
 
 
 
 
